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Abstract 
Abstract 
The assessment of quality of life as a primary outcome in cancer clinical trials is now almost 
universal. Such data are necessarily longitudinal and multidimensional, and are often severely 
unbalanced by missing values or early patient death. However, to date, their reporting in the 
applied literature has generally used simple descriptive summaries that ignore many of these 
complexities. Not only can these be misleading, but they generally do not allow firm 
conclusions to be drawn about a major endpoint. The aim of this thesis is to assess the practical 
application of recent developments in statistical methodology for the analysis of quality of life 
data collected using self assessment questionnaires within cancer clinical trials. Its emphasis 
is on the use of relatively simple and flexible tools that will allow more reliable and powerful 
inferences to be drawn from the data than is done at present. 
The principal statistical tools considered are random coefficient and marginal models. It 
is shown that these can be successfully used for the analysis of continuous, binary and ordinal 
responses. In particular, they offer a simple approach to the analysis of repeated multivariate 
outcomes and can be very easily extended to model the complex patterns of response that are 
often seen in following cancer treatment. 
In relation to the problem of censored quality of life as a result of patient death, analyses 
that attempt to combine the survival and quality of life endpoints in a single variable are 
contrasted with those that consider the two endpoints as a multivariate problem. It is shown 
how this latter model can provide a summary of the quality of life response conditional on 
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patient survival that with further work should have great application to such quality of life data. 
Finally, the problem of intermittent missing data is reviewed. The implications of missing 
data for some of the analyses presented in the thesis are assessed, and two models that attempt 
to determine the nature of intermittent missing data are developed. It is concluded that the 
problem of non-ignorable intermittent missing data presents a very challenging area of further 
research. 
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Abbreviations 
The following abbreviations are used throughout the text of the thesis. 
Abbreviation 
ALR 
ARx 
CI 
cov 
CRC 
CRC NSCLC study 
CRC HAP trial 
E-M algorithm 
FM 
FUDR 
F2 
GEE 
Gy 
HAD scale 
HAI 
K-M 
log lh 
MAR 
MCAR 
ML 
MRC 
MRC LU07 study 
MQL 
NMAR 
Definition 
alternating logistic regression 
auto-regressive of order x 
confidence interval 
covariance 
Cancer Research Campaign 
CRC non small cell lung cancer study 
CRC Hepatic artery pump trial 
estimation-maximisation algorithm 
multiple fraction radiotherapy (MRC LU07 study) 
fluro-deoxyuridine 
two fraction radiotherapy (MRC LU07 study) 
generalised estimating equation 
Gray (unit of radiation) 
Hospital Anxiety and Depression scale 
hepatic artery implant (CRC HAP trial) 
Kaplan-Meier 
log likelihood 
missing at random 
missing completely at random 
maximum likelihood 
Medical Research Council 
MRC non small cell lung cancer study 
marginal quasi-likelihood 
not missing at random 
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PQAS partitioned quality adjusted survival 
PQL penalised quasi-likelihood 
PSE present state examination 
QALY quality adjusted life year 
QAS quality adjusted survival 
Q-TWiST quality adjusted TWiST 
OR odds ratio 
REML restricted maximum likelihood 
(R)IGLS (restricted) iteratively generalised least squares 
RSCL Rotterdam Symptom Checklist 
SD standard deviation 
SE standard error 
SIP sickness impact profile 
TNQOL time with normal quality of life 
TWiST time without symptoms and toxicity 
WLS weighted least squares 
UWLS unweighted least squares 
var variance 
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Notation 
The following general notation is used consistently throughout the thesis. Any additional 
notation required, this is explained in more detail in the relevant section of work. 
Definition Symbol Dimension 
Indices 
Subject 
Measurement occasion (fixed for all subjects) 
Measurement occasion (different across subjects) t 1,..., mi 
Quality of life dimension I 1,..., L 
Ordinal response categories k 1,..., K 
Variables 
Response variable subject i at fixed occasion j 
Response variable subject i at time t 
Response vector for subject i over fixed occasions j=1,..., m 
Response vector for subject i over variable occasions t= 1,..., m, 
Response vector for all subjects over fixed occasions 
Yp 
Yu 
yr 
yj 
Y 
real 
real 
lxm 
lxmr 
1 xnm 
1 xM 
n 
(M=ý mr) r=i 
mxp 
Response vector for all subjects over variable occasions y 
Matrix of p explanatory variables for subject i xi 
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1 Introduction 
The use of quality of life assessment in clinical trials has become increasingly common and 
'quality of life' is now included as a primary endpoint in the protocol of many clinical trials. 
Based on a search of the literature and previous work by Fayers and Jones (1983), Schumacher 
et al. (1991) reported on the steadily increasing number of articles which use the term 'quality 
of life' in the title, or as a keyword, from 1982 through to 1989. Since 1989, this trend has 
continued and is highlighted by the number of special conferences and symposia that have 
recently taken place, as well as the introduction of the quarterly journal 'Quality of Life 
Research' in 1992. 
This increase in use illustrates a realisation that the quality, as well as the quantity, of 
survival is important in the evaluation of treatment efficacy, and is particularly relevant in 
cancer clinical trials because of the often very aggressive and invasive treatment regimens that 
patients face. Moreover, there remain many cancers - for example, non small cell bronchial and 
gastrointestinal - for which no decisive chemotherapeutic treatment has been found. Therefore, 
palliation is the primary concern of treatment in these areas, and alongside symptomatic relief, 
patient quality of life is the main outcome of interest. 
The definition of the term `quality of life' was up until recently vague and was applied in 
many different contexts including the level of patient side-effects or toxicity, the degree of their 
symptoms, as well as their overall well-being. A consensus has now been reached that the 
outcome of interest is health related quality of life, which should be considered as 
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1. multidimensional. comprising important elements of a patient's emotional, social 
and physical well-being; 
2. subjective. relying primarily on the patient's own judgements; and 
3. non-static and subject to changes over a patient's lifetime. " 
(Olschewski et al., 1992). It is also suggested that, dependant on the nature of disease and 
treatment regimens under research, it may be appropriate to include symptoms and side effects 
of treatments - such as vomiting and pain - as well as patient satisfaction with the treatment 
received within a quality of life assessment (Hayfield et al., 1992, Girling et al., 1994). 
If quality of life is best assessed by the patient, ideally this will be done by interview or 
present state examination (PSE) (Fallowfield, 1990). However, time constraints on both 
clinician and patients, as well as cost, mean that in clinical trials this is rarely feasible. The 
solution has been self assessment questionnaires which can be easily completed by the patient 
with or without supervision. 
There exist a large number of such quality of life measuring instruments. Some of these are 
classed as generic and question general aspects of quality of life, whereas others are more 
disease specific and relate to particular symptoms or problems posed by the disease in question. 
For example, the Hospital Anxiety and Depression (HAD) scale (Zigmond and Snaith, 1983) 
is a generic instrument, whereas the Rotterdam Symptom Checklist (RSCL) (de Haes et al., 
1990) is disease specific and deals primarily with items relating to issues concerned with the 
treatment of cancer. 
The questionnaires are comprised of a number of questions or items which address different 
aspects or dimensions of patient quality of life. Responses to these items are either binary 
(yes/no) or on a given ordinal scale. As an example, a typical item relating to patient anxiety 
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Box 1.1 
Typical item from the HAD scale 
"I get sudden feelings of panic 
(3) Very often (2) Quite often (1) Not very often (0) Not at all" 
from the HAD scale is given in box 1.1. 
Using factor analysis or subjective reasoning by the questionnaire designers, many of these 
instruments then allow weighted or simple summations of these individual items to give 
summary scores for overall, or dimension specific, quality of life. For example, the HAD scale 
consists of fourteen items all measured on a four point ordinal. scale. By summing the ratings 
of seven of these items, a summary depression score is obtained. The remaining seven items 
can be similarly aggregated to give an anxiety score. In contrast, the Sickness Impact Profile 
(SIP) (Bergner et al., 1981) involves weighted summaries of binary responses for 136 items 
relating to 12 dimensions of patient quality of life. For some instruments, recommended 
boundaries for a `normal score' in each dimension are also available. For example, with the 
anxiety and depression scores on the HAD scale, a score s7 is deemed to be normal, a score 
between 8 and 10 suggests a possible case of clinical anxiety or depression, whereas a score 
z 11 is considered to identify definite cases. 
All of the instruments used in medical research have undergone assessment of validity, 
reliability and responsiveness. For a particular instrument, this means that: (i) it measures what 
it was designed to measure (validity); (ii) on repeated use on the same subject under identical 
conditions it produces the same result (reliability); and (iii) it will be able to exhibit changes 
in underlying response that do occur (responsiveness). Rather than developing new 
29 
Introduction 
instruments, it has been advocated that in study design, use should be made of existing 
instruments where possible. This not only the saves time and resources involved in reinventing 
(and validating) tools which already exist, but it should make it easier to compare quality of life 
across studies (Aaronsen, 1989). As the focus of this work is on the analysis of quality of life 
data, the evaluation and validation of the quality of life measurement instruments which have 
been used for data collection are not considered further. Details of validation techniques have 
been given by Bowling (1983), Bergner et al. (1981), Chinn and Burney (1987) and Guyatt et 
al. (1991). Reviews of the practical use of available instruments have been done by Fallowfield 
(1990), Bowling (1983) and, on behalf of the MRC cancer therapy committee working party 
on quality of life, by Maguire and Selby (1989). 
A comprehensive review of the analysis of quality of life data and associated problems was 
given by Cox et al. (1992). This review and subsequent discussion, examined the important 
issues which need to be addressed for analysis of quality of life data. With the focus on the 
practical application of recent developments in statistical methodology, the work of this thesis 
will address four particular areas of concern raised by these authors. Namely, the analysis of 
repeated measurement data, multiple dimensionality, patient dropout due to death, and missing 
data. Each successive chapter will tackle a distinct problem and hence the relevant literature 
is reviewed therein. The objective of the thesis is to provide a detailed account of the practical 
use and extension of new statistical methods for the analysis of self assessed quality of life data, 
for cancer clinical trials in particular. For this aim, the work is presented in terms of examples 
using quality of life data collected in three recent cancer clinical trials. Although concise 
details of each trial are given in Appendix 1, a brief outline of each is included here. 
Descriptions of the quality of life measuring instruments which were used in each study are 
given in Appendix 2. 
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The first study is the Cancer Research Campaign, Clinical Trials Centre, non-small cell lung 
cancer trial (CRC NSCLC). This is a randomised trial designed to compare the results of 
palliative radiotherapy in patients with previously untreated non-small cell lung cancer. In the 
first randomised group (denoted split course) patients were given an initial intensive dose of 
radiotherapy. They were then re-assessed at 4 weeks. If they were considered well enough, 
they underwent a second randomisation which determined whether a second intensive dose was 
administered. Patients in the second randomised group (denoted continuous course) received 
the standard 4 week continuous radiotherapy course. Quality of life was measured using the 
HAD scale and the RSCL. This was done before the start of treatment and then weekly for an 
eight week period. 82 patients were entered into the study, 42 to receive the continuous 4 week 
course and 40 the split course. Within the examples used in this thesis, the added complication 
introduced by the second randomisation in the split course group will be ignored, and the data 
analysed according to the two main randomisation groups. No difference in patient survival 
between these two groups was seen. 
The second study (CRC HAP) also comes from the Cancer Research Campaign, Clinical 
Trials Centre, in collaboration with the Charing Cross and Westminster Medical School. The 
objectives of the study were to assess the survival, quality of life and tumour response in 
patients with colorectal hepatic metastases who were treated by intra-hepatic arterial fluro- 
deoxyuridine (FUDR) infusion (denoted HAI) compared with that in patients receiving the 
conventional symptomatic treatment (denoted control). Quality of life in the study was 
measured prior to randomisation, and monthly at the same time as clinical follow-up. Three 
measurement instruments were used in the study: the SIP, the RSCL, and the HAD scale. Only 
the data from the RSCL and the HAD scale are used in this work. 100 patients were entered and 
randomised into the study, 51 to the HAI group and 49 to the control group. A survival 
advantage for the HAI group with no apparent difference in quality of life was reported by the 
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study investigators (Allen-Mersh et al., 1994). 
The final data set comes from the MRC lung cancer working party (MRC LU07). Once 
again it is concerned with the palliative care of patients with non-small cell lung cancer. The 
aim of this study was to assess whether radiotherapy given in two fractions one week apart 
(denoted F2) gave equally good palliation as a conventional multiple fraction course (denoted 
FM). Self assessed quality of life in the study was measured daily using a diary card (Fayers 
and Jones, 1983) from the start of treatment and for six months thereafter. 369 patients were 
entered and randomised into the study, 184 to receive the shorter course (F2) and 185 to receive 
the conventional treatment (FM). The results of the study (Bleehan et al., 1991) showed no 
evidence of a survival difference between the two treatment arms. Descriptive analyses of 
quality of life data highlighted transient dysphagia following treatment in both groups, but no 
evidence of a palliative gain of the conventional longer dose to the shorter dose was reported. 
Further details of the quality of life in each of these studies is given in Chapter 2 using 
descriptive analyses that are typical of those which have generally been used in the reporting 
of quality of life in the literature. The use of such descriptive techniques is reviewed in the 
chapter, along with a discussion of their relative merits in addressing the four issues of concern 
outlined by Cox et al. (1992). 
Chapters 3,4 and 5 concentrate on the analysis of continuous, binary and ordinal repeated 
measurement data respectively. In Chapter 3, the use of random coefficient (hierarchical) 
models (Goldstein, 1986, Goldstein, 1995, Longford, 1995) for the analysis of unbalanced 
univariate repeated continuous outcomes is demonstrated. This is then extended for the 
analysis of multidimensional outcomes. These analyses use the overall summary scores from 
the HAD scale and RSCL in the CRC NSCLC study. In Chapter 4 random coefficient and 
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marginal models, in the form of generalised estimating equations (Liang and Zeger, 1986), are 
used for the analysis of binary repeated measurement data for the univariate case. Once again, 
this work is then extended to the multivariate case. Also covered in this chapter, is the analysis 
of complex patterns of response which are often seen in quality of life data in cancer trials as 
a result of the invasive nature of the treatment (Girling et al., 1994). The data used in the 
chapter come from a dichotomisation of the ordinal responses obtained from individual items 
of the RSCL in the CRC NSCLC study, and the daily diary card in the MRC LU07 study. In 
Chapter 5, this work is extended further for the analysis of repeated ordinal data (Ware et al., 
1988, Zeger, 1988). Once again this work uses the responses obtained from individual items 
of the RSCL in the CRC NSCLC study. 
In Chapter 6, the problem of patient dropout due to death is addressed. As a result of the 
severity of patient disease in cancer clinical trials, patient death during the study is often 
inevitable. This makes interpretation of the available quality of life data difficult, as well as 
being a possible source of bias. In this chapter, statistical methods for the analysis of 
longitudinal data subject to dropout (Diggle and Kenward, 1994, Little, 1995, Wu and Carroll, 
1988, Schlucter, 1992) are reviewed, and their relevance in solving the problems faced in the 
analysis of quality of life data are assessed. As an alternative approach to the same problem, 
analyses which combine quality of life and survival to a single endpoint are also reviewed. The 
appropriateness of such quality adjusted survival analyses have been a source of conflict in the 
literature but have been rarely used in practice for the analysis of self assessed quality of life 
data (Cox et at., 1992, Schumacher et al., 1991). The data used for this work are that of the 
CRC HAP trial. As full survival and quality of life data are now available for this study, the 
problems faced as a result of patient death during follow-up are easier to combat. In order to 
recreate the more realistic scenario often faced in the light of patient death - that is, individuals 
for whom survival is censored - this full data set has been restricted to contain only information 
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on patient survival and quality of life available on June 1st 1993. Patients still alive at this time 
were considered censored and any quality of life data they provided beyond this date was 
ignored. When used, this data set is referred to as the 'restricted' data, whereas the complete 
data set is referred to as the `full' data. 
The repeated assessment of quality of life data over a long period of time, in a group of 
patients who often become too ill to complete questionnaires, means that quality of life data is 
often subject to large amounts of missing responses. For example, Hurny eta!. (1992) reported 
compliance rates varying between 37% and 58% at each measurement occasion, and reports on 
behalf of the MRC lung cancer working party of studies gave daily compliance rates of about 
70% (MRC lung cancer working party, 1989,1991 a, 1991b, 1992). In the work presented in 
Chapters 3 to 6, it is assumed that the problem of missing data can be ignored, and the 
occurrence of missing data considered only as an issue which generates unbalanced data. It has 
been well documented in the literature however, that the bias implications of missing data may 
not be ignorable and will depend on the underlying reasons for data being missing (Rubin, 
1976, Laird, 1988). In Chapter 7, the issues raised by the assumption of ignorable missing data 
made in Chapters 3 to 6 are formally addressed using data from the CRC NSCLC study. 
Each chapter is concluded with a summary of its main results and a discussion of the issues 
raised. Finally, in Chapter 8, the implications of the work as a whole are considered in the 
context of issues that may be useful for further research. 
It should be noted that the emphasis throughout the thesis is on the practical application and 
interpretation of statistical methodology for the analysis of quality of life data, rather than the 
future treatment implications of the quality of life results presented in each example. These 
examples should therefore be seen as a demonstration tool, as opposed to a means of drawing 
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conclusions for the purpose of directing the treatment of patients. This is particularly important 
in the case of the CRC NSCLC study for which the precise treatment schedules have not been 
considered, and also for the CRC HAP trial which is presented in an incomplete state. It is also 
recognised that the small sample size and extent of missing data in the CRC NSCLC study, 
mean that these data do not justify the depth of analysis which are presented here. 
All data analyses presented use MLn (Rasbash and Woodhouse, 1995) and S-Plus statistical 
software (Becker et al., 1988). OSWALD (Smith and Diggle, 1994), an additional library of 
S-Plus functions for the analysis of longitudinal data is also used. Any further statistical 
programming that is required for data analysis is presented in Appendix 3. 
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2 The Exploratory Data Analysis of Quality of Life Data 
2.1 Introduction 
Although most of the work in this thesis concentrates on more formal model based analyses 
of quality of life data, the multidimensional, as well as longitudinal, nature of quality of life 
data means exploratory data analysis is an important stage of the analysis process. In fact, a 
large proportion of reported studies in quality of life research have relied solely on such 
analyses. Anderson et al. (1993) plotted median quality of life scores over time. Reports on 
behalf of the MRC lung cancer working party (1992,1993b) gave summaries of the number of 
patient days spent with improved quality of life compared with baseline and plotted the 
proportion of patients over time recording symptoms of a particular grade or above. 
Fallowfield (1986) and MRC lung cancer working party (1991b) reported quality of life data 
results similarly. The primary aim of the chapter is to review these and other approaches which 
have advocated for the exploratory data analysis of continuous, binary and ordinal quality of 
life data. This is done with practical examples using data from the three studies outlined in 
Chapter 1. The chapter's secondary aim is to give a clear description of many aspects of these 
data which are presented in the more formal statistical analyses developed in subsequent 
chapters. 
The chapter is structured to discuss exploratory data analysis for repeated continuous 
outcomes in Section 2.2 and repeated categorical outcomes in Section 2.3. The presence of 
missing data and patient death during follow-up are major issues for the analysis of quality of 
life data. In Section 2.4, a number of approaches for the informal examination of each are 
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reviewed as means to determine their implications for inference. The advantages and 
disadvantages of the different types of display are discussed within the relevant sections with 
a general discussion highlighting areas of particular concern given in the final section of the 
chapter. 
2.2 Repeated continuous data 
This section of work examines different approaches for exploratory data analysis for quality 
of life responses that can be considered as continuous - that is the validated summary scores 
which are generally obtained by summing individual item responses on standard quality of life 
measuring instruments. Although these scores may only take some integer value within a 
limited range - for example, the summary HAD scores take integer values within the range 0 
to 21 - assuming the scores to be continuous is the approach generally taken in the literature and 
is probably the most accessible solution for practical analysis. The work is divided into four 
areas of exploratory data analysis: individual patient profiles, summary statistics, population 
average profiles over time and associations across dimensions. 
2.2.1 Individual patient profiles 
Although rarely reported, an important first step in exploratory data analysis is the 
examination of individual patient profiles (Diggle et al., 1994). These not only allow an 
informal examination of the consistency of the response across patients, but can help highlight 
errata and outlying individuals in the data, as well as patterns of missing responses during the 
follow-up period. Further, if it is feasible to display more than one dimension, an informal 
examination of the relationship between dimensions is then also possible. 
The obvious problem with individual profiles is that the large number of patients in a study 
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Figure 2.1: Random sample of individual patient profiles of HAD anxiety and depression scores for the 
CRC NSCLC trial. The scores are plotted over time from baseline (0) through the eight week follow-up: 
(a) split course radiotherapy; (b) continuous course radiotherapy. Discontinuities in the connecting line 
indicate missing responses. The timing of radiotherapy for each patient is shown at the top of the figure. 
Anxiety responses: ; depression responses: --------. 
will often make it impractical to display concisely the behaviour of all patients in a single study 
and random noise within individuals makes overall patterns difficult to determine. A simple 
solution is to focus on a simple random sample of the individuals with these again plotted 
separately or overlayed over a scatter plot of all the data. Alternatively, with moderately sized 
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studies, if the scores can be sensibly categorised - for example, with the use of `normal' scores - 
a lexis diagram can be a useful way of displaying large amounts of data in a very concise way. 
Such ideas are demonstrated in figures 2.1,2.2 and 2.3. Figure 2.1 shows the anxiety and 
depression scores over time for a random sample of subjects in the CRC NSCLC study. For 
clarity, subjects who provided at least four quality of life responses over the eight week follow- 
up were selected. The timing of radiotherapy treatment is marked on the figure to make it 
possible to identify any obvious trends in patient responses as an immediate result of treatment 
as advocated by the MRC lung cancer working party (1991 a). 
These profiles give a good overview of the data and the typical behaviour of patient scores 
during the follow-up period. They clearly highlight the differences in patient experience both 
in terms of the behaviour over time and in the underlying level. In the sample shown, they also 
show some possible relationship between the anxiety and depression responses over time. 
(a) 
012345678 
Weeks since randomfselbn 
(b) 
01 234567 Weeks since randoetbn 
8 
Figure 2.2: HAD anxiety scores over time from baseline (0) through the eight week follow-up for 
patients in the CRC NSCLC study with random profiles of a selection of patients overlaid: (a) split 
course radiotherapy; (b) continuous course radiotherapy. 
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However, only viewing a small sample of the subjects in the data set it is unclear whether the 
patterns are consistent throughout. In particular, the sample displayed here is very selective 
as it relied on patients having at least four responses. 
In figure 2.2, the anxiety scores for all individuals are plotted against time with the profiles 
highlighted for the same individuals shown in figure 2.1. Since the scores are not strictly 
continuous and can take a limited number of values overall, there will naturally be some 
repetition of the same score by different individuals. To avoid scores being superimposed when 
this occurs, the responses in figure 2.2 have been `jittered' - that is, a small degree of random 
noise has been added to observed measurement occasion and score. 
The problem with the figure is that with the exception of the patients whose observations 
have been connected, it is impossible to see patterns of individual profiles, and even then, if 
the connected profiles are subject to missing data, the overall profile is not clear. It does, 
however, allow the extent of the variation in the data to be assessed, although it is not clear 
whether this derives from variation between or within subjects. 
In figure 2.3, the RSCL physical responses for all subjects in the CRC NSCLC study are 
plotted in a lexis diagram. The data are reclassified into 'normal' and 'abnormal' scores 
according to the RSCL guidelines (de Haes et al., 1990). Normal responses are shown as solid 
lines, abnormal scores (20 units or more) by a dashed line. Discontinuities in the lines 
represent missing responses. An asterix at the end of the patient response line denotes the time 
of death for that patient to the nearest week of follow-up. Patients are ordered from top to 
bottom by date of entry into the study and again the timing of radiotherapy is shown at the top 
of the figure. 
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Figure 2.3: Lexis diagrams of patient physical quality of life profiles over time (from baseline 0) in 
terms of the RSCL normal score classifications: (a) split course radiotherapy; (b) continuous course 
radiotherapy. Normal scores: ; abnormal scores: --------; patient death: *. 
In this example, the figure highlights the degree of missing baseline responses for patients 
on the continuous course radiotherapy who were recruited in the middle of the study (figure 
2.3(b)). It also highlights missing data prior to death for each of three patients who died during 
the course of quality of life follow-up. The prevalence of abnormal physical score seems 
similar between the two treatment groups, and no particular patterns over time are revealed. 
On the whole, although it is impossible to obtain clear inferences from any plots of 
individual profiles over time, they can highlight consistencies (and inconsistencies) in patterns 
over time in terms of the underlying level of response, the occurrence of missing data, and how 
this relates to previous quality of life responses or patient death. In addition, they allow 
examination of the total variability of the data and, with treatment schedules clearly shown in 
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the figures, the immediate effects of treatment on patient quality of life can also be highlighted. 
2.2.2 Individual patient summaries 
Since longitudinal data has repeated assessments on the same subject, the total variability 
of the data can be partitioned into that which is derived between subjects and that which derives 
within, that is, differences in the underlying responses between subjects and the variability of 
individual responses around this underlying response for a particular subject. Although 
individual patient profiles allow some examination of the overall variation in the data, it is 
generally difficult to determine how this variation partitions into that between and within 
subjects. Such information is important however as it indicates whether subjects tend to be 
consistent in their underlying responses or not, which then has substantial implications for the 
generalisation of conclusions to be later drawn from an analysis. The examination of individual 
patient summaries during exploratory data analysis is therefore important. 
Such analyses have been advocated by Matthews et al. (1990) not only for exploratory data 
analysis, but for formal statistical analysis of longitudinal data. Here they are presented only 
for descriptive purposes. This is because the unbalanced nature of quality of life data 
somewhat complicates their use for formal analysis (Matthews, 1993). 
For continuous data, an often reasonable summary of a patients response is an overall mean, 
or a fitted regression line over time. In figure 2.4, separate regression lines fitted for each 
subject over time are shown for the HAD anxiety responses in weeks 1-8 from the CRC NSCLC 
study. These are plotted for each treatment group separately. Also shown on the figure are the 
distributions of the fitted intercepts and slopes for the two patient groups. 
The figure shows an underlying fall in the level of anxiety over the period which appears 
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(a) split course radiotherapy; (b) continuous course radiotherapy. Distribution of subject specific 
intercept (c) split course; (d) continuous course. Distribution of subjects specific slopes (e) split 
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more consistent across patient in the split course than for those on the continuous course. In 
contrast, fitted responses for the underlying level of response at one week seem more consistent 
between subjects in the continuous course group. A number of obvious outliers are seen in the 
figures. In particular, one subject in the split course showed a marked increase in their 
response over time, and one on the continuous course showed a marked decrease. Examination 
V) 
N 
0 
(b) 
I 
(d) 
20 0 5 10 
44 
The exploratory data analysis of quality of life data 
1.0 
0.8 
0.6 
0.4 
0.2 
0.0 
No. of 
Pts 
49 31 20 13 12 9533322210 HAI 
49 30 20 16 10 7654310000 Control 
0 6 12 is 24 
Thne (morons) 
30 36 42 
Figure 2.5: Kaplan-Meier representation of the time to abnormal physical quality of life or death in 
the CRC HAP trial. HAI: ; control: --------; censored observations: +. 
of the data for these individuals showed that they had only three and two responses 
respectively. 
Matthews et al. (1990) discuss alternative summary statistics for continuous data. One 
which may be of scientific interest for quality of life data analysis, is the time to an event of 
interest. An example which is shown in figure 2.5 is the time to the first occurrence of 
`abnormal' quality of life. Here, the RSCL `normal' score classification has been used to 
determine the time to the first occurrence of abnormal quality of life or death for the CRC HAP 
trial. Because some patients may be censored, this is presented using a Kaplan-Meier survival 
curve. In this example, no difference between the two groups is observed. Unfortunately, this 
event definition makes it is impossible to separate the quality of life and survival experience 
of patients and may therefore be best restricted to situations where patient quality of life is 
expected to deteriorate progressively, and in cases with a short follow-up period, so that patient 
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death occurs rarely during the period of quality of life assessment. 
2.2.3 Summaries over time 
Having examined the variation of responses across subjects, the most obvious method of 
summarizing a continuous response over time is to plot patient group mean scores at each 
measurement occasion against time. For an indication of the precision of the mean, confidence 
intervals can be displayed, calculated with either a specified confidence level at each time point 
or a more conservative overall confidence level for the period as a whole using a Bonferroni 
correction (Armitage and Berry, 1987). Using both of these intervals will give limits for the 
range of confidence, with the pointwise intervals being too narrow and the Bonferroni intervals 
being too wide as they assume that all time points are independent and therefore over adjust. 
An example is shown in figure 2.6 where the mean HAD anxiety score at each weekly 
measurement occasion in the CRC NSCLC study is plotted against time by treatment group. 
Both pointwise and Bonferroni 95% confidence intervals are shown on the figure given by the 
inner and outer horizontal bars respectively. Also shown is the number of patients contributing 
to the estimated mean at each time point. 
In this case the figure highlights a slight fall in the mean anxiety score over the period in 
both treatment groups. The mean response for the patients on the continuous course of 
radiotherapy is also shown to be consistently lower than that for those treated on the split 
course although all confidence intervals throughout the period overlap. 
A problem with displaying data in this way is the tendency for over interpretation of 
confidence intervals which fail to recognise that the data derive from repeated assessments of 
the same individuals. Further, in studies where quality of life follow-up is long relative to the 
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Figure 2.6: Mean anxiety scores over time from baseline (0) through the eight week follow-up for 
the CRC NSCLC trial with pointwise and overall 95% confidence intervals given by the inner and 
outer horizontal bars respectively. Split course radiotherapy: ; continuous course 
radiotherapy: --------. 
expected patient survival, patient attrition due to death makes the figure difficult to interpret, 
particularly in terms of the overall trend. This problem has been addressed by several authors 
(Stephens et al., 1992, Hopwood et al., 1994) and is discussed in more detail in Section 2.4. 
A further problem with the presentation of group mean quality of life scores is the lack of 
an intuitive interpretation of the scores which makes it difficult to convey the meaning of 
results to people with no knowledge of the measurement instrument used, and difficulties in 
comparing results across studies (Fayers and Jones, 1983, Cox et al., 1992). Cox et al. (1992) 
suggest that a solution is to present results on a transformed scale representing the "percentage 
out of the maximum" for the instrument. Although such transformations may have more 
intuitive appeal than the raw scores, comparisons across studies may still not be possible across 
studies using different measurement instruments as the sensitivity of different instruments to 
quality of life changes might vary greatly. 
47 
The exploratory data analysis of quality of life data 
A representation which may improve an analysis for easier comparison across studies is to 
present results in terms of the instrument defined `normal' scores which, it is hoped, would be 
more consistent in their classification of responses. The use of summaries of `normal' scores 
over time is exemplified in figure 2.7 for the CRC NSCLC RSCL physical data previously 
shown in figure 2.3. In the figure, the proportion of patients recording `abnormal' scores at 
each follow-up is plotted over time. Again the numbers of patients contributing data at each 
time point are given. In the example presented a slight decrease in the quality of life response 
over time is seen. There is however an indication of a discrepancy between the proportion of 
patients with `abnormal' scores in the two groups at baseline. This may be related to the excess 
of missing data at baseline in the continuous course which was shown in figure 2.3, and 
highlights the importance of profiles of individual patient data. 
For the examples in figures 2.6 and 2.7, quality of life was measured at very short intervals 
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Figure 2.7: Proportion of patients in the CRC NSCLC trial giving 'normal' scores for the RSCL 
physical dimension plotted over time from baseline (0) and throughout the eight week follow-up 
where normal scores are classified as responses greater than 20. Split course radiotherapy: --; 
continuous course radiotherapy: --------. 
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which meant that the exact timing of measurement was as planned in the study protocol. When 
assessments are less frequent - for example, monthly - time constraints on a clinician or patients 
being unable to attend follow-up appointments, typically the actual timing of follow-up will not 
always be as planned. Summaries of mean response over time then become more difficult as 
there are no longer distinct time points at which the required means can be calculated. The 
most obvious solution is to group follow-up times, for example, to the nearest month. This has 
been done in figure 2.8 which shows the mean RSCL physical quality of life scores over time 
for the restricted data set for HAP trial. It shows very little difference between the pump and 
the control groups over the first year of follow-up. Beyond the first year, although some 
difference seems apparent, examination of the number of patients contributing data stresses the 
problem of falling patient numbers which make these apparent differences difficult to interpret. 
Missing data and patient death during follow-up can have serious implications for the 
interpretation of these mean summaries. It is again therefore very important that patient 
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Figure 2.8: Mean RSCL physical scores over time from baseline (0) for two years follow-up for the 
restricted HAP trial data. Follow-up is grouped to the nearest month. HAI: ; control: --------. 
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numbers are given on a figure. 
An alternative to grouping data together in fixed time points, is a kernel smoother (Hastie 
and Tibsharani, 1990). The basic principle of kernel smoothing is to obtain a smooth 
representation of the data with time by grouping data within a `moving window' of a given 
width. For each successive window, some summary of all the data points within the window 
is calculated. These summaries are then joined over time. The wider the width of the window, 
the smoother the resulting summary over time will be. For example, a lowess kernel smoother 
(Cleveland, 1979) is used in figure 2.9 again for the restricted data from the CRC HAP data. 
A lowess smoother is a particular kernal smoother which is insensitive to outliers. Within each 
moving window, a weighted least squares regression line is fitted with weights determined by 
the distance of each point from the centre of the window. The residual of each observation 
from this fitted line is then calculated, outlying observations are down weighted and the line 
re-fitted and the process repeated a number of times. The value of the lowess curve for each 
window is then simply the predicted value for the line at the centre of the window. Figure 2.9 
shows little difference between the HAI and control groups, although the response of the 
control group is shown to lie consistently below that of the HAI group for most of the follow-up 
period. Although for the control group, the line does begin an upward turn towards the end of 
the follow-up period it is much less sensitive to the outlying values observed for this group at 
the end of follow-up than the profile given by simply grouping data together as in figure 2.8. 
As it is now impossible to give the precise number of subjects contributing data at each time 
point, the raw data is shown on this figure as an indication of the amount of available data. This 
clearly shows the depletion of data towards the end of follow-up. Full details of lowess and 
other kernal smoothers are given in Hastie and Tibsharani (1990). 
Using mean profiles over time is perhaps the most important part of exploratory analysis for 
so 
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Figure 2.9: RSCL physical scores for the restricted data taken from the CRC HAP trial: HAI: "; 
control: +. The underlying response is highlighted using a lowess kernel smoother: HAI: 
control: --------. 
longitudinal quality of life data as it generally addresses the primary questions of interest in the 
data - the difference between patient groups and the behaviour of response over time. Because 
of problems of missing data, irregularly spaced follow-up assessments and patient attrition due 
to death, it is important that either patient numbers are given within a figure, or the overall 
profiles are overlayed on the raw data. In addition, as measures of confidence and the profiles 
themselves ignore the dependency of observations within the data, such profiles should not be 
over interpreted for formal analysis. 
2.2.4 Associations between dimensions 
Although many different dimensions are measured as part of a quality of life assessment, 
an aspect of the data which has generally not been reported in the literature is the correlation 
(or association) between responses in the different dimensions. Since the data are longitudinal 
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and the total variation can be partitioned into that between and that within subjects, the 
associations across dimensions need also to be partitioned in the same way. That is, the 
correlation between dimensions between subjects, and the correlation between dimensions 
within subjects need to be evaluated separately. 
When data are balanced, the most simple estimate of the association between subjects is 
obtained by calculating the subject specific mean scores for each dimension in turn over the 
follow-up period and then to examine the associations across dimensions between these subject 
specific means. This investigates whether subjects who tend to have high scores on average in 
one dimension tend also to have high scores in other dimensions. This is shown in a scatter plot 
matrix in figure 2.10 for all four quality of life dimensions of quality of life measured in the 
CRC NSCLC study. It shows a high positive association between subject specific means in the 
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Figure 2.10: Scatter plot matrix of the subject specific means over time for each of the four quality 
of life dimensions measured in the CRC NSCLC study for a representation of between subject, 
between dimension correlations. The HAD anxiety and depression scores have values in the range 
0-21, those for the RSCL physical and psychological scores are in the range 0-40. 
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Figure 2.11: Scatter plot matrix for the within subject between dimension correlations for the quality 
of life data for the CRC NSCLC study. 
physical and psychological dimensions of the RSCL. Although positive, the associations seen 
between other dimensions are generally weaker. 
The within subject across dimension associations address the question whether, on a 
particular occasion, subjects who have higher than expected observed responses in one 
dimension also have higher than expected responses in a second dimension. For reasonable 
estimation of such correlation, Bland and Altman (1995b) suggest the residuals from subject 
specific regression analyses be used. For descriptive purposes, it is perhaps sufficient to simply 
subtract the subject specific mean responses from their respective observed responses and 
examining the pattern of association of these `residuals' across all subjects. This is shown in 
figure 2.11 for the NSCLC quality of life data. This clearly shows that although there was a 
high degree of association between the two dimensions of the RSCL within subject, those 
between the two dimensions of the HAD scale were very much weaker. Some positive 
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association between depression and physical well being is also shown. 
Each of these methods, however, depend on the data being balanced. When data are 
unbalanced, although visual displays of association for descriptive purposes may still be used 
with caution, estimation of correlation coefficients is not recommended without the varying 
degrees of precision on each subject specific mean taken into account (Bland and Altman, 
1995a, 1995b). 
2.3 Repeated categorical data 
Although many of the most commonly used quality of life instruments have a validated way 
of summarizing individual items on the questionnaire to give a simple summary score, which 
may then be treated as continuous responses, there remain some instruments - for instance, the 
daily diary card - for which such a summation is not feasible or relevant. This section focuses 
on exploratory data analysis for the binary and ordinal data which are obtained from such 
instruments. It also considers the analysis of individual items within questionnaires in general. 
This enables individual aspects of a patient's life to be examined and effects investigated which 
may be masked by the calculation of an overall summary measure. The binary responses 
presented are generally dichotomies of the ordinal responses of the individual items on the 
measurement instruments such as the example item given in box 1.1 for the HAD anxiety scale. 
As for the previous section, this work is separated into four subsections addressing the use of 
individual summaries, summary statistics, profiles over time and across dimensional 
associations. 
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2.3.1 Individual summaries 
As with a continuous response, examination of the individual patient behaviour in order to 
examine the consistency of responses across subjects is as important as the more commonly 
reported population summaries for patient groups. For ordinal, and in particular, binary data, 
this is best done using a lexis diagram. Such diagrams allow large proportions of the data to 
be displayed, and the small number of possible response categories can generally be quite 
easily distinguished on a single figure. This is shown in figure 2.12 in which the prevalence 
of dysphagia in the MRC LU07 study is plotted over time for a random sample of patients in 
each treatment group. A solid line indicates that no symptoms of dysphagia were reported, the 
dashed line indicates some symptoms - that is, a response in category 2 or above. Again, 
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Figure 2.12: Random sample of subjects and their reported symptoms of dysphagia measured daily 
from the start of treatment (0) through the following eight week period in the MRC LU07 study for 
(a) multiple fraction radiotherapy (FM); (b) two fraction radiotherapy (F2). No symptoms (category 
1): ; some symptoms (category 2 or above): --------. Discontinuities in the lines indicate 
missing responses. 
55 
The exploratory data analysis of quality of life data 
periods of radiotherapy are shown on the figure. The figure reveals a large proportion of 
patients in both treatment groups reporting some symptoms of dysphagia towards the end of the 
radiotherapy for a few days in both treatment groups, although the exact timing of the onset and 
relief of symptoms varies greatly across the patients shown. 
2.3.2 Summary statistics 
The use of summary statistics for the analysis of binary and ordinal responses is less 
common than for continuous data. It is however just as useful in highlighting whether variation 
derives primarily from differences between or within subjects. The natural summary statistic 
for such data is the proportion of patient time with a response in each category, where this is 
calculated for each subject as the number of responses given in each category taken as a 
proportion of the total number of responses given by that subject. Two possible summaries of 
the proportions are shown in figures 2.13 and 2.14 for summary statistics calculated for the 
MRC LU07 activity quality of life scores from the daily diary card. These scores were 
measured on a five points scale ranging from 1 (normal work/housework) to 5 (confined to 
bed). Further details of the item are given in box A2.3 in Appendix 2. Figure 2.13 shows the 
distributions of the proportions in terms of box plots. The middle 50% of the data is shown by 
the shaded block with the median give by the white bar. The tails of the box go out to the 10th 
and 90th percentiles with other outlying points shown as individual lines. The figure here 
shows the distributions in all but the middle category to be positively skewed with a large 
proportion of patients spending none of their time in some of the categories. This is 
particularly marked for categories I and 5 for which the 90th centile is zero. It also highlights 
the large degree of variability across subjects with a large spread for the middle 50% of the data 
in the middle categories. No obvious differences between the treatment groups are seen. 
These data are also summarised in figure 2.14. Mean and median proportions of responses 
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Figure 2.13: Distribution of the proportion of responses each patient gives in each category (1 to 5) 
for the activity rating of quality of life on the daily diary card in the MRC lung cancer study during 
the four week treatment period. The middle 50% of the data is shown by the shaded block with the 
median given by the white bar. The tails of the box go out to the 10th and 90th percentiles with other 
outlying points shown with individual lines. Multiple fraction radiotherapy (FM) and two fraction 
radiotherapy (F2). 
in each category are plotted with their respective 95% confidence intervals. Given the skewed 
nature of the distributions, the summaries based around the median will be preferable to those 
around the mean. No apparent differences between the two treatment groups are highlighted. 
Although showing a clear summary of patient experience over the period as a whole, and 
allowing a simple treatment comparison between the treatment groups, the problem with figures 
2.13 and 2.14 is that they do not allow examination of patterns of change over time. Thus 
patterns of change over time, such as that highlighted in figure 2.12 for the dysphagia data 
would be missed. Assuming a linear trend in log odds, for binary data, overall trends could be 
identified in a similar way to that for continuous data, with subject specific rates of change in 
the in log odds of symptoms obtained from a logistic regression analysis and plotted in the same 
way as in figure 2.4. In such a case, the underlying subject specific model is then perhaps too 
sophisticated for simple exploratory data analysis. 
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Figure 2.14: (a) Mean and (b) median proportion of responses given in each category (1 to 5) with 
95% confidence intervals for the activity scores on the daily diary card. Confidence intervals for the 
mean are truncated at 0 and 1. Intervals given for the median are based on critical values of the sign 
test. Multiple fraction radiotherapy (FM): ; two fraction radiotherapy (F2): --------. 
2.3.3 Summaries over time 
The most commonly used way to summarize patient quality of life measured on a binary or 
ordinal scale is to consider the proportion of patients falling into each category over time. 
These proportions can be plotted separately for each category, cumulatively over categories by 
considering the proportions in category k or below (or above) for all k, or for a simple 
dichotomy of the response. Such figures summarize the data to give an impression of the level 
of quality of life at each specific time in the study and can be useful in highlighting changes in 
the distribution of patient responses at particular times during the study follow-up. They have 
been used by many authors (MRC lung cancer working party, 1991a, 1991b, 1992,1993b, 
Fallowfield et at. 1986). Two such examples are presented here. 
Figure 2.15 shows the proportion of responses in category k or below (k=0,1,2) recorded on 
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Figure 2.15: Proportion of patients recording responses in category k or below over time from 
baseline (0) through the eight week follow-up for the `shortness of breath' item on the RSCL 
questionnaire used in the CRC NSCLC trial for patients on the (a) split course radiotherapy; (b) 
continuous course radiotherapy. 
the RSCL shortness of breath item in the CRC NSCLC study, where a score of 0 reflects no 
symptoms to a score of 3 that implies very restrictive symptoms. It shows an increase in the 
proportion of patients reporting symptoms of grade one or below (and therefore grade two or 
below) over time. This increase is perhaps more apparent in the continuous course 
radiotherapy group. 
Figure 2.16 plots the proportion of patients over time reporting some symptoms of 
dysphagia (difficulty in swallowing) -a response in category 2 or above - in the MRC LU07 
study. It clearly highlights that patients in both treatment arms experienced a transient period 
of dysphagia during the immediate period following radiotherapy treatment as was suggested 
from the random selection of individual profiles in figure 2.12. There was some difference in 
the pattern of response between the two groups with a lower proportion of patients affected in 
the F2 radiotherapy course. A similar picture was observed by the MRC lung cancer working 
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Figure 2.16: Proportion of patients reporting some symptoms of dysphagia (category 2 or above) over 
time from the start of treatment (0) through a subsequent eight week daily follow-up. Multiple fraction 
radiotherapy (FM): ; two fraction radiotherapy (F2): ----------. 
party (1991b) with the same data set although in their analysis they concentrated of symptoms 
of category 3 or above. A formal statistical comparison of each these examples is presented 
in Sections 4.4 for the MRC LU07 dysphagia data and 5.3 for the CRC NSCLC shortness of 
breath data. 
2.3.4 Associations between dimensions 
The examination of associations between dimensions for binary and ordinal repeated 
measurement data is just as important as for the continuous case and it is again important to 
distinguish between correlations between and within subjects. Methods for the analysis are, 
however, more difficult and have not been discussed in the literature. As with the continuous 
case, it is clear that to estimate associations across dimension between subjects, a subject level 
summary of the data is needed, with associations between these summaries then examined. For 
ordinal data with sufficient ordered categories, the simplest approach for a crude representation 
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is to treat the responses as continuous and continue as in Section 2.2.4. For binary data, a 
solution is less clear. An attempt is made in figure 2.17 using the dichotomised responses - no 
symptoms (0/1) versus some symptoms (2/3) - for six items on the RSCL in the CRC NSCLC 
study. For each subject, for each dimension, the proportion of positive responses was 
calculated and these subject specific proportions are then plotted in a scatter plot matrix. 
For the within subject correlation (figure 2.18) the subject specific proportions are treated 
as an average for that subject, and the deviations from this average for subject's individual 
responses were calculated and displayed in the same way as figure 2.11. Neither of these 
figures show a clear indication of any association between scores in the different dimensions 
either between or within subjects. In chapter 4, a formal statistical model is used to investigate 
this further and determine whether there really was little association between the different 
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Figure 2.17: Scatter plot matrix of the proportion of days recorded with symptoms in six items of the 
RSCL for subjects on the CRC NSCLC study showing the between subject between dimension 
associations. 
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Figure 2.18: Scatter plot matrix showing the within subject between dimension associations for a 
binary response for individual item response from the CRC NSCLC study. 
dimensions, or whether such simple representations are particularly unclear. 
2.4 Missing data and patient death 
A major problem for any analysis of quality of life data is incomplete data. This may be due 
simply to patients failing to return a questionnaire at a specific time, or as a result of patient 
death during follow-up. Whatever the source, incomplete data causes concern as to whether 
the available data are representative of the study population as a whole. For example, if 
subjects miss assessments because they are generally unwell and have a poor quality of life, any 
analysis based solely on the available data will be subject to some bias. An examination of the 
patterns of missing data in the study is therefore needed to assess the possibility of such a bias. 
A similar problem is patient death during follow-up and it is important to determine whether 
the quality of life experience of those who die early in follow-up is the same as those who have 
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a longer survival. Although alike in nature, the two issues raise different problems for analysis 
and need to be examined separately. In this section informal examination of the patterns of 
non-response is addressed. More formal analyses are discussed in Chapter 6 for patient death 
and in Chapter 7 for missing data. 
2.4.1 Missing data 
Missing data have been reported as a particular problem in quality of life studies. If the data 
available are to be assumed representative of the study population there should be no evidence 
that a group of non-responders are systematically different from those who do respond. In 
particular, if comparisons of different groups of patients in the study are to be made - such as, 
treatment comparisons - the extent of missing data should be reasonably equal within these 
groups over time, as well as in its relationship to patient quality of life. 
The obvious starting point for examining missing data is to tabulate compliance rates over 
time and by patient, that is, the proportion of responses available at each time point, and the 
proportion of total responses given by each patient (Fayers and Jones, 1983). Such summaries 
are presented for the CRC NSCLC study in tables 2.1 and 2.2. Table 2.1 shows the proportion 
of available responses at baseline and for the eight weeks following treatment, whereas in table 
2.2, a summary of the number of questionnaires completed by each patient is given. Both tables 
Table 2.1: Proportion of available data at each weekly assessment for the CRC NSCLC study. 
Week 
Continuous 
course 
Split 
course 
baseline 12345678 
0.48 0.55 0.57 0.57 0.50 0.52 0.57 0.57 0.50 
0.60 0.45 0.53 0.55 0.55 0.50 0.53 0.55 0.53 
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Table 2.2: Proportion of the total possible responses (maximum=9) given by each patient in CRC 
NSCLC study. 
Proportion of questionnaires returned 
Split course 
Continuous course 
0 0.11-0.44 0.56-0.89 1 
10 
8 
6 
9 
18 
20 
6 
5 
show the compliance rates overall and as stratified by treatment group and show no difference 
between the two. Since the focus of investigation in this section is missing data due to non- 
compliance and not due to death, all proportions are given out of the possible total given 
patients' survival. 
To determine whether compliance is related to quality of life or underlying patient 
condition, the MRC lung cancer working party (1993b) considered compliance rates (in terms 
of the proportion of completed responses per subject) and their relationship with baseline 
patient characteristics. They gave their results in tabular form. Here similar results are shown 
in figure 2.19 as scatter plots of baseline physical and psychological scores as well as baseline 
Karnofsky and FEV I against the number of available questionnaires for each subject. The data 
used here are from the RSCL in the CRC NSCLC study. To avoid points being superimposed, 
a small amount of random noise has been added to the data points. For this example, no 
striking relationships between the number of responses given by individual patients and their 
baseline response are shown. 
A further suggestion from Hopwood et al. (1994), that is not shown here, is a comparison 
of mean quality of life profiles over time for groups of patients giving different numbers of 
quality of life responses. To be effective, this relies on quality of life being measured over a 
fairly long period and more importantly a reasonably sized patient sample. It would therefore 
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Figure 2.19: Scatter plots of baseline patient data against the number of available quality of life 
responses to the RSCL questionnaire in the CRC NSCLC study: (a) RSCL physical score; (b) RSCL 
psychological score; (c) Karnofsky score; (d) FEV I. 
be more suitably applied to the MRC LU07 data than to the CRC NSCLC study data. 
An added complication with the examination of patterns of missing data is the irregular 
timing of patient follow-up since this makes it difficult to determine whether data are missing 
or simply measured at an earlier or later occasion. 
2.4.2 Patient death during quality of life assessment 
Although both missing data and patient death during follow-up can both be classed very 
generally as issues of non-compliance, they are very different. The problem of missing data 
is. whether the data available are representative of the quality of life experience of the sample as 
a whole. On the other hand, patient death raises the question of whether there is agreement in 
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the overall quality of life behaviour of patients with different lengths of survival. As full 
examination of this is not possible unless all patients have been followed until death, in the next 
section quality of life differences in patients for whom survival is known is investigated. More 
formal methods of analysis for which the full data set, including censored individuals, can be 
used are considered in Chapter 6. 
Two different approaches are described here. The first is based on the idea of Hopwood et 
al. (1994) for examining patterns of missing data. Mean quality of life profiles for patients 
grouped by their observed survival time are estimated and plotted over time. An example is 
given in figure 2.20 for the HAP trial RSCL physical scores. In this example, the mean profiles 
were estimated by data grouped to the closest month. Kernel smoothers could also have been 
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Figure 2.20: Mean RSCL physical scores over time from baseline (0) for a period of two years for 
the CRC HAP trial grouped by survival time: (a) <1 year; (b) between I and two years; (c) >2 years. 
Follow-up in each case in grouped to the nearest month. HAI: ; control: ----------. 
e. ..., 
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used. Very similar patterns of response over time for patients treated with a HAI in all three 
survival groups are seen. This is similarly so for patients in the control group. Unfortunately, 
unless samples sizes and numbers of observed deaths are large, these figures are of limited use. 
This is shown figure 2.20(c) in which the mean profile shown is estimated using a maximum 
of four subjects. 
As an alternative, Morris et al. (1986) plotted mean quality of life over time measured 
backward from death to examine whether the behaviour of quality of life differed across 
different survival times and in particular if there was a noticeable change in quality of life 
towards the time of death. Such an analysis is shown in figure 2.21, with quality of life 
responses now grouped to the nearest month prior to death overall. Figure 2.21(a) shows this 
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Figure 2.21: Mean RSCL quality of life over time from death going backwards for a maximum of two 
years for the restricted data of the CRC HAP trial: (a) Overall; and grouped by survival (b) s1 year; 
(c) >1 year. HAL ; control: --------. 
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for the whole sample, whereas figures 2.21(b) and 2.21(c) show the data grouped by observed 
survival. Again, subjects for whom time of death is not known are not included. For the CRC 
HAP study, this figure shows an increase in the average level of quality of life towards death 
which was not apparent when the data were plotted from the time of entry into the study. Given 
this evident change in the quality of life experience, for reliable inferences from these data, it 
is clear that patient survival should be incorporated into the formal data analysis in some way. 
It is important to note however, that grouping the data in this way (from time of death) means 
that it is not possible to make unbiased treatment comparisons as we are no longer guaranteed 
to have patient groups which can be considered the same at the start of time (in this example 
24 months prior to death). 
2.5 Summary and discussion 
This chapter has reviewed some methods of descriptive analysis that have been used for the 
analysis of quality of life data in the literature, and other relevant exploratory data analyses that 
may be used for future analyses. The different methods can be classified into four main areas: 
individual profiles; summary statistics; population averages over time; and associations 
between dimensions. In turn these areas allow the examination of typical patient responses 
over time; underlying behaviour of patients and how this varies across patients; an overall 
population summary of response; and how responses in the different dimensions are related to 
each other. To fully understand the behaviour of repeated measurement quality of life data 
collected in many dimensions, an exploratory data analysis should include at least the first three 
of these. Further, to determine their implications to be assessed not only in terms of the 
interpretation of descriptive displays, but also for more formal analyses which may be 
performed at a later stage, it is vital that a comprehensive analysis of the missing data in a study 
is also carried out. 
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For analyses based on individual profiles, a selection of random profiles is perhaps the best 
way of indicating typical responses over time when quality of life is measured on a continuous 
scale. For binary and ordinal data, lexis diagrams with different response categories 
highlighted by different line styles were shown to be very informative and allowed much more 
data to be displayed. These may also be used for continuous responses categorised in terms of 
normal responses and can also serve as a useful tool for examining patterns of missing data or 
the nature of quality of life response prior to death. Diggle et al. (1994) have also suggested 
that, rather than showing random profiles, individuals are ordered in terms of some analysis 
factor of interest in the data. Profiles are then shown for selected quantiles of this ordering 
statistic. Again, such a presentation may be of particular use in studies where patient death 
during follow-up was an issue with profiles shown for different quantiles of survival. 
Summary statistics have been recommended in the literature for formal statistical analysis 
of longitudinal data in general (Matthews et al., 1990). Not only do these recognise the 
longitudinal data structure, but also are intuitively appealing and require only that a summary 
measure of individual patient data of scientific interest can be defined. Unfortunately, their use 
for formal statistical analysis is somewhat complicated if data are unbalanced. However, for 
descriptive purposes, they are such a flexible and simple tool that they should form an integral 
part of exploratory data analysis for quality of life data. 
The most commonly used method of exploratory analysis of quality of life data in the 
literature is a plot of means over time. The examples in the literature have tended to have had 
observations spaced equally for all subjects, making calculation of means at each time trivial. 
If this is not the case, population summaries can still be presented either by explicitly grouping 
observations by time of measurement in an appropriate manner, or by the use of kernel 
smoothers. The main problem of displaying mean profiles over time, is that they are 
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susceptible to over interpretation of apparent differences. To avoid this, it is recommended that 
some attempt is made to show the degree of confidence on a figure. This may be by confidence 
limits, the number of patients contributing data at each time point, or by overlaying mean 
profiles on the raw data. 
A final part of the exploratory data analysis for quality of life data which was discussed in 
this work, is the examination of associations across dimensions. With many dimensions of 
quality of life invariably measured in a study, a sensible scientific question relates to how these 
dimensions relate to one another. As the data come from repeated assessments of subjects, 
simple scatter plots across dimensions are not appropriate. Instead, the variation in the data 
has to be partitioned into that between and that within subjects. Associations are then 
investigated within each partition. This is easily done for continuous data and was 
demonstrated in Section 2.4. Binary and ordinal data pose more of a problem however, and 
further work is needed in this area to determine simple descriptive tools to display cross 
dimension associations for such types of response. 
To summarise, there exist many different approaches to exploratory data analysis within the 
four general areas of exploratory data analysis discussed in this chapter, as well as for the 
examination of patterns of missing data. Although most of the work in this thesis concentrates 
on formal statistical models for data analysis, the quantity of data which is generated in a 
quality of life study requires that comprehensive exploratory data analysis is carried out before 
undergoing more formal analysis. In order to fully understand the data, at least, this should 
include examination of individual profiles, summary statistics as well as population averages 
over time. Finally, patterns of missing data and the relationship between underlying quality of 
life and patient survival also need to be thoroughly examined. 
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3 Hierarchical Models for Repeated Continuous Outcomes 
3.1 Introduction 
Many approaches exist for the formal statistical analysis of repeated continuous outcomes. 
These range form the very simple to the more complex. Concise reviews of these methods are 
given by Crowder and Hand (1993), Everitt (1995) and Diggle et al. (1994). Unfortunately, 
many of the simpler analyses require that all subjects are measured at the same times in follow- 
up, and each have full sets of responses. In the light of missing data or irregularly spaced 
follow-up times, this can lead to the analysable data set being very much reduced. The more 
complex models, which on the whole are due to recent advances in statistical methodology have 
provided a number of techniques which do not have such restrictions, and can easily handle the 
analysis of unbalanced longitudinal data, (Zeger and Liang, 1992, Goldstein and MacDonald, 
1988, Longford, 1995). This chapter demonstrates the use of hierarchical (or multilevel) 
models which is one approach for which software is available. 
Multilevel models are random coefficient models (Longford, 1995, Goldstein, 1995) 
suitable for the analysis of data with some underlying hierarchical structure where it may 
reasonably be assumed that units within each level of hierarchy are randomly drawn from some 
underlying population. They have been used extensively in educational and social research to 
model child attainment data for children nested within classes nested within schools (Goldstein 
et al., 1993). For example, a study which assesses the reading ability of children over many 
different schools in a particular district has two levels of hierarchy. The level one units are the 
students which are nested within the different schools. These schools form the level two units. 
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At level two it is assumed that the individual mean scores for each school are randomly 
distributed around the underlying mean score for the district as a whole. This gives level two, 
or between school, variation. Similarly, the scores of individual students are assumed to be 
randomly distributed around the underlying mean score for their school, constituting the level 
one, or within school variation. 
Repeated measurements fall naturally into this framework. At level one, observations taken 
over time are nested within subjects. These subjects are drawn from some population to give 
the level two units. The variation at level two derives from the differences in individual 
responses between subjects. At level one, it is simply the deviation of individual observations 
from the subject's individual response. A possible model for such a scenario is given in 
equation (3.1), where yj denotes the response for subjection occasion j made at time xU. 
y;; =a+ßxýi+(ul+vrxrý+eÜ) where 
(u;, v; )~ N(O, E,, ) 
2 eýý- N(O, o, ) 
(3.1) 
In this model, the underlying response over time for the population of interest is given by 
the parameters (a, P). The variation at level two derived from differences in individual 
response profiles are given by the subject level residuals on the population intercept and slope (u;, vi) 
for subject i. Combining these two components, gives a response profile for subject i, 
E(yU I x; ý, ui, v; )=((% +u, )+(ß +v, )x, (3.2) 
In Section 2.2.2, similar subject specific regression lines were used to model the HAD anxiety 
data of the CRC NSCLC study. The differences between that model and the multilevel model 
of equation (3.1), are the distributional constraints on the subject specific components and the 
focus of estimation. In Section 2.2.2, the subject specific components were assumed fixed and 
were estimated explicitly and separately for each subject. In the multilevel (or random 
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coefficient model) they are assumed to be random variables from an underlying multivariate 
Normal distribution with variance Eb and, rather than the residual pairs (ul, v1) (i=1,..., n), it is 
this variance that is of interest in estimation. As estimation of the residual variance, oe , 
is also 
required, the fixed analysis of Section 2.2.3 uses (2n + 1) parameters, whereas the random 
coefficient model uses only six. This makes the model much more flexible both in terms of 
modelling the fixed (or population) parameters, but also the components of variance. Their 
parameterisation and estimation procedures also make them very easy to extend to more than 
two levels of hierarchy. 
In Section 3.2 the model, its assumptions and estimation are described in more detail. The 
subsequent work in the chapter then demonstrates the application of the model to the quality 
of life data from the CRC NSCLC study. In Section 3.3, the most simple models are used to 
analyse the HAD anxiety data. Section 3.4 then extends the basic two level model used so far 
to a three level model, and shows how hierarchical models can be used to analyse the 
multidimensional endpoints of continuous quality of life outcome data. In Section 3.5, these 
analyses are extended to demonstrate the modelling of the variance components in the data. 
3.2 Hierarchical models for continuous outcomes 
The following section describes the most general hierarchical statistical model, its 
assumptions and the estimation of its parameters. The notation for the general model with 
h=1,..., H levels, is first described. Throughout, the description of the model is translated into 
the more familiar notation already introduced for the basic two level model for repeated 
measurements given in equation (3.1). 
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3.2.1 Notation 
Y is the (Nx 1) vector of responses which is ordered in its hierarchical structure such that, 
at the hth level, Y can be naturally partitioned into n chi subvectors each consisting of the n; 
ýý 
observations on the rth unit at the hth level where, 
N is the total number of observations (or level one units); 
n (h) is the number of units at the hth level; 
and n, '° is the number of observations in the rth h-level unit. 
For the two level repeated measurement structure, the highest level of hierarchy (H=2) is 
the subject level. Consequently, in the notation of equation (3.1), where the subjects (or level 
two units) are indexed by i, for i=r the rth level H (or level two) unit corresponds to the ith 
subject and n «, the number of units at this level, is equivalent to the total number of subjects 
n. Y=(y Tl ,..., y 
T )T where y; =(yii,..., yim the vector of observations for subject i, at occasions 
j=l,..., mi. The total number observations measured for the rth H-level unit, n; 
H) =n; H)=mi 
3.2.2 The model 
In its most general form, the hierarchical (or multilevel) model is written 
Y=xOßO+E X(h)P(h) 
h 
where ßu is a (pox 1) vector of fixed parameters; 
(3.3) 
ß(h)°(ß I, )T, 
, 
ßR (,, )T is a (n 
«)p «)x 1) vector containing the n (ti) subvectors of the p (h) 
random parameters or coefficients at level h where each of these subvectors have 
dimension (p(h)x1); 
Xo is the (Nxpo) design matrix for the p0 fixed parameters; 
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and X (h) is the (Nxn (h)p (h)) design matrix for then(h)p(h) random parameters (or 
residuals) at the hth level. The matrix is block diagonal with the blocks 
corresponding to the hth level partition of Y. 
In terms of the two level repeated measurement model of equation (3.1), 
ß0=(a, ß)T is the population intercept and slope; 
ß(2)=((UI, vl),..., (u", v"))T is the (2nx 1) vector containing then, (2x 1) subvectors of 
the intercept and slope residuals for each subject; 
and p( =(e, T,..., e; 
)T, is the(Nx1) vector of level one residuals where e, =(e,,,..., eim, )T 
for subjects i=1.... , n. 
The design matrices X0, X(2) and X(l) are given by, 
Xo= 
1 xýý 
.., 
1 x... 
i 
i=l,..., n, X()= 'N X(2)=diai 
1 xýý 
\1 
Xjmi 
They have dimension (Nx2), (Nx2n), and (NxN) respectively. 
3.2.3 Model assumptions 
In the general notation, at the hth level, it is assumed that the ß; `) (r=1,..., n (h)) are 
independent, identically distributed, multivariate Normal random vectors with zero mean and 
variance 0(h). Var(ß(h)) is then an (NxN) block diagonal matrix with Q on the diagonal. 
This can be written, var(ß(`))=I, u)® At">, where ® denotes the Kronecker product, the matrix 
operation which multiples every element of the left hand matrix by the right hand matrix. I. 
is the (nxn) identity matrix. The elements of Q(") are referred to as the variance components. 
The random coefficients across levels are also assumed independent. That is, for 
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h#h 1. 
From equation (3.3) it follows that 
H 
V=Vßi(n=E X(h)yaz(R(h))X(h)T 
h=1 
(3.4) 
implying that for each level h partition, V is block diagonal. Specifically, at the level H, this 
reflects the fact that observations taken on different top level units are assumed independent. 
At this level, these diagonal blocks correspond to 
HT 
var(y) =E x, var('`ý ; "'ý for the r=l,..., n(H) H-level units (3.5) 
h=I 
Put in the context of the simple repeated measurement model of equation (3.1), n(')=a; and 
n(s)_E __ h 
Qu Quv 
2 
Quv 0 
v 
where aü=var(ui), a2=var(v, ) and a., =cov(u,, v, ). Also var(Y)=diag(var(yj)) 
where var(y, )= 
/ 
aü+2au, 'u+a +ae am+auv(xl1+x, 2) +ax, rxu 
2222 
°w+2a.  xj2+Qýi2+Q. 
o2+QVýxim; -1 
+ximý+Q(xim, 
-Ixim) 
22 
11 a+°u 
Jx 
i/ +xim? +O v(xi /xim ,) 
For a specific case with 2 subjects, measured on m1=2, m2=3 occasions, var(Y)= 
where 
2222 
Qr+2QwJxl1+ýYII+ýe 
aZ aM+Oýýýxu+xºz)+Oýý ix1z 
aM+ Quv(xi i +xiz) +Q 
ýl 
IX12 
xz °x. +2a., xix+arti'ix+az, 
°w+Qwý(xu+x;, ")+Qv(XirXi, n) I 
aý+ZQw, xm +oý, m , 
+af 
(3.6) 
Vi 0 
0 VZ 
76 
Hierarchical models for repeated continuous outcomes 
I and 
au+2auJr21 +aWl +ae aM+awv(X21 +JC22)+aý21X22 
V2 - aý+o1,, (x21+x22)+o x2ºx22 a, 
2, +2aZ22+ävx22+a. 
Clio+Cluv(x21+x23)+ClZ21X23 Clw+auv(x22+x23)+avX22x23 
°2+Qmv(x21+x2s)+° 
x21x23 
°ý+° v(x22+X23 23 
°. 2+20w+Q+Q, 2 
and the block diagonal nature of var(Y) reflects the fact that observations on different 
individuals are assumed independent. 
3.2.4 Estimation of the model parameters 
A number of estimation procedures exist for such models. That used here is based on 
generalised least squares (GLS). A review of the alternative algorithms is given by Goldstein 
(1995) and Longford (1995). 
If V=var(YIX0I) is known, the generalized least squares estimators for 0, and var(%) are 
0o =(Xo V -'Xo)-'Xo V -l Y var(Oo) =(Xö V -lXo)-, (3.7) 
Similarly, since V=E`(Y-Xoßa)(Y-Xoß, j, if ß', the parameters of V, are the focus of 
interest and P. is known, the generalised least squares estimate of Ie is 
V'=V®V (3.8) 
TT 
COT 
T 
where Y'=(y; ... y, for yr ,a vector of squares and products of residuals for the rth H- 
level partition, r=1,..., n«, which is given by the upper triangular elements of the rth diagonal 
block of (Y-Xep, )(Y-X, pe)T. V'=var(Y') and X' is the design matrix which links Y' to V. 
After some algebra, Goldstein (1995) shows var($*)=2(X'TV*TX`)-1. 
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In terms of the repeated measurement example of equation (3.1), ß'=((;. 2, o. Y, a2, a; 
)T. From 
equation (3.6), it follows that the design matrix X' which links Y' to V can be written 
(I 
X'=diag{x, } where x, *= 
2j,, 
1 xf l +xi1 
1 xi2+xi3 
1 Xil +Xim 
I 2x, i 
z xil 
xJfxi2 
xuxrs 
II 
0 
0 
xrlXim, 
2x1 
I Xim, 
-1 
+Xim, Ximr-1Ximi U 
ll xim 2 x;.. I 
and Y'=diag(y, ) where y, '= 
(y 
yilYi2 
yuy, 3 
YJIylm, 
2 
yi2 
yim, 
-Iyim; 
yim; 2 l 
Goldstein (1986) demonstrates that when neither V nor ßo are known, equations (3.7) and 
(3.8) can be solved iteratively with a starting value for V given by its ordinary least squares 
estimate. He shows that the iteratively generalised least squares (IGLS) estimates obtained 
from this routine are asymptotically efficient. Under the further assumption of multivariate 
Normality of response, they are equivalent to maximum likelihood (ML) estimates. It is known, 
however, that ML estimates of the random parameters are biased. This is because the sampling 
variability in the fixed parameters, that are used in their estimation, is ignored (Patterson and 
Thompson, 1971). Unbiased estimates can be obtained using restricted maximum likelihood 
(REML). In a further paper (Goldstein, 1989a) the IGLS procedure is modified to give 
restricted IGLS (RIGLS) estimates which are equivalent REML estimates under the 
assumptions of multivariate Normality of response. The distinction between the results of the 
two procedures is most important for smaller sample sizes. Full details of the both these 
estimation processes are given by Goldstein (1995); computational details are given by 
Goldstein and Rasbash (1992). 
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Finally, the log likelihood of the estimated model is obtained by evaluating the model log 
likelihood (log lh) for the parameter estimates of the fixed and variance components. Nested 
models can then be compared with a comparison of deviances given by -2 log lh. 
Although standard errors can be obtained for both the fixed and variance components, it is 
not recommended that those on the variance components be used for inference. This is because 
they are based on asymptotic Normal properties which are unlikely to hold except in 
particularly large samples. Instead it is recommended that inference about the variance 
components in a model is based on a comparison of model deviances. In the examples 
presented in subsequent work, although standard errors will be given for estimated variance 
components, they are presented only as a guide. 
3.2.5 Estimation of residuals 
Although the random components are not of primary interest in this analysis, it is still useful 
to be able to obtain estimates for them. This may be for diagnostic purposes, or to show 
estimated individual profiles as typical response profiles. Although they are not estimated 
explicitly in model estimation, using the parameter estimates of the multilevel model, it is 
possible to obtain conditional (or shrunken) estimates for them, where the conditioning is upon 
the estimated fixed and variance components (Goldstein, 1986,1995). The implication of this 
is that the residuals of extreme (or outlying observations) will tend to be lower than expected. 
In the context of the two level repeated measurement example, this will result in fitted values 
which are closer to the population mean than would be obtained from the subject specific 
analysis presented in Section 2.2.3. Estimation uses simple linear regression. 
Re-arranging equation (3.3) gives the overall residual component 
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H 
Ex(h)p(h) _Y-XoOo (3.10) 
h=1 
where the elements of P(), the residuals at level h, are the parameters of interest. Since the 
residuals at each level are independent, this is a linear combination of the total residuals at each 
level. For each level, h=1,..., H, predicted values for ß(h) can therefore be obtained from a 
linear regression of ßch" on the overall residual component (Y-XOOO), 
A(h)_W(h)TV-1(Y-X800) (3.11) 
where W(h)=cov(Y-X0 0, 
ß('))=XO)(I. ü)(&Q(')), and V=var(Y). It is because these estimated 
regression coefficients, given by W(h)TV-1, are based on the estimated variance components 
from the model, that the predicted B are conditional and have smaller variance than those that 
would be estimated unconditionally from a regression model based (hypothetically) on 
observed 
{h 
, (Y-Xocn)}. 
3.3 Application of the two level repeated measurement model 
Within this section, the basic two level model for the analysis of repeated continuous 
outcomes is demonstrated with an analysis of the CRC NSCLC study, HAD anxiety data. The 
basic objective of the analysis was to determine the strength of evidence for a change in the 
level of anxiety over time and also to determine whether this response was different in the two 
treatment arms. The models have been fitted using MLn software (Rasbash and Woodhouse, 
1995) and RIGLS. 
The analysis is presented in three parts. Section 3.3.1 focuses on modelling the change in 
response over time. This analysis uses responses on the 57 patients in the study who gave at 
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least one HAD anxiety score during the eight week period following radiotherapy. In Section 
3.3.2, this model is extended to consider differences between the two treatment groups. For 
this analysis, an adjustment for baseline anxiety is made. As baseline data was not available 
on some of the patients used in the initial analysis, this second analysis uses a smaller data set 
containing only 37 patients who were divided 15: 22 between the continuous and the split course 
radiotherapy groups. Section 3.3.3 examines the assumptions of the models. 
All parameter estimates from these models are presented with standard errors (SE). As these 
are based on asymptotic Normality assumptions, for the variance components of the models 
they are considered only as a guide and not used as the basis of significance testing of the 
individual estimates. 
3.3.1 Modelling a change over time 
With anxýij representing the jth anxiety response of the ith subject and occ, the timing of 
response measured in weeks following the start of treatment, a model for a change in the level 
of anxiety over time was formulated in three stages. The three models used are described 
below. 
Null model 
An overall mean response a was assumed constant over all occasions and treatment groups. 
anxö=a +u, +eü (3.12) 
Model one - occasion as a fixed effect 
A linear trend in response over time with the measurement occasion fit as a continuous 
covariate in the interval [0,7], where occasion 0 denotes 1 week following the start of 
treatment, 
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anxýý =a + ßoccýý+ui+e; ý (3.13) 
Here the parameter a gives an estimate of the intercept (or mean response at 1 week after the 
start of treatment) for the population. The intercept for patient i is then given by (a +u, ). The 
slope, ß, gives an estimate of the rate of change in response over the period which is assumed 
constant across subjects. 
Model two -occasion as a random effect 
In model two, the occasion effect was allowed to vary over individuals, such that the rate of 
change in score over the follow-up period is different for each patient. This corresponds to the 
basic model of equation (3.1). 
anxýý=a + ßoccj+u, +v, vccýý+e,, (3.14) 
Again the parameter a gives an estimate of the intercept (or mean response at one week) for 
the population. The intercept for patient i is then given by (a +u1). With the slope now allowed 
to vary over patients. The rate of change in response for subject i is (ß +v. ), with ß estimating 
the average rate for the population in general. 
As described in Section 3.2, it is the variance of the subject specific effects, ui and v,, in 
each of these models which are estimated, rather than the effects themselves. However, 
conditional estimates of these effects can be obtained as described in Section 3.2.5. A 
comparison of the goodness of fit of these models was made using a comparison of scaled 
deviances, where the scaled deviance was given as the difference in the -2 log lh of the two 
models. 
The results of sequentially fitting the above models are given in table 3.1. The fixed 
parameter estimates gave some evidence of a fall in the level of anxiety over the period with 
a reduction in the deviance from the null model to model one of 15.6 on 1 df. The estimated 
rate of the fall was 0.17 units per week (95% CI=[0.09,0.25]). By allowing a random slope 
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Table 3.1: Parameters estimates (SE) for modelling the rate of change over time for the CRC NSCLC 
HAD anxiety scores. 
Parameter estimates (SE) 
Model Null One Two 
Fixed parameters 
a (cons) 4.98 (0.57) 5.54 (0.59) 5.63 (0.59) 
0 (occ) -0.17 (0.04) -0.19 (0.06) 
Random parameters 
Level two a. ' 17.90 (3.47) 17.80 (3.44) 18.35 (3.72) 
a2 --0.11 (0.04) 
aW -- -0.28 (0.28) 
Level one a2 3.03 (0.25) 2.88 (0.24) 2.32 (0.21) 
-2 log Ih 1582.0 1566.4 1547.8 
These results correspond to a set of 57 patients who gave at least one HAD anxiety response 
following the start of treatment. the time of measurements is measured in weeks from I to 8 coded 
occ=0,..., 7. 
across subjects, a slight increase in the estimated average rate of the fall in anxiety was seen 
(-0.19,95% CI=[0.07,0.31]). The standard error of this estimate was slightly increased 
compared to that of the previous model. This was expected given the increased variability 
across subjects which has been allowed by the introduction of the random slope. In conjunction 
with the larger rate of fall in the response level over the period, was an increase in the intercept 
parameter. 
The estimates of the random components indicated a large degree of variation across 
subjects. Within all three models, the estimated variance of the intercept, a,,, was very high 
relative to the fixed estimate. Consistent with the reduction in precision of the fixed parameter 
estimates, it increased further on inclusion of a random slope. The negative covariance 
between intercept and slope, given by a.,, suggested that subjects who witness a more marked 
reduction in their level of response tended to have relatively higher initial responses than those 
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with a more modest fall in response. This could be an artefact of the bounded nature of the 
response - subjects with relatively low initial scores have less scope for change in their 
subsequent responses over time. There was strong evidence in favour of slope variation across 
subjects shown by a reduction in deviance of 18.6 on 2 df. On this basis, with model two as the 
preferred model, subject specific predicted response profiles were estimated using the 
conditional estimates of the subject specific residuals, (u,, v, ), i=1,..., n. These are shown in 
figure 3.1. Contrasted against those of figure 2.4, they show less variation in overall response. 
In particular, the outlying profiles highlighted in Section 2.2.2 did not stand out in figure 3.1. 
This was because, in the earlier section, the estimated profiles for these subjects were based on 
very few observations, whereas, in figure 3.1 their prediction was based also on the 
distribution of response for all subjects. In the multilevel model, fitted profiles for these 
subjects were shrunk towards the population average. 
Given the variance estimates of table 3.1, expected ranges for both the intercept (initial level 
of response after treatment) and the slope (rate of change in response) can be calculated. Under 
the assumption that the model is correct, these ranges will give boundaries in which about 95% 
of subject specific parameters for the population of interest are expected to lie. They will be 
similar to the reference ranges given on figure 2.4, but since they are based on the full variance 
structure they will be slightly narrower. Calculated as 0: 0.96o,, the expected range for 
subject specific slopes was [-0.84,0.46] around a mean of -0.19. That is, given that the model 
was true, the experience of individual subjects in terms of a rate of change in anxiety score in 
the immediate week following radiotherapy, may be expected to range between a fall of nearly 
one unit per week to an increase of just under half a unit. This is in contrast to an overall 
reference range for subject specific slopes of [-1.51,1.07] for the profiles of figure 2.4 around 
a mean of -0.22. 
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Figure 3.1: Plots of the predicted subject specific profiles from Model two (a) for the split course 
radiotherapy group; (b) for the continuous course radiotherapy group. The distributions of residuals 
for the split course and continuous course respectively are given in (c) and (d) for the intercept 
residuals; and (e) and (f) for the slope residuals. 
From each of these models, the estimated within subject residual variance at level one was 
much smaller than that between subjects. The particular aspect to notice about the estimates 
of the subsequent models is the fall in residual variance on inclusion of the random slope. This 
is to be expected in the light of allowing the estimated subject specific responses more freedom 
to adhere closer to the observed responses for each subject. 
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3.3.2 Modelling the effects of treatment 
The second objective of this analysis was to obtain a comparison of patient anxiety over 
time in the two treatment arms. This was done by extending the current model for a constant 
treatment group difference over time (parallel lines), a diverging difference over time (non- 
parallel lines with the same intercept), and a general difference over time (non-parallel lines 
with different intercepts). To adjust for any pre-treatment differences, patient baseline 
responses (subtracting the overall depression response mean of 7.89) denoted base;, were 
included into the model. Treatment was modelled with rt =0 for the split radiotherapy course, 
1 for the continuous course. 
Model three - adjusting for baseline 
anxýý =a + ßoccýý+Ybase, +ui+v, vccýý+er; (3.15) 
Model four - constant treatment difference 
Model four considered a constant treatment difference throughout the eight week follow-up. 
anxÜ = a+ ß occu+Y basei+ ý rt, +ui+v, occU+eU (3.16) 
Model five - unconstrained treatment difference 
Model five extended model four by allowing a difference between the rate of change in 
response over the period between the two treatment groups. This was done by introducing an 
"occasion by treatment interaction", denoted occ. rt. 
anx, =a+ 3occ, +ybasei+krt, +6occ. rtü+u, +vJOccu+eü (3.17) 
Model six - diverging treatment difference 
Within model six the intercepts within both treatment groups were forced to be equal thus 
giving a diverging treatment difference. 
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anxýý =a + ßoccU+ybasei+8occ. nU+ui+v pccýý+eii (3.18) 
A summary of the results of the analysis is given in table 3.2. Since the inclusion of baseline 
anxiety data caused a reduction in the size of the available data set from 57 to 37, the results 
of model two fitted to this smaller data set are also given in the table. 
The first thing noted from this analysis was the strong effect of the centred baseline giving 
a reduction in the model deviance of 27.3 on 1 df. Because the variable was centred relative 
Table 3.2: Parameter estimates (SE) for difference in HAD anxiety scores over time between continuous 
and split course radiotherapy in the CRC NSCLC study. 
Parameter estimates (SE) 
Model 
- 
Two Three Four Five Six 
Fixed parameters 
a (cons) 6.24 (0.73) 6.42 (0.49) 6.26 (0.62) 6.18 (0.63) 6.43 (0.49) 
P (occ) -0.24 (0.08) -0.25 (0.08) -0.25 (0.08) -0.18 (0.11) -0.19 (0.10) 
Y (base) - 0.72 (0.11) 0.72 (0.11) 0.72 (0.11) 0.72 (0.11) 
t (rt) --0.42 (0.97) 0.62 (0.99) - 
b (occ. rt) --- -0.17 (0.17) -0.15 (0.16) 
Random parameters 
Level two a. 2 18.07 (4.58) 7.07 (2.16) 7.87 (2.20) 7.82 (2.19) 7.68 (2.15) 
a? 0.16 (0.06) 0.16 (0.06) 0.16 (0.06) 0.16 (0.06) 0.17 (0.06) 
aW -0.30 (0.38) -0.01 (0.26) 0.01 (0.26) 0.02 (0.26) 0.02 (0.26) 
Level one a; 2.40 (0.27) 2.39 (0.27) 2.39 (0.27) 2.38 (0.27) 2.39 (0.27) 
-2 log Ih 1033.1 1005.8 1005.6 1004.6 1005.0 
These results correspond to a set of 37 patients who gave at least one HAD anxiety response following 
the start of treatment and a response at baseline. 
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to the overall mean, little change in the intercept parameter - interpretable as the estimated 
underlying week one response for a subject with mean depression response - was seen. The 
inclusion of the baseline responses in the model helped to explain a substantial amount of the 
variation between subjects. This was shown by the reduction in the standard error on a, the 
population intercept, and in particular the reduction in the estimated variance of subject 
specific random intercepts, 02 . 
Model four gave no evidence to suggest a constant difference in the underlying level of 
response between the two treatment groups throughout the period. Subjects in the split course 
radiotherapy arm had on average a slightly lower level of response than those in the continuous 
arm with an estimate of the difference of 0.42 and a 95% CI=[-1.48,2.32]. Similarly, there was 
no evidence that the rate of change over time may have differed across the groups. The 
estimated difference for this rate of change of -0.17 (95% CI=[-0.50,0.161) indicated that the 
level of anxiety of subjects in the continuous group tended on average to fall more than for 
subjects on the split course of radiotherapy although this was consistent with a difference which 
could have occurred by chance. 
Apart from the expected fall in the level two variance parameter ur on inclusion of the 
baseline level of response, there was very little change to the random parameters of the model 
throughout. 
3.3.3 Testing the model assumptions 
The assumptions of the hierarchical model were described in Section 3.2.3. These are 
independent identically multivariate Normality of the random effect at each level, with these 
effects independent across levels. 
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As a test for k-variate Normality, it is suggested (Johnson, 1988) that it is generally 
sufficient to check univariate Normality of the k variates, as well as bivariate Normality of the 
(k) 
2 
variate pairs, although a formal test for multivariate Normality does exist. 
For multivariate k-dimensional Normal random vectors xi, i=l,..., n, with mean z, and 
variance E, the squared (Mahalanobis) distances, 
di =(X1-X)TE-I(Xj-x) (3.19) 
will follow a Chi-squared distribution on k degrees of freedom. In terms of the random 
components of the hierarchical model, this implies that, under the assumed multivariate Normal 
distribution for the r-1,..., n(") units at level h, the squared distances 
ds= p *)TOW-1 ß(') (3.20) 
rrr 
should be approximately Chi-squared random variables with p ctiý degrees of freedom, although, 
the exact distribution of these quantities is unknown. Since the residuals have been estimated 
on the basis of the model and the covariance matrix, it is expected that in reality, it will be less 
dispersed than the X. For a particular model, this can be assessed by using a Chi-squared 
or Gamma plot, in which the squared distances, calculated using the shrunken residuals and 
estimated covariance structure of the model, are ordered from smallest to largest, and plotted 
against the appropriate centiles of the Chi-squared distribution with p(h) degrees of freedom, 
This is shown in figure 3.2 for the level two (subject) random effects of model- six. Also 
shown in the figure are the univariate Normal plots and a bivariate plot of the intercept and 
slope residuals. Although some skewness to the tails of the distributions are seen, each these 
plots show reasonable accordance to the Normality assumptions. 
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Figure 3.2: Residual diagnostics for the level two residuals for Model six using (a) Normal plot of 
intercept residuals; (b) Normal plot of slope residuals; (c) bivariate scatter plot of intercept and slope 
residuals; (d) Gamma plot of the Mahalanobis distances. 
A common feature of longitudinal data is serial correlation. Therefore, as well as the need 
to check the Normality assumptions of the level one residuals, some check for independence 
of the residuals is also needed. This can easily be done by plotting the level one residuals at 
occasion j against those at occasion j-1, or at lag one. This is shown in figure 3.3 along with 
a Normal plot. The same assumption can also be assessed by modelling an auto-correlated 
structure for the level one residuals (Goldstein et al., 1994), that is e, =pe,, _I+V0. 
The resultant 
change in -2 log lh was 0.1, and the estimated auto-correlation coefficient 0.08, giving no 
evidence of a violation of the model assumptions. 
3.3.4 Conclusions 
The overall conclusion from the modelling attempted so far was that although there was 
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Figure 3.3: Residual diagnostics for the level one residuals for Model six showing (a) Normal plot 
of residuals; (b) scatter plot of residuals against residuals at lag one. 
some evidence of a fall in the level of anxiety over the follow-up period, there was no evidence 
that the extent of this fall was related to the treatment received (model six). Similarly there was 
no evidence of a difference in the underlying level of response between treatment groups 
(model four). 
There was an apparent inconsistency in the results of the two models, with the average 
profile - given by (S, 
a) - for subjects on the split radiotherapy course lying above that of 
those on the continuous course in model six, and below in model four. In Normal linear 
regression modelling, this would not happen. However, in the hierarchical model, as the total 
residual is formed of a subjects component, (u,, v, ), as well as the residual component, eö, such 
results may occur. 
One of the advantages of multilevel modelling over alternative models for repeated 
measures data is the ability to explicitly model the variance structure both within and between 
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subjects. In this example the variance estimates obtained highlighted a large degree of 
variation particularly between subjects. This was seen both in terms of the underlying response 
level (intercept term) and the estimated trend over time. However, introduction of baseline 
response (centred around the overall mean) did greatly reduced the variance between subjects 
on the intercept term (model three). 
Despite the lack of evidence for a treatment difference it was decided for completeness that 
a treatment component should be retained in the model. On the basis of the model deviances, 
and an examination of the residuals from models four and six, the latter was taken as the 
preferred model to be used in further examples of model extensions. 
3.4 Multiple dimensions in response -a three level model 
One of the major issues in the analysis of quality of life data arises from its multi- 
dimensionality with responses often taken in many distinct areas of quality of life. Although 
the most commonly used measuring instruments have scoring systems which give overall 
summary scores in appropriate dimensions, to combine these dimensions further to give a single 
overall score is inappropriate. Therefore problems of multiple comparisons of scores in several 
dimensions can arise in the assessment of treatment comparisons. Cox et al. (1992) suggest 
Bonferroni type corrections be used as a simple solution. An alternative solution is presented 
by Tandon (1990) using global statistics (O'Brien, 1984). This approach, which has also been 
advocated by Pocock et al. (1987) combines the results of multiple analyses into a weighted 
global score with weights determined by the precision of the individual estimates. This gives 
an overall test statistic for the hypothesis of an overall treatment benefit in favour of one 
treatment which can be used to complement the results for each individual item. Unfortunately, 
the approach does not allow estimation of a combined covariate effect, simply a test statistic. 
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It is also directional, meaning it is only appropriate if the direction of effect is consistent over 
all variables. 
Although a global statistic could be formed from the results of a series of two level models, 
repeated measurement data with multivariate outcomes can be modelled within the framework 
of a three level model. Such a model will have advantages over both Bonferroni corrections 
and global statistics because it gives dimension specific estimates of covariates of interest, as 
well as enabling full estimation of the covariance structure between dimensions, between and 
within subjects. This not only enables estimation of the correlation between dimensions, but 
also makes it possible to make a direct comparison of the ways in which the covariate effects 
vary across dimensions. For example, it becomes possible to test directly whether the response 
to treatment is the same in all dimensions, whether a patient's physical morbidity is affected 
to a greater extent than their psychological morbidity, or whether the pattern of change in 
response over time the same in all dimensions. Given homogeneity of a parameter of interest 
across dimensions, a combined estimate over all dimensions can then be estimated directly from 
the model. Like the global statistic, this appropriately weights for the precision of the 
dimension specific effects. The analysis also has a technical advantage when complete 
responses for all dimensions are not available. Unlike the global statistic which requires 
observations available in all dimensions at a single time, the three level multivariate model can 
cope with unbalanced data across dimensions as it draws upon information about the covariance 
structure of the available data to give information about those which are missing. It will 
therefore have an increased power over the respective univariate analyses and global statistic. 
Within the three level model, the individual dimensions are regarded as level one units 
nested within measurement occasions at level two, nested within subjects at level three. The 
within and between variance components (at level two and level three) are considered in exactly 
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the same way as for the two level analysis. At level one, the differences between dimensions 
are assumed fixed, that is differences between dimensions are not regarded to derive from 
random variation. The assumptions of the model are the same as those of the univariate two 
level model. In this section, after giving details of the parameterisation of the model, it is used 
for the analysis of the responses from the HAD scale in the CRC NSCLC study which is 
measured in two dimensions. The results of the analysis are contrasted against those given by 
the corresponding univariate analyses. 
3.4.1 Parameterisation of the model 
To illustrate the parameterisation of the three level model for multivariate repeated 
measurement data, the two level model of equation (3.1) is extended to three levels to 
incorporate a multidimensional response. Letting yj, denote the lth dimensional response 
(1=1,..., L) for the jth measurement of the ith patient, the underlying model is written 
L 
}z cý y;;, - -E 
{a, + ßºoccr; +ur. f+vr. occg .. +ep.. f,, º f 
(3.21) 
where z1 =1 when yr, is a response in dimension 1,0 otherwise. It is assumed here that the 
covariates of the model for each dimension is the same. This is done for simplicity and is not 
a necessary restriction of the model. 
The (fixed) parameters a, and ß, represent the population average effects for response in 
the 1th dimension for a given mean response in the other dimensions. Subject specific 
responses are assumed distributed randomly around these population averages with the extent 
to which subject i deviates from (a,, (3) given by (u11, v11). Over all dimensions, as in the 
univariate case, these residuals, (u,, vT)={(u,, I..., u, L), 
(vII ,..., vi, 
)} 
, are assumed to 
be independent 
identically distributed multivariate Normal random vectors with mean 0 and, for a simple two 
dimensional case, variance, Q= 
IN 
where Zur F'V 
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2 
Qw/ Qr12 °rvi arlV2 °2VI °V12 
4Y = 
ýV= 
aMI2 01,2 
' Qr2Vl QMY2 QV(2 QV2 
(3.22) 
Here, the variance components aZ, a2, and au,, 1=1,2 are specific to the lth dimension and 
correspond to the variance components a,, a. and au,, estimated in the univariate model. The 
covariance terms 0u12 and 012 indicate how the intercept and slopes in the two dimensions co- 
vary across subjects. The terms auny2 and ou2i,, give information about the relationship between 
a subject specific intercept in one dimension and the slope in the second dimension. In the 
subsequent example, these latter terms are constrained to be zero, and E, is assumed diagonal. 
At level two, the within subject residuals, eý=(eLý,..., eüL), are assumed to have a multivariate 
Normal distribution with mean 0 and variance (for the two dimensional case) 
G"' 
U(2) = E, _ 
°. ' °. n 
where 0e! 2 
describes how, on individual occasions, the responses within 
z 0,12 °e2 
subjects deviate from the mean for that subject. For example, on a particular occasion, when 
a response in one dimension is a long way from its expected value, whether responses in other 
dimensions tend also to be a long way from their expectation. 
For the general case with L dimensions, E., Ev , 
E., and Ee will be of the same structure 
with dimension (LxL). By constraining the inter-dimensional covariances at levels three and 
two to be equal to zero, the responses at each level can be treated as independent. The results 
from this model will be the same as those obtained from the L corresponding univariate 
analyses. 
3.4.2 Extension of the current analysis 
The analyses so far for the anxiety data gave the following basic model, 
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"- 
Q2 Url2 
2 
arl2 Qr2 
For simplicity, the same underlying model for the depression scores was also used. This gave 
a multivariate model written, 
2 
qolýý, =E { a, +ß, occY+y, baser+öIocc. rtý+un+vitoccýý+eýp }z; jn (3.24) 
r=i 
At level three (between subjects), the variance components are given by j)(3) =E 
EN EEY NY 
, where 
At level two (within subjects) E. and E( are 
2 
are 
rt 
as given 
I0 
UNV0 
2) 
in equation (3.22) and ENV= 
oNY` NV 
n<z> =E= r 
The results from this model, alongside those of the corresponding univariate models are 
shown in table 3.3 for the fixed parameters and table 3.4 for the random parameters. Very 
slight differences were apparent. These are attributable to the additional covariance structure 
Table 3.3: Fixed parameter estimates (SE) for the multivariate and appropriate univariate models for the 
anxiety and depression outcomes of the HAD scale measured in the CRC NSCLC study. 
Parameter estimates (SE) 
Univariate Multivariate 
Anxiety a (cons) 6.43 (0.49) a, (cons) 6.42 (0.59) 
P (occ) -0.19 (0.10) 0, (occ) -0.20 (0.11) 
y (base) 0.72 (0.11) yi (base) 0.72 (0.09) 
8 (occ. rt) -0.15 (0.16) b, (occ. rt) -0.12 (0.17) 
Depression a (cons) 6.83 (0.52) a2 (cons) 6.79 (0.55) 
P (occ) -0.17 (0.11) ß2 (occ) -0.15 (0.10) 
Y (base) 0.72 (0.12) Y2 (base) 0.62 (0.10) 
8 (occ. rt) 0.19 (0.16) 82 (occ. rt) 0.10 (0.14) 
anxýý =a + (3 occýi +y basei+S occ. rlýý +uJ+V f occýý +eýý (3.23) 
2 
ar/2 Qr2 
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which has been introduced giving a slightly different interpretation to the parameters. They 
now reflect population average effects in one dimension for given population effects in the 
second dimension. Some difference was also due to two outlying depression responses given 
on separate occasions by two subjects. Examination of the anxiety scores of these subjects at 
these occasions did not reflect the same outlying behaviour. Given the full covariance structure 
estimated in the multivariate analysis, the outlying depression responses had less leverage. It 
is believed that the large differences between a., 2 and aü estimated from the univariate 
depression model (table 3.4) was also attributable of these outlying responses. 
Since the three level model estimates the full covariance structure of the data, a direct 
comparison of parameter estimates across dimensions is possible. Given no evidence of a 
difference between the dimensions, combination of the scores to give a simple overall summary 
Table 3.4: Dimension specific random parameter estimates (SE) for the multivariate and appropriate 
univariate models for the simultaneous analysis of the anxiety and depression responses of the HAD 
scale in the CRC NSCLC study. 
Parameter estimates (SE) 
Anxiety 
Univariate Multivariate 
Level two aM 7.67 (2.1 5) C121 7.51 (2.08) 
a', 0.17 (0.06) aVt 0.17 (0.06) 
a, 0.02 (0.26) aw, -0.01 (0.21) 
Level one 02 2.39 (0.27) Gel 2.39 (0.27) 
Depression 
Level two a;, 
a', 
Level one 
Oily 
a" 
7.76 (2.27) 
0.15 (0.06) 
-0.19 (0.28) 
3.08 (0.34) 
2 
Qv2 
Q 
W2 
2 aei 
9.11 (2.40) 
0.13 (0.06) 
-0.36 (0.25) 
3.10 (0.34) 
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may then be obtained. Naturally this estimate will have more precision than several dimension 
specific estimates. This is of particular interest for the estimated treatment effect. In this 
example, although the treatment effects in the two dimensions had different signs, there was no 
statistical evidence of a difference in the treatment by occasion interaction for each dimension 
(p=0.17). By fitting a single parameter in place of the two dimension specific parameters for 
the different slopes, a summary estimate of the difference in rate of change in anxiety and 
depression over the follow-up period of 0.01(SE 0.14) units per week was obtained, giving no 
evidence of a difference in the improvement of quality of life over time between the two 
treatment groups. 
The further gain of the three level model for the analysis of multidimensional repeated 
measurement data over other analyses suggested in the literature stems from the ability to 
estimate the inter-dimension covariance structure. Given this information, it is then possible 
to obtain an estimate of the correlation between dimensions which allows for its repeated 
measures aspect. Bland and Altman (1995a, 1995b) discuss estimation of such quantities when 
data are balanced, and in Section 2.2.4 this was presented as part of an exploratory data 
analysis. Since the data from the CRC NSCLC study are unbalanced, the calculation of 
correlation estimates is complicated and they were not presented. Given the covariance 
estimates from the multivariate model, appropriately adjusted estimates of association, both 
within and between subjects, can be estimated from this model despite the unbalanced nature 
of the data. These are presented in table 3.5. Within each 2x2 block of the table, the estimated 
covariance (SE) between dimensions are given below the diagonal, the estimated variances, as 
given in table 3.4, are given in bold type on the diagonal, and the estimated correlation between 
dimensions, as calculated from the appropriate covariance and variances, are given above the 
diagonal. 
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Table 3.5: Covariance / correlation estimates between dimensions as given from the multivariate model. 
Covariance (SE) / Correlation 
Intercept Slope 
Dimension Anxiety Depression Anxiety Depression 
Between subject 
Anxiety 7.51 0.65 0.17 0.47 
Depression 5.39 (1.72) 9.11 0.07 (0.04) 0.13 
Within subject 
Anxiety 2.39 0.15 
Depression 0.46 (0.22) 3.10 
Within each 2x2 block of the table, the estimated covariance (SE) between dimensions are given 
below the diagonal, the estimated variance of responses, as given in table 3.4, are given in bold on 
the diagonal, and the estimated correlation between dimensions, as calculated from the appropriate 
covariance and variance estimates, are given above the diagonal. 
The correlation estimates between subject give the level of association of average levels of 
responses across subjects. The estimate of 5.39/«7.51 x9.11)=0.65 for the intercept term 
suggested that subjects who on average had a high anxiety response also had relatively high 
depression scores. For the association of the subject specific slopes in the two dimensions, the 
positive correlation of 0.47 suggested that changes in the level of response over the follow-up 
period in one dimension tended to be accompanied by changes in the same direction in the 
second dimension. These relationships are reflected in the scatter plot matrix of residuals 
shown in figure 3.4. 
The within subject correlation estimates correspond to estimation of the association between 
dimensions within a subject on each occasion. That is, whether a higher than average response 
for a subject on a particular occasion (given their underlying profile) in one dimension is 
matched by a similarly higher than average response in a second dimension. The very low 
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estimate of 0.15 for these data indicates that at individual occasions there was little association 
between the responses in terms of differences from their expectation. This lack of relationship 
is shown in figure 3.5 in terms of a scatter plot of predicted level two residuals for the two 
dimensions. This figure also shows univariate Normal plots of the residuals and a Gamma plot 
for a test of bivariate Normality of the residuals. Similar plots for checking the assumptions 
of the level three residuals are given in figure 3.6. These show satisfactory univariate Normal 
distributions in all cases. 
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3.4.3 Conclusion 
This work has demonstrated the extension of the simple two level model for repeated 
measurements to three levels for the analysis of multidimensional repeated measurement data. 
The analysis has many advantages over univariate analyses, with Bonferroni corrections to 
adjust for multiple comparisons, and global statistic methods that have been suggested in the 
literature. These all stem from the ability to model the data from all dimensions simultaneously 
and thus obtain estimates for the inter and intra dimension covariance structure both within and 
between subjects, even with highly unbalanced data. Given these estimates, it is possible to test 
homogeneity of estimated covariate effects in each dimension, and then if appropriate, to 
combine these estimates to a single effect. This not only gives an global test statistic, it also 
gives a global estimate for the effect of interest. Such an estimate may be of particular interest 
in quality of life studies, when the bulk of available information to convey often causes 
problems. 
Although the example presented here was very simple - including only two dimensions with 
the same underlying model - this was only done for ease of presentation and is not a restriction 
of the models themselves. 
3.5 Modelling complex patterns of level one variation 
An assumption within the modelling framework which has not yet been discussed is that of 
constant residual variance across occasions within subjects. In the presence of variance 
heterogeneity, the conventional modelling approach would be to try and eliminate it using a 
variance stabilising transformation. A multilevel model however allows the heterogeneity to 
be modelled explicitly (Goldstein, 1995). As well as overcoming the problem by forcing an 
underlying structure on the residuals, this variance modelling also enables the specific sources 
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of heterogeneity to be investigated which itself could be of interest. For instance, subjects on 
one treatment regimen may tend to exhibit more variation in their responses than subjects on 
another regimen. Alternatively, residual variation may be related to the underlying level of 
response. Although variance modelling can be done at any level, modelling of the level one 
residual components is illustrated here. For simplicity, the univariate model for the HAD 
depression scores given in tables 3.3 and 3.4 is extended for complex residual variation. The 
residual variance is modelled in terms of two covariates, both as a function of treatment 
received and level of baseline response. The extensions to the model parameterisation are first 
laid out. 
3.5.1 Re-parameterisation of the model 
In the basic model of equation (3.1), the level one variance is assumed constant across 
subjects, that is var(eý)=Q2 for all i. Assuming we can partition the population into two 
subgroups (1 and 2) with the level one residual in each subgroup denoted e1 and e21J 
respectively, the level one residual can be written, 
e, =el, z, ü+eiuz2u (3.25) 
where z, ü and z2u are 
dummy variables defined so z,, =1 for subgroup 1,0 for subgroup 2, and 
z2U=0 for subgroup 1,1 for subgroup 2. Denoting the residual variance in each of these 
subgroups (1 2l and ae2 the level one residual variance then becomes 
var(e, )=oelz1U oiz2Y (3.26) 
In terms of the general model notation of Section 3.2, this is just a simple extension of the 
level one design matrix, I(» to the (Nx2) matrix (Z Z2), where Z, andZ2 contain the elements 
1az 0 
and z2,, corresponding to Y. The variance components, o., and a 2, form A(') e' 
0 az e2 
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An alternative and more flexible way of modelling the variation is to concentrate on the 
difference between the two variances directly. In this model a single dummy variable is used 
to define subjects in the second subgroup. The level one residuals eý,, can then be written, 
er; =e ,,, +e2; 1T 2;! (3.27) 
where e2. is the additional residual for subjects in the second subgroup with the level one 
variance then modelled as, 
2 
Väf(C, Ü+e2iJZ2iJ) =(, el +2 Qr/2 Z2ij (3.28) 
The interpretation of a., is unchanged with 20C, 2 giving the additional 
level one variation for 
subjects in the second subgroup and may be positive or negative. 
In terms of the more general notation, V is the (Nx2) matrix (1N Z2), where 1N is an 
(Nx 1) vector of ones and n("= 
n`l ar12 
°. Iz 0 
The conclusions from the two model specifications will be identical. The latter, however, 
gives more flexibility in terms of further modelling, and makes the model easy to generalise to 
more than two subgroups, or to the case in which the residuals are structured in terms of 
continuous explanatory variables. For example, for a continuous covariate, xü, for subject i at 
occasion j, 
eu=eou+e1Uxij and var(eü)=QA+2 °,, xü 
where 20, E 
is the additional level one variance due to a one unit change in x,, . 
3.5.2 Extension of the current model for the study data 
The basic model which is extended in this example using the CRC NSCLC HAD scale 
0a/2 U 
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depression data has the same parameterisation as model six (table 3.2). For dep,, the 
depression response for the ith subject at the jth measurement occasion, 
depU = a+ ß ocyY base, +8 occ. rtü+u, +vjoccu+eU (3.29) 
The residual components of this model were modelled in terms of two covariates already 
defined - treatment and baseline response. 
Model seven - residual variation modelled as a function of treatment 
Allowing the residual variation to be a function of treatment group tested the hypothesis that, 
within subjects, patient depression within one treatment group was more variable than in the 
second group. 
depýý=a+ P occü+Y basei+8 occ. rtU+ur+vioccu+eai+elurtr (3.30) 
where eW denotes the within subject residual for all subjects, el, is the additional within 
subject residual for the continuous group and rti is the treatment covariate which equals 0 for 
patients in the split course, 1 for the continuous group. The variance at level one was modelled 
as 
var(eou+eiUri) °Q, o+2aýoj ni (3.31) 
where C F2 the variance of the within subject residual components for patients in the split 
course group, and 2o, ß is the additional variation experienced by subjects in the continuous 
radiotherapy arm. 
Model eight - residual variation as a function of baseline depression 
Modelling the residual variation as a function of baseline depression, tested the hypothesis that 
subjects with low baseline scores tended to exhibit different amounts of residual variation than 
those with a higher baseline score. This difference was modelled as a linear trend in increasing 
baseline score 
dep,, =a+ßocc, +ybaser+8oec. r +ur+vrocc, +eW+e, baser (3.32) 
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where, as in the fixed part of the model, each subject's baseline depression score was modelled 
as a difference from the overall mean depression score. The variance at level one was 
parameterised as, 
var(eoi+e21jbase, )=a2 +20X02base; (3.33) 
where vO is the expected residual variation for subjects with a mean baseline depression score, 
and 2aeOJ is the expected increase in this variance for each unit increase in baseline score. 
The results of extending model six for the depression scores, to examine the level one 
variance components, are given in table 3.6. Inferences for these analyses were made on the 
basis of changes in the model deviances because of the difficulties in interpreting the 
asymptotic standard errors of the variance components, as discussed in Section 3.2.4. 
Table 3.6: Parameter estimates (SE) for modelling level one heterogeneity for depression scores. 
Parameter estimate (SE) 
Model six Model seven Model eight 
Fixed parameters 
a (cons) 6.83 (0.52) 6.88 (0.53) 6.91 (0.50) 
P (occ) -0.17 (0.11) -0.19 (0.11) -0.18 (0.11) 
8 (base) 0.72 (0.12) 0.72 (0.12) 0.70 (0.12) 
y (occ. rt) 0.19 (0.16) 0.19 (0.18) 0.15 (0.16) 
Random parameters 
Level two a'. 7.76 (2.27) 8.44 (2.39) 7.15 (2.03) 
a',, 0.15 (0.06) -0.36 (0.32) -0.17 (0.26) 
aMV -0.19 (0.28) 0.20 (0.07) 0.16 (0.06) 
Level one a; 4p 3.08 (0.34) 1.96 (0.29) 3.50 
(0.42) 
°Au - 1.20 (0.40) 0.31 (0.04) 
-2 log lh 1044.3 1032.3 986.2 
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Evidence of variance heterogeneity related to treatment was seen with a change in deviance 
of 12.0 on I df. The estimated difference in variance suggested that subjects receiving the 
continuous treatment course tended to have a larger degree of within subject variation (1.96 
versus 4.36). The evidence of a linear relationship with the level of depression response at 
baseline was even more convincing with a reduction in the model deviance of 58.1 on 1 df. The 
estimated relationship showed an increasing within subject variance with an increasing level 
of baseline response. 
3.5.3 Conclusions of the model 
The model extensions demonstrated here were used in an attempt to explain the possible 
heterogeneity of the within subject level one variance. It was seen that there was some 
evidence that the extent of within subject residual variance was related to treatment received 
(model seven), and also to baseline response for which it was estimated that the within subject 
residual variation changed from 3.50 for mean baseline depression, at a rate 0.62 units change 
per 1 unit change on the mean baseline response. However, when these results were examined 
further using plots of the level one residuals in model six for the depression data by the two 
covariates of interest in this analysis (figure 3.7), it was seen that, particularly in terms of the 
relationship with adjusted baseline response, these observed relationships were attributable to 
two outlying observations. Both of these patients were on the continuous radiotherapy course, 
and had baseline depression scores above the overall mean. Omitting these patients and 
repeating the heterogeneity analyses yielded no evidence of variance heterogeneity. 
These observations, emphasised that, although modelling of the variance components is 
possible, the results may not be robust to non-Normality or outliers. This will be particularly 
important in small samples when the results are more likely to be influenced by a few subjects 
with rather extreme results. Careful inspection of these aspects is therefore important before 
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Figure 3.7: Within subject (non-standardised) residuals from model six for the CRC NSCLC HAD 
depression scores: (a) Normal plot for Normality; and plotted (b) by treatment group; and (c) by 
baseline depression from which the overall mean depression score has been subtracted. 
claiming evidence of variance heterogeneity, and it was concluded that heterogeneity of the 
level one residuals was not a problem in these data. 
3.6 Summary and discussion 
The work presented here has demonstrated the use of hierarchical (or multilevel) models for 
analysis of quality of life data given as repeated continuous outcomes. Their flexibility for the 
analysis of longitudinal data which is severely unbalanced (in this case due to missing data) as 
well as incorporating multiple dimensional outcomes was demonstrated. The models require 
a number of critical assumptions, but although not well developed within the multilevel 
literature, model checking was shown to be relatively straightforward using estimated shrunken 
residuals. Further work is needed in this area in order to determine the exact properties of these 
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shrunken residuals for the assessment of multivariate Normality. Although shown to be non- 
robust to outlying observations, modelling of residual variances is also feasible to look for 
evidence of variance heterogeneity. A further problem with longitudinal data, which has not 
been discussed here in detail, is serial correlation. In terms of the two level model, this would 
occur at level one and result in the non-independence of the level one residuals. It has been 
argued by Jones (1990) that, after incorporating random subject effects, further serial 
correlation of the within subject residuals may be unlikely. However, the flexibility of the 
hierarchical model structure makes inclusion of a component of serial correlation to test this 
assertion straightforward (Goldstein et at., 1994). 
Because of the flexibility of the models, it is important that an appropriate analysis strategy 
is pre-defined. This should involve exploratory data analysis as outlined in Chapter 2, and 
outlining questions of scientific interest pertaining to the population (or fixed) effects and 
perhaps more importantly, those to be addressed in terms of the random components 
representing the between and within subject variation. This importance was demonstrated in 
Section 3.5, where the results of the analysis modelling of the level one variance were seen to 
be heavily dependent on a few outlying observations. Further work is perhaps needed in this 
area to determine whether this is a problem relating to examples with small samples or a more 
general concern of the modelling strategy. 
Perhaps the most important use of hierarchical models for the analysis of quality of life data 
is the ability to incorporate data from many dimensions of quality of life measured into one 
analysis, thus obtaining overall covariate effects, as well as appropriately adjusted estimates 
of inter-dimension associations within and between subjects. The multivariate example given 
here was the most simple case with only two dimensions with an equal number of responses in 
each dimension. However, the model does not require such restrictions. For instance, as often 
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occurs in quality of life studies, a subject may have a response in one dimension where their 
response in another dimension is missing. In this situation the multivariate model in fact gives 
a technical advantage over univariate approaches in that, given the reasons underlying the data 
being missing can be ignored, the analysis draws upon information available about the 
correlation structure between dimensions, improving the precision of dimension specific 
estimates. 
Within this analysis, the substantial amount of missing data (detailed in tables 2.1 and 2.2) 
were treated simply as causing an unbalanced data problem. In terms of the introduction of bias 
due to missing data, they were ignored. The implications of this, along with a more detailed 
consideration of the missing data problem, are discussed in Chapter 7. 
In terms of the example presented, another concern was the small sample size on which the 
analysis was based. Of the 82 subjects in the study, 57 contributed at least one post 
randomisation response. With the inclusion of baseline responses only 37 cases out of these 
57 were included in the main analyses presented. For the use of these types of models in 
practice, larger samples than this would generally be recommended, not least from a scientific 
point of view - little can be inferred from 37 patients who exhibit a large degree of variability. 
Although a simulation study carried out to investigate the robustness of the analysis in such a 
small sample gave no evidence of bias in any of the fixed or random parameter estimates when 
a restricted iteratively generalised least squares procedure (RIGLS) was used, further work is 
still needed in this area to help determine methods for sample size calculations when such 
models are to be used for data analysis. 
Alternative analyses for repeated measurement data are possible. These are reviewed by 
Crowder and Hand (1993) and Everitt (1995). For balanced data these include modifications 
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to a split plot analysis of variance or, for more complex correlation structures, multivariate 
analysis of variance (MANOVA). With unbalanced data and missing values these approaches 
become infeasible. In addition, MANOVA has been shown to lack power when the number of 
measurement occasions is large as is often the case in quality of life studies in cancer research. 
Antedependence models (Kenward, 1987) achieve greater parsimony and hence precision than 
MANOVA by restricting the correlation structure to take various sensible forms. However, 
they do not cope well with unequally spaced data and their results may be difficult to present 
simply for clinical purposes. Simple methods based on constructing summary statistics for each 
subject (Matthews er al., 1990) which are intuitively simple become more difficult when 
subjects have different numbers of measurements, yielding varying precision, or if some 
subjects have very few measurements (Matthews, 1993). Moreover, such analyses ignore 
information available from other subjects in terms of the distribution of subject specific 
profiles. Marginal modelling approaches such as weighted least squares and generalised 
estimating equations (GEE) (Zeger and Liang, 1992) provide an alternative framework which 
can cope flexibly with unbalanced data and may allow more general correlation structures than 
the simple autoregressive model. Within such models, the focus of the analysis is solely on the 
underlying mean process. The parameters defining the variance structure are regarded as 
nuisance parameters necessarily included in the analysis to adjust the precision of the estimates 
of this mean process. Unlike the hierarchical model, they do not therefore allow any inferences 
to be drawn about the nature of this variance structure. They do perhaps have an advantage 
over the hierarchical model, in that, being based very closely to models for cross-sectional 
analyses, their results are perhaps easier to communicate to non statisticians. Such models are 
discussed in more detail in Chapter 4, where their use and interpretation are contrasted with the 
hierarchical model for the analysis of repeated binary outcomes. 
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4 The Analysis of Repeated Binary Outcomes 
4.1 Introduction 
With a few exceptions, quality of life measuring instruments consist of a series of questions 
to which patients respond with a binary outcome - "do you suffer from this symptom, yes/no? " 
- or on an ordered categorical scale - "rate the severity of symptom on a scale of 0-3". 
Generally, the number of positive responses or the ordinal ratings are then summed to give a 
`continuous' score which may then be analysed using the methods discussed in the previous 
chapter. In some instances, this summation of items may not be recommended (for example, 
with the daily diary card) and in all cases it will result in a loss of detail about the prevalence 
and severity of particular symptoms which may be of interest to a clinician or patient. Thus the 
ability to analyse the repeated data on the original categorical scale may be advantageous. The 
current and subsequent chapter are devoted to this topic. In this chapter, two different 
approaches to the analysis of binary outcomes are discussed. This work is then extended for 
repeated ordered categorical outcomes in Chapter 5. Although other analysis options do exist, 
the use of marginal and random effect models are discussed. For reviews of these and other 
models see Diggle et al. (1994), Agresti (1989), Landis et al. (1988). 
In Chapter 3 the general theory of random effect models for the specific case of variance 
components analysis was outlined. In Section 4.2, this model is extended for use with binary 
outcomes, and the theory behind marginal models given. The basic assumptions and 
formulation of each model is reviewed, and their estimation and interpretation discussed. The 
use of the models, and more importantly the differences between them, are demonstrated using 
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two examples with data from the MRC LU07 diary card and the RSCL in the CRC NSCLC 
study in Section 4.3. Sections 4.4 and 4.5 present two extensions of these basic models to 
tackle two very different problems faced in the analysis of quality of life data in practice, those 
of complex patterns of response over time and multidimensional outcomes. 
4.2 Marginal and random effect models for repeated binary data 
Cox (1972) outlined a number of possible approaches for analysing multivariate binary 
outcomes many of which needed further research to be of practical use. Since then, with much 
research and improved computing facilities, many of the ideas which Cox proposed have 
become practicable for data analysis. Two classes of model that have received much attention, 
and which are particularly useful for the analysis of longitudinal data, are those Cox referred 
to as the logistic and latent variable models, more generally now referred to as marginal and 
random effects models. It is these two classes of model that will be discussed here. Although 
the structure of each model is discussed in greater detail in subsequent sections, a simple 
illustration of the differences between them and their interpretations for binary data is outlined 
below. Similar discussions are given by Zeger and Liang (1992), Neuhaus et al. (1991), and 
Diggle et al. (1994). 
The fundamental difference between the marginal and random effect models is the way in 
which they incorporate the dependence between repeated observations on the same subject. For 
a binary response vector, y, =(y,,,..., y, ), measured for subject i, over measurement occasions 
j=1,..., m1, the marginal model has a generalised linear model for its expectation 
incorporating the dependence between observations as nuisance parameters in the residual error 
component of this model. In contrast, the random effect model assumes that the dependence 
between observations comes as a result of some subject specific random effect, conditional 
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upon which, the observations within subjects are assumed independent. This is demonstrated 
in equations (4.1) and (4.2) which give the most basic form of each model to investigate the 
effect of a treatment covariate, x, . As 
for a standard generalised linear model, g(. ) is a link 
function, with e, the binomial error with E(e, )=0. 
Marginal model 
yr=g `(ocMtß, ari)+e, M, var(elM)=Vi (4.1) 
Random effect model 
y, =g -1(aRE+ßRExl+ur)+e, 
RE, 
u, -N(O, a; ), Var(elRE)=diag(var(e; ý)) (4.2) 
This difference in incorporating the dependence between observations leads to a very 
different interpretation of the parameters of the two models. In the marginal model they are 
population average effects and where g(. ) is the logic link function, exp(PM) is the odds ratio 
of symptoms for subjects who undergo treatment versus those who do not. In the random effect 
model they are subject specific effects conditional upon a subject's underlying response 
determined by the random effect, u,. Exp((i") is then the odds ratio of a positive response for 
subject 1 if he has treatment versus if he does not. 
Although this difference in interpretation exists for the analysis of all types of outcome - 
continuous or discrete - by taking the expectation over the distribution of the random effects, 
it is possible to transform the parameters of the random effect model to give a marginal 
(population average) interpretation, 
-1(aRE+ßRExi+ui), f(ui)dur E(yilxi)= f., 
If g(. ) is the identity link, this integration is trivial, 
(4.3) 
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EViýxý)=ýaRE+flRExlý+r u purýdur YY Jul ý` (4.4) 
and since E(u, )=0, shows an equivalence between the marginal and random effect parameters 
for this case. It is for this reason that the distinction between the interpretation of the two 
models is often overlooked for continuous outcomes where the identity link tends to be used. 
However, for other link functions, the distinction can be crucial. In particular, with the logit 
link function commonly used for the analysis of binary outcomes, taking expectation over the 
random effects, equation (4.3) cannot easily be reduced further, 
E(7jlx; )=J 
exp(a RE+ßRExi +ul) 
. 
f(u, )du, 
u, 1 +exp(aRE+pREx, +uI. ) 
(4.5) 
However, Neuhaus et al. (1991) show that equation (4.5) implies that I(3REIz1pM1, with 
equality only in the trivial case when u, =0 for 'all i. More specifically, they show that if the 
covariate x, has no effect, ßM.. 3RE[1-p(0)] where p(O) is the intra subject correlation amongst 
y,, defined as 
var(9, ý) P(ý)= E(6U)E(1 -6y) 
where logit(O)=«RE 
(4.6) 
In practical application, as this 
relationship is based on the assumed distribution of u, as well as the assumption that the 
covariate has no effect, the ratio D 66 
would be expected to approximate to [1-p(O)J. Further, 
Zeger and Liang, (1992), show that if the random effects, u1, i=1,..., n, are assumed to follow 
a Normal distribution with mean 0 and variance oü, 
pRE-(0.346Qý+1) 2 (4.7) 
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4.2.1 Marginal models for binary longitudinal outcomes 
The simplest form of the marginal model for binary longitudinal outcomes was proposed by 
Liang and Zeger (1986) and uses a standard generalized linear model for the expected response 
9U, for subject i at occasion j, conditional on a set of p covariates, which are given by the 
(mjxp) design matrix xi, 
E(yi) =9, =g -'(x, ß) (4.8) 
The var(y1) is an (m, xm, ) matrix made up of two components: an (m, xm, ) diagonal variance 
matrix which defines the Binomial variance of y,, as a known function of the mean parameters 
9, 
j, 
A, =diag{A;,,. (1-9, j)}, j=l,..., m,; and an(m, xm, ) `working' correlation matrix, denoted R,, 
which defines the correlation structure of the data. Given these two components, var(y, )=V, * 
is simply 
Vi =Ai'R, Aj' (4.9) 
Estimates for the marginal parameters ß can be obtained by solving the multivariate 
analogue of the score equations for generalised linear models, or generalised estimating 
equations (GEE1), 
s cR)=ý de, 
T 
v'' 80 a ,. ý d(3 
(4.10) 
If Rj, and therefore Vi , is correctly specified, these score equations will be the optimal 
estimating equations for ß as given by Godambe (1960) and 
dei TVt" de, 
(4.11) var(ß)=Io=ý 
i"ý dß dß 
However, Liang and Zeger (1986) showed that even if Ri is incorrectly specified, estimates for 
$ obtained from the score equations of equation (4.10), although not fully efficient, will still 
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be consistent. Further, they show that a robust estimate for their variance is given by 
var(O)=I1'I011I where 
n d6, T 
, -t T -t da, l ( i, =E dß vi (v, -A; )(y, -o; ) 
Vi. 
dal 
(4.12) 
Although the `working' correlation matrix R,, can take any form, good specification is 
required to maximise efficiency. Liang and Zeger (1986) suggested that this is best obtained 
by assuming a general form of the matrix with unknown parameters p. For example, for 
longitudinal data with fixed measurement occasions, j=1,..., m, exchangeable or auto-regressive 
general forms can be assumed for some underlying lag one correlation p. That is, 
IPP.. 
R, ex(P) PP... and R, AR (P)= 
PPý 
respectively. 
PpI 
I1Pp2p3IPý 
2 PP 
pm2 ... p1p 
M-1 ... p2 p1 
Estimates for p are obtained via some function of the Pearson residuals following estimation 
of P. The specific form of the function used depends on the general form of the correlation 
structure. Examples are given by Liang and Zeger (1986). GEE1 is then an iterative process 
where at the first iteration, starting values for p or an independence model are assumed. 
Although GEE1 performs well in estimation of ß, estimation of p relies on the basic 
assumption underlying the general form of R, which is generally arbitrary. If information about 
the correlation is of interest, it is therefore suggested GEE1 is not used (Liang et al., 1992). 
Prentice (1988) suggested that when such inferences about the correlation structure are 
required, a general model for the two-way cross products and their expectations is incorporated 
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into the analysis to give direct estimation of correlation parameters, p. This analysis (GEE2) 
uses an iterative procedure with a second set of estimating equations for p using the cross- 
products and their expectation and of the same form as those of equation (4.10). Fitzmaurice 
and Laird (1993) presented a similar model with the two-way associations modelled in terms 
of log odds ratios. Although giving more efficient estimates for the association parameters than 
GEE1, Carey et al. (1993) show that GEE2 relies on the correct specification of a model for the 
association parameters - whether in terms of correlation or odds ratios - and thus may only be 
an improvement over GEEI if there exists some a priori knowledge of the association structure. 
Further, the increased complexity with the additional set of estimating equations makes 
estimation computationally intensive and impractical even when the number of repeated 
measurements is relatively small (for example, m, =5). For these reasons GEE2 will not be 
practical for many quality of life problems when the number of measurement occasions is large, 
and is therefore not used here. 
Other specifications of the marginal model are also possible. For example, Carey et at.. 
(1993) have suggested a model which improves the estimation of association parameters and 
avoids the computational difficulties of GEE2. They call the approach alternating logistic 
regression (ALR) because both the marginal distribution and the association parameters are 
modelled using logistic regression. For ALR it is assumed that the association between pairs 
of observations, (y,, ya), j*k, may be represented by a log odds ratio, which in the most simple 
case is assumed to be some constant, p. In this case, the odds ratio of positive response 
'between yU and y,,, denoted 'F , is equal to exp(p). Estimation is an iterative two stage 
process. In stage one, GEEI is used along with a current estimate for a to give estimates for 
Given these estimates, the estimate for p is updated using a logistic regression of each y. 
on each ya (j<k), with an offset derived from the current estimates of ß and p. Formally, 
denoting E(y, ý)=9U, E(yy, k)=v,, and assuming a constant log odds ratio for all pairs (yi, ya), 
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j<k, the stage two logistic regression for p is 
logit Pr(yV=lly, k)=Py, k+ offset ýa. i3ý 
where offset=log 
8; ý-v; jk 
(, 
the log odds of y;,, =1 for y; k=0. This can be evaluated using 1-0; ý-e; k+Vtik 
current estimates of the marginal expectations A. and 9, k from the stage one solution to GEE1 
and an estimate for VUk which itself can be evaluated from the current estimate of p and the 
stage one marginal parameters using the expression derived by Lipsitz et al. (1991): 
f'k-Vi 
-4P(P-1)0, jOik}2 for ps1 v'Jk. 2(p-1) 
p eriieik for p=1 
(4.14) 
where flik=(1-(l -P)(ei+ejk)} . 
To demonstrate the general use of these models, only GEEI is used. 
4.2.2 Random effect models for longitudinal binary outcomes 
The random effect model for repeated binary outcomes accounts for the correlation between 
observations on the same subject by assuming that each subject has their own underlying 
propensity of a positive response which is incorporated into the model as a random effect. 
Given each subject specific effect, observations within subject are then assumed to be 
independent binomial random variables. 
For subject i at occasion j the effect of a covariate xu on the outcome yU can be represented 
in the logistic regression model, 
y,, =9, j+eu (4.15) 
where y, j=1 for a positive outcome, 0 otherwise and 
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eU= 
exp(a +Px, +ut) 
1 +exp(a +ßxu +ur) 
(4.16) 
The subject specific random effect is denoted ui and is assumed Normally distributed with zero 
mean and variance o2.. Given u;, the residual eU, j=l,..., mr, for subject i are assumed to be 
independent binomial random variables with variance vU=ae9U(1-8U) where a. 2 is an over 
dispersion parameter. Although other appropriate link functions may be used for binary 
outcomes, the work here focuses on the commonly used logit link given in equation (4.16). 
Re-writing this simple model of equation (4.16) in terms of its linear predictor for logit(8U), 
8U 
tog 
1-6U =a+ 
ß"o+u1 (4.17) 
the interpretation of the parameters is clear: (a+ui) can be interpreted as the log odds of a 
positive response for subject i; and ß as the effect of a unit change in the value of the covariate, 
xü, on this subject specific log odds. For example, if y, =1 for subject i, reporting symptoms 
at occasion j, and xU is a treatment group indicator, the interpretation of exp(ji) is the odds 
ratio of symptoms for subject i if he undergoes treatment. 
As for continuous outcomes, the model can be considered as a hierarchical model with two 
levels. At level two is the variation between subjects given by the random effect u1, and at level 
one is the independent binomial errors for observations within subjects. Written in the general 
notation of the hierarchical model, equation (4.16) becomes 
9, =g -1(x, p"+x(')ß(2) =gu (4.18) 
where g(. ) is the logit link function, P. is a (pox 1) vector of fixed parameters acted on by a 
po) design matrix xj and ß1ý2) is the vector of random parameters acted on by the design 
matrix xj (2) . 
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A number of procedures are available for estimation of the fixed parameters ßo and the 
variance components var(ß(2)) (Stiratelli et at., 1984, Longford, 1988, Goldstein, 1991,1995, 
Zeger and Karim, 1991, Breslow and Clayton, 1993). As it is easily implemented within 
software for practical use, that attributable to Goldstein (1991,1995) involving marginal and 
penalised quasi-likelihood and (restricted) IGLS, is considered here. 
This is a two stage procedure involving the linearisation of the gýj in stage one followed by 
parameter estimation of this linear function in stage two. The linearisation of gýj uses a Taylor 
series expansion where it is assumed that parameter estimates from the previous iteration are 
known. For the (t+l )th iteration, a first order Taylor series expansion of gýj is written 
gU(H, "1j)=g, j(H, 
)+x, (ßor. i-ß0, )g' (H, )+(xi2)32)g'1(H, ) (4.19) 
where H, denotes the realised expectation of gi,, from the tth iteration. It is the definition of H, 
that forms the distinction between the marginal and penalised quasi-likelihood procedures. 
Under marginal quasi-likelihood (MQL), the Taylor expansion is carried out about the fixed 
part of the model and hence H, =xtat. The penalised (or predictive) quasi-likelihood (PQL) 
incorporates the estimated residuals from the previous iteration, 0, , into this expression, that 
is H, =x; ß,, +xi2, ßk ) such that the expansion is carried out around the predicted value for the ith 
subject. In this case the last term of equation (4.19) becomes r2)(ß(2)-O12))g'jý(H, ). 
Whatever the chosen expression for H,, by defining xj*=xrg'ýý(H, ) and xr (Z)=xi2)g'ü(HI), 
equation (4.15) can be written as a linear function of the parameters of interest: 
"f i(Z)(2) 
y; =x; ßo,. I+xr ßi *º', ej 
(4.20) 
where yy yj-(gjj(H, )-xr pS, }, zj= Oij(1-®, j) 
for vr=(vrj,..., vi,,, ) with o. constrained to equal 
one. The IGLS (or RIGLS for small samples) procedure can then be applied to this function 
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to obtain estimates for ßa«1 and var((3j2 )r, 1. 
Binomial variation at level one is assured by the 
definition of v1 and the constraint on o2=1. If this constraint is removed, (12 can be estimated 
as an over dispersion parameter. For an improved approximation, a second order Taylor series 
expansion may be used although this obviously adds to convergence time. For details of see 
Goldstein (1995). 
In simulation studies, Rodriguez and Goldman (1995) show that the MQL procedures can 
lead to a large degree of bias. PQL however has been shown to perform well (Goldstein, 1995, 
Goldstein and Rasbash, 1996). A potential problem with the models is that parameter 
estimation is non-robust to the failure of the assumed distribution of random effects, therefore 
diagnostic checking of residuals is particularly important. 
4.3 Marginal versus random effect models in practice 
Within this section, the use of marginal and random effect models for the analysis of binary 
quality of life data is compared to demonstrate both the practical application and the inferential 
differences of the two models. Thb first example is based on data from the activity item on the 
daily diary card within the MRC LU07 study. The second analysis uses the individual shortness 
of breath item on the RSCL within the CRC NSCLC study. In both cases, the binary response 
was created by dichotomising the score on the original ordinal scale. For the marginal models, 
GEEI with independence and exchangeable `working' correlation matrices were used. 
Corresponding random effect models were fitted using RIGLS first order MQL and first order 
PQL. The second order PQL model did not converge. An over dispersion parameter was also 
fitted within the random effect models. As this is not possible for the marginal model, the 
comparison between the two classes of model is made between the marginal model with 
exchangeable working correlation matrix and the PQL model with the binomial variance 
constrained at the lowest level. 
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4.3.1 MRC LU07 daily activity scores 
For the first example data from the activity item on the daily diary card for the first four 
weeks of follow-up within the LU07 study was analysed. This corresponds to the data 
presented in figure 2.13. Responses were dichotomised from the original five point scale as 
follows: 1/2= few or no symptoms (yýý=0); 3-5 = limitations (yj=1). Details of the scoring of 
the original scale are given in box A2.3 in Appendix 2. The focus of the analysis was to assess 
the prevalence of limitations in activity in the two treatment groups controlled for age was 
estimated. The results of these models are shown in table 4.1. The top half of the table gives 
the results for the marginal models, the lower half give those for the random effect models. The 
basic form of the two models are given below. 
Vial Random effects 
log =a"'+ "'a a +S"ýrt log 'i =axe+pREage +SRErt +u 
1-64 
p g' 1-6; j (4.21) 
Statistically, the example demonstrates the importance of the robust standard error for a 
poorly specified correlation structure for the marginal model. Based on the naive standard 
errors from the independence model, gross errors of interpretation would result. In contrast, 
it seemed that the exchangeable correlation structure was reasonable for these data, shown by 
the robust standard error being little changed from the naive estimate. Comparing the robust 
standard errors from the two models demonstrated that even when the correlation structure was 
poorly specified, reliable inferences could have been made using the robust standard error 
which in the independence model was very close to that of the exchangeable model. Similarly, 
the example demonstrates elements of the earlier discussion for the random effects model with 
the parameter estimates of the 1st order MQL model very close to those of the marginal model 
whereas those from the first order PQL were much greater. The exchangeable marginal model 
and the first order PQL model with constrained binomial variance (PQL (1)) are used for 
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inferential purposes. 
Concentrating first on the results from the exchangeable marginal model, it was estimated 
that the odds of reduced activity in the FM group was 1.25 times that in the F2 group (95% 
CI=[0.79,1.88]). There was no evidence to suggest that this difference was not due to chance. 
Table 4.1: Coefficients and SE for logistic regression model of daily diary card LU07 activity data. 
Marginal (GEE! ) 
Independence Exchangeable 
Estimate Naive SE Robust SE Estimate Naive SE Robust SE 
a (cons) 0.81 (0.04) (0.15) 0.87 (0.15) (0.15) 
P (age) -0.02 (0.003) (0.014) -0.019 (0.014) (0.014) 
b (rt) -0.18 (0.05) (0.22) -0.22 (0.22) (0.21) 
Estimates for the correlation structure 
p=0.68 
Random effect (MLn) 
Ist order MQL 1st order PQL (1) 1st order PQL (2) 
Estimate SE Estimate SE ß1N/ß" Estimate SE 
a (cons) 0.88 (0.15) 2.11 (1.90) 0.46 2.22 (0.36) 
P (age) -0.019 (0.014) -0.051 (0.03) 0.37 -0.06 (0.03) 
8 (rt) -0.20 (0.22) -0.42 (0.45) 0.52 -0.49 (0.52) 
Estimates for the variance structure 
a2=3.10 (0.28) a. 2=11.7 (1.16) 0.45 a2 =16.2 (1.55) 
o; =1 a; =1 aý=0.45 (0.008) 
age=patient age - 68.2, where 68.2 is the mean age of the sample in years 
rt=1 for F2 course, 0 for FM course 
For MQL and PQL (1), a, is constrained to equal I to give binomial variation at level one. 
The ratio ß"r/PR£is calculated using ß~ from the GEE1 exchangeable model, and 3RE from the PQL 
model. 
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The reporting of symptoms was also shown to fall with increasing age. This may be due to a 
lower expectation of activity levels in the older patients. The estimated difference in the odds 
of symptoms for a one year difference in age was -2%, 95% CI=[-4%, +1%]. Estimated from 
a marginal model, this represented the odds ratio for the population as a whole. So for the 
population as a whole, the odds of reporting adverse levels of activity in a group of patients 
aged 50, would be expected to be 25% higher than that in a group of patients aged 60. Again 
there was no evidence to suggest the observed age effect was not simply due to chance. 
The first order PQL estimates for the random effects model showed a large degree of 
variation between the reporting of symptoms across subjects. This was consistent with that 
seen in the summaries of subject specific responses shown in figure 2.13. All coefficients in 
this model were consistent in sign with those of the marginal model, although as expected they 
were much larger. In terms of the treatment covariate, the subjects specific treatment ratio was 
1.52 for the multiple fraction course of radiotherapy (FM) over the two fraction course (F2) 
(95%CI=[0.63,3.68]). Given a subject's underlying odds of reporting adverse symptoms of 
activity, this reflects a 52% increased odds if they were treated with the multiple fraction course 
rather than the two fraction course. For the age covariate, the estimated change in the subject 
specific odds of reporting adverse activity for a one year increase in age was -5% (95% 
Cl=[-10%, +I%]). Thus given a subject's underlying odds, and all other variables remaining 
constant, at the age of 50 their odds of reporting problems with activity would be expected to 
be 67% higher than that at age 60. As for the marginal model, there was no evidence to suggest 
that any of the observed effects were not due to chance. 
Table 4.1 also shows the ratio of the marginal and random effect parameters. The 
theoretical estimate according to the result of Zeger and Liang (1992) in equation (4.7) is given 
in the final row of the table amongst the estimates for the variance parameters. Some 
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Figure 4.1: Normal plots of the standardised level two residuals for the random effects model for 
MRC LU07 activity data with distributionally constrained variance of level one residuals. 
differences between those observed and the theoretical estimate were seen. This is because the 
theoretical estimate was based on not only on the assumption of Normality of the level two 
residuals, but also that the working correlation matrix was correctly specified. In terms of the 
residuals of the model with distributional constraint at level one, these showed a strong 
indication of a lack of Normality (figure 4.1(a)). The striking 'S' shape of the distribution 
occurs as a result of patients responding positively or negatively throughout the whole follow- 
up period. 
There was also some evidence of under dispersion with this model shown when the 
constraint on a. was removed (PQL (2) in table 4.1). This signifies that within this model, the 
level one residuals were less dispersed than expected given their expectation. This was because 
the subject specific effects, u1, allow the expectation for each observation to realise a value 
close to that observed, thus leaving the residuals, eU too small for the binomial variation. This 
was also signified by an increase in the estimated variance of subject specific effects, oY, in the 
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unconstrained model. This will once again be largely explained by those subjects reporting 
positively and negatively throughout. Given their random effect, the expected value at each 
occasion with be very close to that observed. 
4.3.2 CRC NSCLC shortness of breath 
The second example uses the individual item `shortness of breath' taken from the RSCL 
used in the NSCLC study. Again the response was dichotomised to give a binary score: 0/1=no 
symptoms (yj=0); 2/3=symptoms (yj=1). The analysis here focused on a constant treatment 
difference and a linear trend in log odds over time. The resulting models are given in equation 
(4.22). A marginal profile is shown is figure 4.2 and shows a clear downward trend in the odds 
of reporting shortness of breath over time and a consistently lower odds for patients in the 
continuous radiotherapy course. 
Marginal Random effects 
log 
! 
ii 
=OLM+ßMOCC;; +öMrl; log 
Iii 
=aRE+ßREOCCiI+BRErti+ui 
I -e 1-6 (4.22) 
The results of this analysis (table 4.2) show some evidence of a linear trend in log odds 
equating to a fall in the prevalence of symptoms over the period. Within the marginal model, 
this is given by an odds ratio of 0.86,95% CI=[0.79,0.94], for each additional week of 
follow-up, giving an estimated 14% reduction in the odds of symptoms each subsequent week, 
(95% CI=[6%, 21 %]). From the random effects model, the corresponding reduction in subject 
specific odds was 31%, 95% CI=[ 16,43%]. No evidence of a treatment difference was found, 
although, consistent with figure 4.2, the odds of shortness of breath were 27% lower (95% 
CI=[76% lower, 124% higher]) in the group of patients treated with the continuous course of 
radiotherapy. In terms of the effect on the subject specific odds, given a patient's underlying 
odds of reporting shortness of breath, given the continuous radiotherapy course they had a 48% 
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Figure 4.2: Marginal profile for the odds of reporting symptoms of shortness of breath on the RSCL 
in the CRC NSCLC study over the eight week follow-up for patients on the split course of 
radiotherapy: ; and the continuous course: --------. 
lower odds (95% CI=[93% lower, 278% higher]) of symptoms than if given the split course. 
There was a large degree of variability in the subject specific logs odds resulting in a 95% 
reference range for the probability of symptoms of [0.01,0.99], demonstrating that some 
subjects reported no symptoms at all whereas others reported them consistently throughout the 
follow-up. 
The ratio of the marginal and random effects coefficients again showed some difference 
from the expected ratio using the results of Liang and Zeger (1992). A normal plot of the level 
two residuals (figure 4.3) again showed a heavy tailed distribution which corresponds to some 
subjects reporting no symptoms throughout the follow-up thus having large negative residuals 
against the large positive residuals of subjects reporting symptoms at each occasion. There was 
also some evidence of under dispersion noted from removing the constraint on oe . 
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Within this study, quality of life was measured on patients pre-treatment. It was felt that 
including these data into the model as a covariate might help control for those subjects 
reporting positive or negative throughout and so improve the distributional assumptions of the 
random effects. The results are given in table 4.3 with baseline dichotomised in the same way 
as the response, base, =1 for subject i with symptoms graded 2/3 at baseline; 0 otherwise. 
Table 4.2: Coefficients and SE for RSCL shortness of breath item. 
Marginal (GEE1) 
Independence Exchangeable 
Estimate Naive Robust Estimate Naive SE Robust SE 
SE SE 
a (cons) 0.55 (0.26) (0.39) 0.49 (0.38) (0.37) 
3 (tune) -0.15 (0.06) (0.05) -0.15 (0.03) 10.05) 
8 (rt) -0.26 (0.26) (0.58) -0.31 (0.56) (0.57) 
Estimates for the correlation structure 
p=0.69 
----------------------------------------------------------------------------- 
Random effect (MLn) 
Ist order MQL 1st order PQL (1) 1st order PQL (2) 
Estimate SE Estimate SE p M/(1 RE Estimate SE 
a (cons) 0.51 (0.43) 1.27 (0.73) - 1.79 (0.89) 
(time) -0.15 (0.06) -0.36 (0.10) 0.41 -0.50 (0.08) 
6 (rt) -0.29 (0.58) -0.65 (1.01) 0.48 -0.96 (1.32) 
Estimates for the variance structure 
o; =2.53 (0.72) a2. =7.76 (2.18) 0.52 o2=14.5 (3.72) 
o; =1 a2=1 a, 
1=0.42 (0.04) 
occ=week of measurement coded 0-7 for weeks 1-8 
rt= I for the continuous, 0 for the split course radiotherapy 
For MQL and PQL (1), a2 was constrained to equal 1 to give Binomial variation at level one. 
The ratio aM/pRE was calculated using ßM from the GEEI exchangeable model, and 1RE from the PQL 
model. 
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The introduction of the baseline symptoms gave an obvious reduction in the variance 
between subjects, and gave strong evidence that patient symptoms at baseline had a great 
bearing on patient symptoms following treatment. From the marginal model, it was estimated 
that the group of patients who reported shortness of breath at baseline were 37.5 times more 
likely to report symptom following the start of radiotherapy (95% CI=[9.5,141.5]). In terms 
of the effect of baseline on the subject specific odds, the constrained PQL model estimated that 
given their underlying propensity to report shortness of breath, if a subject reported symptoms 
at baseline, they were 113 times more likely to report symptoms following the start of 
radiotherapy than if they did not report symptoms (95% CI=[17.9,758]). 
The residuals from this model are shown in figure 4.4 and show a much better distribution 
in terms of Normality than those of the model without baseline. This indicates that the 
adjustment for baseline has gone someway to adjusting for the effect of subjects who respond 
positively or negatively throughout. Unfortunately, in terms of the ratio of parameter estimates 
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Figure 4.3: Normal plot of the standardised level two residuals for the shortness of breath item on 
the RSCL in the CRC NSCLC study. 
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Table 4.3: Parameter estimates for shortness of breath in CRC NSCLC study with an adjustment for 
baseline. 
Estimate (SE) 
a (cons) 
ß (occ) 
8 (rt) 
y (base) 
Marginal 
-1.99 (0.62) 
-0.23 (0.07) 
-0.007 (0.64) 
3.60 (0.69) 
Estimates for the variance structure 
a=0.46 
Constrained PQL Unconstrained PQL 
-2.07 (0.94) 
-0.39 (0.10) 
-0.05 (0.90) 
4.73 (0.97) 
-2.46 (1.11) 
-0.51 (0.08) 
-0.07 (1.11) 
5.98 (1.81) 
aý =4.66 
a; =1 
oz =8.48 
or =0.42 
The marginal model presented used an exchangeable working correlation matrix. 
Ratio 
pMlpRE 
0.59 
0.14 
0.76 
0.62 
from the marginal and random effects models, these results were less convincing than those of 
the previous model. There was also some evidence of underdispersion of the level one 
residuals. This suggested that in the previous analysis, this may not have been due to the 
subjects responding positively and negatively throughout. Both this underdispersion and the 
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Figure 4.4: Normal plot of standardised level two residuals for analysis of reporting shortness of 
breath with an adjustment for baseline. 
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inconsistency of the ratio between the marginal and random effect parameter estimates, 
suggests that caution is needed with the use of random effect models for such analyses and more 
research is needed to determine what is causing the problems. 
4.3.3 Conclusion 
The work of this section detailed two classes of model for the analysis of binary response 
data: modelling of the marginal response with allowance for the data dependence via an 
appropriate working correlation matrix; or by assuming the dependence between observations 
on the same individual arises due to some latent process which is modelled as a random effect 
under some distributional assumptions. Each of the models have their advantages and 
disadvantages which have been discussed in the previous sections: the marginal model does not 
allow inferences to be made about the association parameters (the correlation structure of the 
data); perhaps more seriously, the random effect model is non-robust to failure of the 
assumptions about the distribution of its random effects which may be particularly problematic 
for repeated binary data. These factors aside, it should be recognised that the parameters 
estimated from the two models have very different interpretations and they should not be 
regarded as alternative ways of answering the same question. 
4.4 The analysis of complex patterns of binary response 
A problem that often occurs in the analysis of quality of life data relates to the potentially 
complex response functions over time which can occur when the prevalence of symptoms 
increases as a result of treatment. This was demonstrated by MRC Lung cancer working party 
(1989) reporting bouts of nausea and vomiting following chemotherapy. In such cases, plots 
of the marginal response over time give a very informative description but do not allow a 
formal treatment comparison or adjustment for covariates of interest. In this example a 
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marginal model is used in conjunction with a natural smoothing spline to give the same 
informative description of the data and in addition allows estimation and formal testing of a 
treatment difference. This is demonstrated by modelling the apparent treatment difference in 
the prevalence of dysphagia measured on the daily diary card following radiotherapy treatment 
in the MRC LU07 study, described in Chapter 2. 
A summary of the data has already been given in Chapter 2 and involved daily reporting of 
dysphagia symptoms by patients over a6 month period. For this example, the ordinal response 
of the diary card was dichotomised to give a binary response such that yýý, the response of the 
ith subject on the jth day, takes the value 0 if the patient reported no symptoms (a score of 1 on 
the diary card), or 1 otherwise. A positive response can then be interpreted as the reporting of 
any symptoms of dysphagia. The marginal response profile shown in figure 2.16 highlighted 
a dramatic increase in the prevalence of symptoms following the start of treatment which fell 
back to baseline levels once radiotherapy had finished. The extent of this increase appeared 
different across the two treatment groups although no formal comparison was made. The 
objective was to obtain a model for these data which gave both a reasonable representation for 
the marginal response and allowed unbiased estimation of the apparent treatment difference. 
A generalised estimating equation for a logistic regression model was used to give robust 
standard errors taking account of the dependence of observations taken on the same subject, 
with a natural cubic spline to represent the complex shape in the marginal response. Due to 
computing constraints, only the first eight weeks of the follow-up period could be analysed. 
This period captured the entire period of treatment related symptoms and the return to baseline 
shown in figure 2.16. Before presenting the results of the analysis, the definition and use of 
cubic splines is first discussed. 
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4.4.1 Natural cubic splines 
A cubic spline is a series of cubic functions which are joined together smoothly at a series 
of specified time points or knots in the follow-up period. The smoothness of the function is 
obtained by constraining the value of the 1st and 2nd derivatives of functions evaluated at their 
adjoining knots to be equal. A natural cubic spline has the additional restriction that it is linear 
outside the first and last knots. The advantage of splines is that a natural spline with p knots 
can be expressed with a design matrix with p parameters and can therefore be easily be 
incorporated into a multiple regression analysis. 
By definition the natural cubic spline for a data series y=(y,,..., ym) observed over a period 
x,, j=l,..., m, with p knots at times x=k1,1=1,..., p is linear up to k,, beyond which it is a series 
of cubic splines written, 
Y=«o+«, x+ý ß, ý, (x) 
ý. ý 
(4.23) 
where 4, (x)=(xx-kß)3 for xtk,, 0 otherwise. The additional constraints ßý= ß, kß=0 ensure 
that the spline is linear forxj2kp and mean that equation (4.23) can be re-written 
2 
Y=aO+aýx+ý ßýýý(x) 
ý-ý 
(4.24) 
where the functions »'(x) =4,, (x)- (k 
-ka OP_I(x)+ Mk-' ') ýp(x), for 1=1,..., p-2, are straightforward 
to evaluate and give an (mxp) design matrix defining the spline which can be incorporated into 
a multiple regression analysis (Benjamin and Pollard, 1980). Alternative formulations of this 
design matrix are possible and are discussed in Hastie and Tibsharani (1990). 
4.4.2 The analysis of transient dysphagia following radiotherapy 
For this problem the natural cubic spline with knots at the limits of the data and at 7,14,21, 
28 days were chosen to represent the shape of the marginal log odds of reporting symptoms. 
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This was assumed to be the same for each treatment group. The treatment difference was 
modelled as a constant log odds ratio. Defining rt, =1 for the F2 treatment group, the marginal 
model for the 6, ij=E(yij) can then be written 
4 
logit(6; 
ý)=ao+aixy+E 
ß; 0; (xj)+Srt; (4.25) 
º=1 
As a naive analysis for comparison purposes, equation (4.25) was also fitted excluding the 
spline and assuming an independence working correlation matrix, giving a model for a constant 
log odds and log odds ratio through time. This model will be referred to as the constant model. 
For the analyses including the spline, three different structures for the working correlation were 
used: independence; exchangeable; and autoregressive of order 1. These models will be 
referred to as the independence, exchangeable and AR). Unfortunately, due to computing 
constraints, it was impossible to iteratively fit the AR! model using GEE! procedure described 
in Section 4.2.2. Instead, R, (p) was assumed fixed with lag one correlation, p=0.8. This value 
was determined from the lag one correlation of the Pearson residuals taken from the 
independence model. All results are given in table 4.4 with the fitted marginal response over 
time plotted in figure 4.5. 
Table 4.4: Estimated treatment difference in reporting symptoms of dysphagia using GEEI with a natural 
spline. 
Model 6 Naive SE Robust SE OR [95% CI] p 
Constant -0.25 0.04 0.18 0.78 [0.55,1.12] - 
Independence -0.25 0.04 0.20 0.77 [0.52,1.14] 
Exchangeable -0.77 0.17 0.34 0.46 [0.24,0.91] 0.50 
AR(1) -0.21 0.11 0.20 0.81 [0.55,1.19] 0.80 
The estimates for p given in the last row of the table refer to the assumed correlation between 
successive units for the exchangeable and the lag one correlation for the AR(l) working correlation 
matrices. Due to computing constraints, that for the AR(l) model was fixed and therefore not 
updated during estimation. 
The 95% Cl for the odds ratio is given with a based on the robust standard error. 
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The estimated log odds ratios given from the constant, independence and AR(1) models 
were all very similar translating to about a 20% lower odds of dysphagia for patient receiving 
the F2 course of treatment as opposed to FM. There was no evidence to suggest that this was 
not due to chance. The exchangeable model, however, gave a very different picture, estimating 
a 54% lower odds in the F2 group with a 95% CI which excluded an odds ratio of 1. From 
figure 4.5 it can be seen, however, that this model did not fit the data very well, consistently 
over estimating the response in the FM group and underestimating the response in the F2 group. 
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Figure 4.5: Fitted marginal profiles for the MRC LU07 dysphagia data using (a) independence; (b) 
exchangeable; (c) ARI working correlation matrices. The observed lagged correlation of the 
Pearson residuals from the independence model: ; and the correlation for the exchangeable: 
----; and AR 1: -------- working correlation matrices are shown in (d). Within (a), (b) and (c), the 
observed profiles for the multiple fraction radiotherapy (FM): ; two fraction radiotherapy: 
---------- The symbols * and + give the fitted profiles for the multiple fraction (FM) and two fraction 
(F2) radiotherapy groups respectively. 
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This was due to a misspecification of the correlation structure of the data, in particular between 
observations close together which formed the bulk of the data. This is shown in figure 4.5(d) 
which plots the observed correlation between Pearson residuals from the independence model 
for different lag times. In terms of the fit of the each model, determined by comparing the 
observed and fitted values shown in figure 4.5, the ARI model was the best as it tended to an 
asymptote of zero slope at the limits of the data whereas the independence model showed a 
slight upward turn of the spline at the lower limit. 
Having adjusted for the shape of the response function over time, this simple analysis gave 
no evidence of a constant difference in log odds over time in the reporting symptoms of 
dysphagia. However, examination of the data and knowledge about the nature of symptoms, 
would suggest that a constant treatment difference is unlikely. Two alternative extensions to 
model a non constant treatment difference were considered. The first was a quadratic 
treatment: time interaction. Like the constant treatment difference, it is addressing a very 
specific hypothesis about the nature of response. The second model used two different splines 
for each treatment group, and thus tested the more general hypothesis of some difference in 
response between the two groups. Significance in each case was assessed by constructing a Chi 
squared statistic for simultaneous contrasts on c df given by 
(QO)T(QVAQTyIQo (4.26) 
where Q is a (c xp) matrix of c contrasts for p parameters, and VO =var(3). For the quadratic 
treatment effect this had 2 df, for the more general hypothesis it had 5 df. Each model was fit 
using an ARI working correlation structure with p=0.8. The results are summarised in table 
4.5. Both naive and robust results are given based on the naive and robust estimated var(O). 
Based on the robust results, no evidence of a quadratic treatment difference was seen 
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Table 4.5: Chi-squared statistic (p value) for testing non constant treatment differences for the MRC 
LU07 dysphagia data. 
Naive Robust 
Chi-squared p value Chi-squared p value 
statistic statistic 
Quadratic 7.38 (0.025) 2.68 (0.262) 
Different splines 13.4 (0.020) 12.02 (0.035) 
(a) 
10 20 30 40 
Days from part of Veabns * 
50 
ö 
S 
(b) 
ý 
N 
ýý 
ý O 
Ö 
0 
0 10 20 30 40 50 
Days from dart of hddlflldfll 
0 
0 
to 20 30 40 50 
D. ys nom . an of w. un. nt 
10 20 30 f0 
Den hom ein of bsa0mt 
50 
Figure 4.6: Estimated response profiles for MRC LU07 dysphagia for non constant treatment 
difference fitted using (a) quadratic; (b) different splines for each treatment group, (c) and (d) show 
the realised estimated treatment difference in proportions for each model respectively. 
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(p=0.262). However, there was some evidence of a difference in shape although this was not 
very convincing (p=0.035). The fitted profiles for each of these models are given in figure 4.6. 
Also shown on the figure is the shape of the estimated treatment difference. This is particularly 
important for the more general hypothesis because it is the only way to visualise the estimated 
effect. In terms of fitting the data, the quadratic treatment effect was the most satisfactory with 
some evidence of over fitting seen when different splines were used with the fitted profile for 
the multiple fraction group starting to upturn. The effect of this upturn is shown quite 
dramatically to affect the estimated treatment difference shown figure 4.6(d). As a result of this 
it was not felt that the results of the model with different splines could be relied upon in terms 
of assessing the difference between the two groups. 
4.4.3 Conclusion 
This analysis has demonstrated the use of cubic splines for accommodating complex patterns 
of response into a marginal model using a natural spline. It has been shown (Ford et al., 1995) 
that omitted covariates in a logistic regression analysis can result in biased and inefficient 
estimation of other covariates of interest. Therefore, the purpose of this analysis was to 
incorporate the obvious behaviour of the marginal response over time into the analysis in order 
to obtain an unbiased and efficient estimate of the treatment effect having adjusted for the 
behaviour in response over time. On the whole the analysis proved successful, in particular, 
a good representation of the response over time was obtained. However, when assumed 
constant over time, little difference was seen in the estimated treatment effect from a model 
which ignored the response over time and that from the model incorporating a natural spline. 
This was the case both in terms of the treatment estimate and its precision. 
The main drawback with the use of splines in an analysis such as this is that the knots have 
to be chosen. If the shape of response over time is simply a nuisance part of the analysis, as in 
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this case, then this is not of great concern. Otherwise, the sensitivity of the results to the choice 
of knots position should be assessed. In this example they were arbitrarily chosen at weekly 
intervals from the start of treatment. Further analyses with the knots chosen at more specific 
time points based on close examination of the data (k=0,9,16,23,30,53 days) did not impact 
greatly on the results presented in table 4.4 although as would be expected the better fitting 
spline did slightly increase the precision on the estimated treatment effect. For example, for 
the AR(1) model the estimated log odds ratio was -0.22 (robust SE=0.20), translating to an odds 
ratio of 0.80,95% C1=[0.55,1.181. The second analysis, when the treatment difference was 
modelled in terms of a difference in shape using two different splines, was not treating the 
splines as nuisance parameters however, and therefore inferences based on such analyses need 
careful examination. Generally it is perhaps better not to use such models and to concentrate 
on the more specific hypotheses about treatment differences. 
It should be noted that this model could just as easily have been fitted using a random effects 
model, but for the objectives here - to give a clear description of the marginal response over 
time and an estimated treatment comparison - the marginal model was more appropriate. In 
other situations - for instance when the timing of treatment is variable for different subjects - 
a random effect model with different splines for each subject may be a suitable model to 
choose. Such models have been used to some degree by Kenward and Welham (1996). Further 
work would be needed to determine whether they may be of use for the analysis of quality of 
life data. Similarly, alternative models could have been applied to model the shape of the data, 
in particular fractional polynomials (Royston and Altman, 1994). For this analysis, little 
success was achieved with such models. 
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4.5 Multivariate binary outcomes - extensions to the multilevel model 
As demonstrated in the continuous case, the simple two level model for repeated 
observations can be easily extended to a three level model to incorporate multivariate outcomes 
with the dimensions as level one, occasions at level two and subjects at level three. This 
extension may be particularly useful in the case of binary outcomes as it allows the analysis of 
individual item responses within a questionnaire instead of summarizing the questionnaire by 
a single summary score. This not only gives a greater insight into the individual aspects of 
quality of life, it may also give a more intuitive outcome measure - the odds of symptoms - 
rather than an arbitrary score. In addition, it allows the estimation of the degree of association 
between the different items thus aiding the understanding of the behaviour of quality of life 
throughout follow-up. This is particularly important in the binary data case when, as discussed 
in Section 2.3.4, it becomes much more difficult to display or summarize the data. 
To demonstrate the use of the multivariate model, an analysis of the individual item 
responses of the RSCL taken from the NSCLC study was used. Each individual item response 
was again dichotomised from the original four point scale to a two point scale as follows: slight 
(0,1), moderate (2,3). For simplicity, a model with a constant odds of symptoms over time was 
assumed and only six out of the possible thirty-six items, chosen to be of particular interest to 
patients with lung cancer were analysed. These items were: pain in the chest, heartburn, 
cough, shortness of breath, dry mouth as well as anxiety. Baseline responses were also 
incorporated into the analysis. Therefore the data used were restricted to the 40 subjects who 
gave a baseline (pre-treatment) and at least one post treatment response to the RSCL. These 
were divided between the two treatment groups in the ratio 17: 23. All analyses used first order 
PQL restricted IGLS estimation. 
The aim of the analysis was to investigate the level of reported symptoms over the follow-up 
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period and how this related to the treatment course received, as well as how the response for 
different symptoms were related to each other. 
4.5.1 Extension of the two level model for binary data 
The two level model for repeated binary outcomes is extended to three levels for 
multivariate repeated binary outcomes in the same way as shown for the continuous case in 
Section 3.4. The dimensions for the level one units are clustered within occasion at level two, 
within subjects at level three. Again the differences between dimensions are assumed fixed, 
and the full covariance between dimensions at level three is estimated. It is at level two that 
the difference lies because the residuals at that level have binomial distribution and their 
variances therefore are known given the marginal parameters. 
As for the continuous case, the model is constructed using a series of dummy variables for 
the response in each dimension. For example, to investigate the effect of covariate x, in each 
dimension, 1=1,..., L, a model for Eo,,,,, )=8, t is 
L 
Iogit(8Ul)=E {aI+ßr'rn+un}züi 
1"i 
(4.27) 
where zj, )=l for dimension 1,0 otherwise, At level three, var(uf) is an (LxL) matrix 
with diagonal elements, var(uj1)=o2,, and off diagonal elements, cov(u,,, ua)=QU,, i, at row 1, 
column k, for dimensions 1*k. At level two, var(e1) has on its diagonal, var(e,, )=oäe,, (1-ej, ), 
with ofk=cov(eIj,, eljj. ) as the off diagonal elements for 1. k. In the following example, the over 
dispersion parameter Qe, is constrained to equal one. As in the continuous case, by setting all 
the off diagonal elements to zero, the model is analogous to fitting L univariate models. 
4.5.2 Reporting of patient symptoms on the RSCL in the CRC NSCLC study 
The objectives of this analysis were to investigate the prevalence of reporting each of the 
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six chosen symptoms of the RSCL between the two treatment groups and over time. It will also 
yield an overall global estimate for difference in reporting of symptoms in the two treatment 
groups if appropriate, as well as information about the association across different symptoms. 
For example, if a patient is reporting chest pain at a particular time, what other symptoms are 
they likely to report (within subject across symptom correlation)? Similarly, if a patient has 
a higher than average odds of reporting symptoms of chest pain over the period, is their odds 
of reporting a second symptom similarly high (between subject across symptom correlation)? 
A sequence of four models were used. Marginal profiles giving the odds of reported symptoms 
at each time are shown in figure 4.7. They show a large degree of fluctuation over time with 
a slight downward trend across all dimensions and very little difference between the two 
treatment groups. 
Model one - constant odds 
The initial model assumed a constant dimension specific log odds over time which was allowed 
to vary across subjects, written 
6 
Iogit(9jýº)=E ( aº+uºº) zºji 
º=1 
(4.28) 
Model two - adjustment for baseline 
An adjustment for baseline symptoms at baseline was then added to the model in the form of 
six dummy variables, baserr=l if a patient had symptom l at baseline, 0 otherwise, for 1=1,..., 6. 
6 
logit(9, r)=E {ar+ybase, r+uýr}zjn (4.29) r. r 
Model three - constant treatment difference in odds 
A constant treatment difference in log odds was then added. Initially six separate treatment 
covariates for each symptom were fitted where rt,, =l for continuous, 0 for the split course. 
6 
logit(O, fl)=ý (a, +ybase,, +8, rt; 1+u, 1}z; 
(1 (4.30) 
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Figure 4.7: Marginal profiles for the odds of reporting symptoms of (a) chest pain; (b) heartburn; (c) 
anxiety; (d) cough; (e) shortness of breath; (f) dry mouth recorded on the RSCL in the CRC NSCLC 
study. 
A Chi-squared test for heterogeneity of dimension specific treatment difference was 
constructed. Given no evidence of heterogeneity, a single treatment effect was used in the 
model. 
Model four - linear trend over time 
Finally a linear trend over time was added to the model. Again six separate parameters were 
used, occ1, coded 0 to 7 for weeks 1 to 8, for the Ith symptom, 0 otherwise. Consistent with 
the heterogeneity test of the previous model, a single treatment covariate across dimensions was 
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used. 
6 
logit(6ýýl)=E {al+ybaseil+ßpccr; l+uii}Z; 
jý)+ön, (4.31) 
1=i 
Again a Chi-squared test for heterogeneity of dimension specific linear trends was constructed. 
In this case, there was strong evidence of a difference in the effects and hence a single covariate 
was not fitted. 
The results from the analysis are given in table 4.6. 
The overall odds of five of the six symptoms was low, signified by estimated odds less than 
one for all but shortness of breath. The estimated between subject variance for each symptom 
was, however, very high in all cases, illustrating large differences in the odds of symptoms 
between subjects. For example, the estimated variance of 2.03 for the log odds of -1.82 of 
grade 2/3 chest pain gave an estimated 95% reference range for the subject specific odds of 
reporting such symptoms of [0.01,2.63]. This translated to subject specific range for the 
probability of [0.01,0.72]. On addition of the symptoms at baseline, a reduction in the between 
subject variance was seen for four of the six symptoms: anxiety, cough, shortness of breath and 
dry mouth. Similarly for these symptoms, the fixed parameter estimates for this model showed 
strong relationships between reporting symptoms at baseline and subsequently. Although such 
strong relationships with baseline response were also seen for the remaining symptoms of chest 
pain and heart burn, their respective variances increased in model two. 
The addition of a separate treatment effect in each symptom dimension showed a marginally 
higher odds of anxiety in subjects on the split course therapy with the reverse in each of the 
remaining symptoms. With the exception of dry mouth, which was marginally significant, these 
146 
The analysis of repeated binary outcomes 
Table 4.6: Fixed parameter and between subject variance estimates (SE) for four sequential multivariate 
binary models for individual items on the RSCL in the CRC NSCLC study. 
1. Constant odds 
2. Baseline 3. Treatment 
adjustment difference 
4. Rate of 
change over 
time 
Log odds Odds Odds ratio Odds ratio Odds ratio 
(SE) [95% Cl] [95% Cl] [95% Cl] [95% CI] 
Fixed parameter estimates 
Chest pain -1.82 
0.16 0.11 1.08 0.74 
(0.30) [0.09,0.30] [0.05,0.24] [0.292,3.97] [0.63,0.88] 
Heart burn -1.45 
0.24 0.18 1.02 0.86 
(0.30) [0.13,0.43] [0.09,0.35] [0.27,3.81] [0.74,1.00] 
-1.78 0.17 0.06 0.60 0.92 Anxiety (0.34) [0.09,0.33] [0.02,0.15] [0.14,2.50] [0.79,1.081 
Cough -0.29 
0.75 0.13 1.09 0.93 
(0.31) [0.41,1.371 [0.05,0.35] [0.33,3.68] [0.81,1.061 
Shortness of 0.11 1.12 0.08 1.24 0.67 
breath (0.45) [0.46,2.731 [0.02,0.28] [0.23,6.82] [0.56,0.801 
Dry mouth -1.61 
0.20 0.10 4.52 0.85 
(0.37) [0.10,0.42] [0.05,0.231 [0.94,21.7] [0.73,0.99] 
Single parameter estimate over all 
dimensions 
CM-squared 7.34 18.6 
test (p=0.02) (p=0.002) 
Estimate 
0.94 Not applicable [0.38.2.32] 
Between subject (level three) variance estimates 
Chest pain 2.03 (0.78) 2.21 (0.82) 2.27 (0.84) 2.87 (0.99) 
Heart burn 2.33 (0.81) 2.60 (0.88) 2.66 (0.89) 2.37 (0.81) 
Anxiety 2.83 (1.00) 2.55 (0.96) 2.61 (0.97) 3.01 (1.08) 
Cough 2.70 (0.82) 2.25 (0.73) 2.32 (0.75) 2.34 (0.75) 
Shortness of 6.24(t. 77) 4.35 (1.39) 4.43 (1.42) 5.93 (1.84) 
breath 
Dry mouth 3.74 (1.22) 3.42 (1.18) 3.58 (1.22) 4.00(l. 32) 
The odds ratios for models 2,3 and 4 are given for: symptoms versus no symptoms at baseline; 
continuous versus split course radiotherapy; and a one week increase in time. Estimated from a 
random effect model, they reflect odds ratios for given underlying subject specific odds. 
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estimates were all small in comparison with their standard error and gave no evidence of a 
difference in the odds of all symptoms between the two treatment groups. A test for 
homogeneity of the treatment difference across all symptoms gave no evidence against the null 
hypothesis (Chi-squared=7.34 on 5 df, p=0.20). Fitting a single treatment parameter gave a 
combined odds ratio estimate of 0.94,95% CI=[0.38,2.63], interpretable as a 6% reduction in 
a subject's odds of symptoms if they were to receive the continuous course as opposed to the 
split course. 
Fitting a linear trend in log odds over time suggested a fall in the odds of symptoms in all 
dimensions over follow-up. This trend was particularly evident for shortness of breath with 
an estimated 33% reduction per week in the subject specific odds of reporting such symptoms, 
95% CI=[ 18%, 46%] reduction. Testing for a homogeneity of linear trend across all symptoms 
gave a Chi squared statistic of 18.6 on 5 df (p=0.002). A single occasion effect was therefore 
not fitted. The estimated overall treatment effect in this model was relatively unchanged from 
that in model three (0.91,95% CI=[0.36,2.27]). 
The estimated covariance structure of the data is of particular interest in this analysis and 
is its advantage over six separate univariate analyses. The estimates given from model four 
with a single treatment effect are presented in table 4.7. The first half of the table gives the 
correlations between subjects which measure the degree of association between the level three 
residuals, u,,, across symptoms. The estimated covariances with standard errors are given 
below the diagonal, translated to correlations above the diagonal. These give an indication 
whether a subject with a higher than `average' odds of one symptom has a higher than average 
odds for a second symptom. Those in the bottom half of the table were estimated within 
subject. Sincea2, was constrained to be equal to one for 1=1,..., 6, the covariance and 
correlation are equal and indicate whether subjects who have higher than expected odds of one 
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symptom at a particular occasion have a similarly higher than expected odds in a second. 
Between subjects, a high degree of positive association was seen between most symptoms. 
Table 4.7: Covariance (SE) and correlation estimates between and within subjects for the reporting of 
symptoms on the RSCL for the CRC NSCLC study. 
Chest pain Heartburn Anxiety Cough Shortness Dry 
of breath mouth 
Between subjects 
Chest pain 2.87 0.52 0.51 0.64 0.44 0.56 
Heartburn 1.34 2.37 0.24 0.44 -0.22 0.35 
(0.71) 
Anxiety 1.50 0.64 3.01 0.55 0.48 0.34 
(0.83) (0.70) 
Cough 1.65 1.04 1.46 2.34 0.49 0.73 
(0.71) (0.61) (0.72) 
Shortness 1.80 -0.82 2.00 1.81 5.93 0.57 
of breath (1.07) (0.88) (I. I I) (0.93) 
Dry mouth 1.89 1.07 1.17 2.21 2.78 4.00 
(0.93) (0.79) (0.91) (0.83) (1.28) 
Within subjects 
Chest pain 1.00 
Heart burn 0.38 1.00 
(0.05) 
Anxiety 0.57 0.33 1.00 
(0.40) (0.06) 
Cough 0.38 0.34 0.35 1.00 
(0.05) (0.06) (0.05) 
Shortness 0.49 0.40 0.45 0.43 1.00 
of breath (0.05) (0.05) (0.05) (0.05) 
Dry mouth 0.62 0.51 0.59 0.42 0.61 1.00 
(0.03) (0.04) (0.04) (0.05) (0.04) 
Within the (6x6) block between subjects, the covariance estimates are given below the diagonal, the 
variance estimates on the diagonal, and the correlation estimates above the diagonal. Given o<<=1, 
for 1=1,..., 6, within subjects, the covariance and the correlation are equal and are given below the 
diagonal. 
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However, the estimated correlation observed between shortness of breath and heartburn was 
negative. The corresponding covariance was however, very small in relation to its standard 
error. The scatter plot matrix in figure 4.8 of the level three residuals from model 4 illustrates 
these associations. Contrasted with the very crude representation of these correlations in figure 
2.17, figure 4.8 demonstrates a major advantage of using the three level model to analyse these 
data giving a very clear impression of the association across dimensions within the data. 
Similarly the multivariate model also gives estimates of covariances (correlations) between 
dimensions within subjects. These estimates (also shown in table 4.7) are adjusted for an 
individual's expected response and show a degree of positive association between symptoms 
which was not at all visible from the crude representation in figure 2.18. Unfortunately the 
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Binomial nature of the residuals at this level does not allow a similar graphical representation 
of these estimates. 
As demonstrated in Section 4.3, residual diagnostics for these random effect models are 
extremely important given the dependency of the results to the assumed distribution of random 
effects. Univariate Normal plots and a multivariate Gamma plot are shown in figure 4.9. In 
contrast to those of the earlier example, the univariate distributions showed reasonable 
Normality. The Gamma plot in figure 4.9(g) shows the squared distances of the estimated 
residuals calculated using the fitted level three covariance matrix and shows their distribution 
to be much less dispersed than expected. That shown in figure 4.9(h) shows the squared 
distances calculated using the empirical covariance matrix of the estimated residuals. This 
closely resembles the expected Chi-squared distribution and highlights an important further 
area of work to determine the distribution of these estimated residuals in order to aid future 
model checking. 
4.5.3 Conclusion 
This analysis showed evidence of a fall in the level of reported symptoms over the follow-up 
period after the start of treatment and no evidence of differences in the odds of the six 
symptoms according to treatment received. For subjects who reported symptoms at baseline, 
their odds of reporting symptoms following the start of treatment was increased. A high degree 
of correlation was seen between symptoms both between and within subjects. 
In general the multivariate model allows a greater insight into the subject response on the 
RSCL than is gained from analysing the summary scores as a continuous measure. Further it 
gives an intuitive outcome measure, allowing the discussion of the odds of symptoms and how 
this changes over time rather than, say, a change in the total RSCL score. However, the model 
151 
The analysis of repeated binary outcomes 
0. 
N 
,_J 
I ýO 
N 
CY 
Hf 
. 
JJ 
. 
ý' 
ý 
ý 
r 
y 
. . r' 
(a) 
0J 
N1 
I 
a-. 
(b) 
:" 
. s' ý z 
ýr: 
ýI c? 
-3 -2 -1 0123 
Quantibs of Standard Normal 
: ''' 
.. ' ý'' 
01 
ý 
(d) 
5_J ýo 
N 
'? -t4 
ý. 
7 
. 
ý 
N 
I' 
-3 -2 -1 0123 
Quanmes of Standard Normal 
(e) 
r". " 
/"' 
{ 
,. r' 
ýN 
y 
17 ý 
-3 -2 -1 0123 
Quantiles of Standard Norma 
(9) 
0 2468 
(2uandlaa of Chi-sguand(e) 
10 
ý 101 
8 
18 
0 
(h) 
m 
N 
N4 
(c) 
Tý 
ýý 
Ni 
i 
ýNý 
ýý 
. 
's, 
/ 
.. 
"r 
-3 -2 -1 0123 
Ouantiles of Standard Normal 
(f) 
. ý' 
lee 
y. 
w 
./ 
-3 "2 -1 0123 
Quantlles of Standard Normal 
'.,, 
I. 
,r 
ýt 
, `titi 
0 2488 
Ousn8les of Chi-Squared(d) 
-. 7Z-71 
10 
Figure 4.9: Residual diagnostics for the multivariate binary model for the CRC NSCLC study showing 
univariate Normal plots for (a) chest pain; (b) heartburn; (c) anxiety; (d) cough; (e) shortness of breath; 
(f) dry mouth; (g) a Gamma plot for multivariate Normality based on the estimated level three covariance 
matrix; and (h) a Gamma plot for multivariate Normality based on the empirical covariance matrix of 
the estimated level three residuals. 
will be sensitive to the Normality assumptions of the level three residuals and so model 
checking is necessary. 
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4.5 Summary and discussion 
This work has reviewed the use of marginal and random effect models (or more specifically, 
hierarchical models), both of which can usefully help the analysis of repeated binary outcomes 
in quality of life data. Given the difference in their interpretation they should not be thought 
of as alternative competing ways of answering the same question. 
Marginal models give overall population covariate effects and treat the associations between 
repeated observations on the same subject as nuisance parameters. Such models are very 
simple to use. In particular, they can be very easily extended to model complex patterns of 
binary response over time which are often seen in quality of life data. The interpretation of 
their parameter estimates is also familiar as they can be considered in the same way as those of 
a cross-sectional analysis. However, if information about the variance structure of the data, 
that is, the dependency between observations on the same subject, is required, more complex 
specifications of these model are needed which may be impractical when the number of 
measurement occasions is high. The models presented here represented a standpoint in middle 
ground, where some attempt to model the correct correlation structure was attempted in order 
to maximise the efficiency of the parameter estimates. Most simply, it is possible to ignore the 
correlation structure altogether in parameter estimation, treating the data as independent and 
using analysis techniques for independent binary outcomes. Using jack-knifing techniques 
(Efron and Tibshirani, 1993), whereby the analysis is repeated n times with one subject 
removed each time, robust standard errors can then be obtained from the standard deviation of 
then jack-knife estimates. These results will be very close to those of a GEE1 with an assumed 
independence `working' correlation matrix. 
Random effect models give subject specific covariate effects. That is, the estimated effect 
of the covariate of interest is on a patient's underlying log odds of positive response which is 
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treated as a random effect from some underlying distribution. In the work presented here, and 
within much of the available software for these models, the random effects are assumed 
Normally distributed. An advantage of the random effect model is that by integrating out over 
these random effects, the random parameters can be transformed to give marginal inferences. 
However, the ability to do this relies on knowing the correct distribution of random effects 
which is the main problem of the random effect model - its results are not robust to failure in 
the assumed distribution of the random effects. For longitudinal binary data, this can be a 
major problem when large numbers of patients give complete positive or complete negative 
responses over the whole follow-up period, as was demonstrated in Section 4.3. Further work 
is therefore needed to determine suitable methods to accommodate this feature of the data for 
more satisfactory modelling of such data. It was shown in Section 4.3.2 that adjusting for 
baseline may sometimes be a simple way to handle the problem. Alternatively, a different 
choice of distribution for the random effects may be used. Such models have been discussed 
by Lee and Nelder (1996), although their formulation is not accessible when the number of 
measurement occasions is high. Alternatively, Monte-Carlo simulation methods may be used 
for full likelihood estimation under more general distributions for the random effects (Gilks et 
a!., 1993). 
Despite the problem of specification of the distribution of random effects, the possibility 
of modelling several dimensions or symptoms within a multivariate repeated measurement 
model could be very valuable for the analysis of quality of life data. Despite its complexity, this 
analysis not only allows examination of the behaviour of response for different symptoms of 
interest, by using a single treatment covariate over all symptoms, it also gives an overall 
estimated effect of treatment which is perhaps more informative and intuitive than a difference 
in the summary scores. Given that the response to the same symptoms is under consideration, 
it would present an estimate which may be compared across studies. 
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Other methods of analysis are also possible. In particular, Zeger and Liang (1992), and 
Diggle et al. (1994) both consider the use of transitional models in which the dependency 
between observations is incorporated into the analysis by explicitly conditioning on previous 
observations by including them as covariates in the model. In addition, summary statistic 
analyses could be used. For example, the proportion of days spent with symptoms calculated 
for each subject could be analysed within a logistic regression analysis. As discussed in 
Chapter 3, with unbalanced data, the analysis would have to suitably weight each subject 
specific estimate in terms of its precision. Again, the parameter estimates from these models 
will have a specific interpretation highlighting that, with binary data, it is important that the 
required focus of research is first determined in order that the most suitable analysis can be 
completed. It should be noted however, that although unfamiliar, within a clinical trial it is 
often the subject specific treatment effects (obtainable from a random effects analysis) that are 
of scientific interest. 
The main restriction with the work demonstrated here is that quality of life data is perhaps 
more commonly measured on an ordered categorical scale rather than as a binary response. 
Although, as done in the examples here, such scales may be dichotomised to form a binary 
outcome, such an approach is not the most satisfactory. This problem is addressed in the next 
chapter which concentrates on the analysis of repeated ordered categorical outcomes. 
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5 The Analysis of Repeated Ordered Categorical Data 
5.1 Introduction 
Many quality of life items are measured on an ordered categorical scale which may, in some 
instances, be combined to give an overall summary score as analysed in Chapter 3. In cases 
when this is not appropriate (as with the daily diary card) or when it is desirable to examine 
particular items on a questionnaire in more detail, a common approach may be to dichotomise 
the score into a simple binary response and apply analyses of the type described in Chapter 4. 
However, both the combination of items to a summary score and the dichotomisation of the 
score, may result in a loss of information as well as power. A solution is to consider analyses 
of all possible dichotomies, and then summarise these to give an overall estimate of the effect 
of interest. A more parsimonious model is to assume the effect of covariates is the same 
regardless of the position of the cut off defining the dichotomy, reducing the question to a 
binary data problem with correlated errors. Such analyses are well developed for cross- 
sectional data. For example, the cumulative odds model, proposed by McCullagh (1980), 
considers the probability of being in category k or below, for k=1,..., K-1, and the continuation 
ratio model, a generalization of the Cox proportional hazard survival model, summarises the 
conditional probability of being in category k given a response in category k or below for 
k=2,..., K (Armstrong and Sloan, 1989). The critical assumption of both of these models is the 
lack of an interaction between the choice of cut point and covariates with the differences 
between cut points are treated as nuisance parameters. 
The extension of these models for repeated measurements has been discussed by several 
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authors. Grizzle et al. (1969) proposed a weighted least squares (WLS) approach which 
considered the full multinominal distribution generated from repeated ordinal data thus giving 
equivalent maximum likelihood estimates for the parameters of interest in the models above. 
Alternatively, Kenward et al. (1994) have used a Dale model (Dale, 1986) to specify fully the 
multinominal distribution of the data for direct maximum likelihood estimation of the model 
parameters. A problem with the WLS analysis is that the data need to be stratified by all 
possible combinations of the covariates, thus requiring continuous covariates to be categorised. 
In addition, as the number of covariates, measurement occasions or response categories 
increases, the observed cell counts fall which can lead to estimation difficulties. The Dale 
model used by Kenward et al. (1994) is similarly restricted by the number of repeated 
measurements that can be easily handled (Lessaffre et al., 1996) and has the additional problem 
of being computationally non-trivial to apply in practice. A further approach which has been 
suggested is to consider the model as a generalised linear model with a correlated error 
structure. Estimation is then a simple extension of that discussed in Chapter 4 and can easily 
cope with large numbers of repeated measurements (Ware et al., 1988, Zeger, 1988). Given 
their relative ease in practical application and their ability to cope with large numbers of 
repeated measurements, it is these models which are applied here for both the cumulative odds 
and continuation ratio parameterisations. Reviews of these and other methods are given by 
Landis et al. (1988), Agresti (1989) and Ware et al. (1988). Ashby et al. (1992) give a general 
annotated bibliography of other proposed methods. 
Section 5.2 describes the parameterisation and the interpretation of the cumulative odds and 
continuation ratio models for cross-sectional data. The extensions of these models for repeated 
measurements in terms of marginal and random effects models are then given in Section 5.3 . 
Their different interpretations are highlighted. The practical application of both models is then 
demonstrated using data from the shortness of breath item on the RSCL measured in the CRC 
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NSCLC study that was analysed as a binary response in Section 4.3.2. 
5.2 Regression models for ordered categorical data 
Within this section, the parameterisation of the cumulative odds and continuation ratio 
models for cross-sectional data is described. The notation assumes that yd is a (K-1)x1 
response vector for subject i, at fixed time j, where y,, =l for a response in category k for 
ordered response categories k=1,..., K-1,0 otherwise. The probability that subject i, is in 
category k at the fixed time j, is E(y,, )=it,,,. Within the notation used in this section, the 
subscript j, that denotes the time of measurement, is redundant as it is assumed fixed. Its 
incorporation throughout, however, is to allow simple generalisation of the models for repeated 
measurement data. Each model is described in terms of a single covariate, x,. Their extension 
top covariates is trivial. 
5.2.1 Cumulative odds model 
The cumulative odds model was introduced by McCullagh (1980). The motivation for the 
model was that the ordinal response represents an underlying continuous unobservable latent 
variable. The model is parameterised in terms of the cumulative probability of response in 
category k or below 
k 
µa=ý aýr (5.1) 
rýl 
By defining zL=Lyl, where L is a(K-1)x(K-1) lower triangular matrix of ones, the cumulative 
odds model for the effect of a covariate xj can be represented in a logistic regression model for µ,, =E(zU) 
with linear predictor 
log 
µük 
=a+ßx,, (k=1,..., K-1) (5.2) 1 -µig 
in 
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Within this model, ß is assumed independent of the `cut-point' k, and can be interpreted as the 
log odds ratio for a one unit change in the value of xi of being in category k or below at time 
j. The var(z, )=ocLV1LT where V, =var(yv) and ae is an over dispersion parameter. 
This transformation by L introduces an extra complication into the usual logistic regression 
model by inducing a dependency between (z; jk, zyki) so that, 
for k*k', cov(z; jk, zUk)=µijk(1-µijk') 
Ignoring this dependence will lead to an underestimation of the off-diagonal elements var(zy) 
and through this the variance of the model parameters. However, as in this case it has a known 
form, it can be modelled directly (McCullagh and Neider, 1989). Alternatively, it can be left 
unspecified, and robust variance estimates can be obtained using generalised estimating 
equations (GEE) introduced in Chapter 4 with an appropriate working correlation structure. 
5.2.2 Continuation ratio model 
The continuation ratio is an expression of the Cox proportional hazards model for discrete 
data and models the conditional probability of being in category k given a response is in 
category k or below (Armstrong and Sloan, 1989). Again this is done within a logistic 
regression model. Following the same notation as above, this is written 
log! ''k=ak+0*xr, (k=2,..., K) 
µjjk 
(5.3) 
Although this provides a different interpretation to the parameters of the cumulative odds 
model - log odds ratios of a response in category k, conditional upon the response 
being in 
category k or below for each unit increase in xi - again the parameter 
ß' is assumed constant 
over all cut-points. In practice, this is most simply derived by defining a new response 
variables zjk, k=2,..., K, where each zük is defined only for the n, k subjects 
in category k or 
below at time j and takes the value I for a response in category k, 0 otherwise. 
For p; k=E(z; 
jk), 
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equation (5.3) can be re-written 
log_ µ''k =a; +ß`x,, (k=2,..., K) 
1-'Ük 
(5.4) 
An advantage of the continuation ratio logit over the cumulative odds model derives from 
this definition of zjk, k=2,... K, which means that cov(zjik, z. , )=0 for k*k/ (Cox, 1972, 
Armstrong and Sloan, 1989). Thus for the cross-sectional analysis, the usual logistic regression 
estimation procedures may be used to obtain correct inferences about the model parameters. 
5.3 Two model extensions for repeated measurements 
The extension of these cross-sectional analyses for longitudinal data involves the 
incorporation of the additional dependence derived from repeated observations taken on the 
same subject. As an extension of the work of Chapter 4, this is demonstrated here for marginal 
and random effect (or more specifically, hierarchical) models for the cumulative odds and 
continuation ratio in turn. 
5.3.1 Marginal models using generalised estimating equations 
Since they yield consistent parameter estimates with robust standard errors without the 
variance structure of the data needing to be correctly specified, the extension of the marginal 
model of Chapter 4 for both the cumulative odds and continuation ratio is trivial. The only 
drawback is that estimates obtained using a poorly specified working correlation structure, 
although consistent, can be inefficient. However, for an improvement over an independence 
working correlation structure, care is needed to realise the correct structure between cut-points 
within occasions as well as that within subjects over time. 
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For the cumulative odds model in particular, various authors have approached this problem. 
Kenward et al. (1994) noted that p, Jkk, =corr(zfJk, zUk, ) 
for k<k' can be derived from the cut point 
parameters ak in equation (5.2). They then show that more efficient parameter estimates may 
be obtained by using the m. (K-1) x m, (K-1) block diagonal matrix working correlation matrix 
R., where the element of kth row and k'th column of the jth diagonal block, {R#}kk,, is 
pýlkk'= exp(ak-ak, ) for k<k', with pjkk'=prjk'k" This matrix is assumed the same for all i and is 
updated at each iteration. Such a structure, although improving on the specification of the 
dependence between (zýýk, zijk, ), still assumes an independence structure for observations over 
time on the same subject. Alternatively, Clayton (1992) used an empirical estimate for Rt 
based on the observed proportions in the different categories at different times. A further 
possible estimate for Rr can be obtained using the Pearson residuals given from an 
independence fit. 
For the continuation ratio model, the conditional independence between observed data for 
each cut point at each time makes specification of an efficient working correlation matrix more 
straightforward. For instance, in a simple case with j=1,2,3 and k=0,1,2,3, exchangeable or 
auto-regressive working correlation matrices for the 3(K-1) variables z* with lag one 
correlation p can be written 
13 PI3 pI3 13 pI3 p2I3 
ex (P)= 03 13 03 , gtAxr(P)= Rj pI3 
13 pI3 
PI3 PI3 13 P2I3 pI3 13 PZI3 PI3 13 
(5.5) 
where 13 is a (3x3) identity matrix. Estimation of p for this problem is, however, not trivial. 
5.3.2 Random effect models using a hierarchical structure 
A multilevel (hierarchical) model for repeated ordered categorical data treats the 
dependence between category cut points as an additional level in the hierarchy, thus extending 
P i3 P I3 13 
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the two level repeated binary response model to a three level multivariate model (Hedeker and 
Gibbons, 1994). In the same notation as before, the most simple random effects cumulative 
odds model is written 
Zijk=P ijk+eijk 
where 
logit(µUk) =ak+ (3Xr+ur 
(5.6) 
(5.7) 
At level two, the residuals e. =(e j,,..., euK-i) are constrained to have a multinominal distribution, 
that is, cov(eijk, eýýk1)=aýµýýk(1-µßk, ) for all combinations of {k, k '} , where a, is an overdisperson 
parameter. At the level three, U. is assumed Normally distributed with mean zero and variance 
a, 2,. It therefore follows that a positive u, signifies a subject specific higher than average odds 
of being in category k or below (on the log scale) and therefore typically a lower than average 
symptom score, whereas a negative ui indicates a lower than average odds of being in category 
k or below and thus a typically higher than average symptom scores. 
Although alternative estimation procedures are feasible (Hedeker and Gibbons, 1994), IGLS 
(RIGLS) with a Taylor series expansion to linearise the link function will be used here to give 
penalised quasi-likelihood estimates (Breslow and Clayton, 1993, Goldstein, 1995). 
Similarly, the random effect (or multilevel) model for the continuation ratio is also a three 
level multivariate binary model written 
fr"" 
Zük-µpk+Vü, teük 
where 
cs. s> 
logit(µ; )=040+0 'x1+ur (5.9) 
However, because of the definition of z;, the variance structure of the continuation ratio model 
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has a much simpler form than that of the cumulative odds model as cov(ejk, eýk, )=0 for k#k'. 
In this case a positive u; ` suggests a higher than average odds of a response in category k given 
a response in category k or below and therefore a typically higher than average symptom scores. 
5.3.3 Model interpretations 
As with the repeated binary case, the interpretation of the marginal and random effects 
models are very different. The marginal model gives population average effects which have 
the same interpretation as those of a cross-sectional analysis whereas the random effect or 
multilevel analysis gives subject specific covariate effects. These will be larger in absolute size 
than their population average counterparts by an amount directly related to the extent of 
between subject variation. 
There is also a very important distinction to be made between the parameters of the 
cumulative odds and continuation ratio models. The former represent covariate effects as log 
odds ratios of being in category k or below for each unit change in the covariate of interest, 
whereas the continuation ratio gives the log odds ratio of a response in category k given the 
response is at least in that category. In each case, the fundamental model assumption is that of 
equivalent covariate effects over all categories. A summary of the different interpretations of 
a parameter ß for symptoms graded an ordered category scale for an arbitrary treatment 
covariate, x,, taking the value 0 or I are summarised in table 5.1. These practical differences 
are demonstrated with an example from the CRC NSCLC study. 
5.4 Example - CRC NSCLC shortness of breath 
Shortness of breath was measured in the CRC NSCLC study using the RSCL on a four point 
scale: not at all (0); a little (1); somewhat (2); very much (3). Ignoring responses at baseline, 
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Table 5.1: Summary of the interpretations of a parameter ß for repeated ordered categorical data where xi 
is a treatment covariate taking the values 0 or 1. 
Model Interpretation 
I Marginal cumulative odds Log odds ratio of symptoms in category k or below for 
treatment 1 versus treatment 0 
2 Marginal continuation ratio Log odds ratio of symptoms in category k given symptoms 
are in that category or below for treatment I versus 
treatment 0 
3 Random effect cumulative The additional effect of treatment I versus treatment 0 on 
odds each subject specific log odds of being in category k or 
below 
4 Random effect continuation The additional effect of treatment I versus treatment 0 on 
ratio each subject specific log odds of symptoms in the highest 
category given symptoms are in that category or below 
information was available on 62 patients. Over the entire period, there was little difference 
between the two groups in the proportions reporting symptoms in categories 0 or 2 (table 5.2). 
There were however slight differences for categories 1 and 3, with a larger proportion of 
patients in the continuous course reporting in category 1 and therefore the converse for 
category 3. Overall this indicates slightly worse symptoms of shortness of breath in the 
intensive split course. Plotting these proportions on a weekly basis (figure 2.15) showed a 
slight increase over time in the reporting of symptoms graded 1,2,3 in both treatment arms. 
In the light of these observations, this example uses each of the four models described above 
to address both the question of whether there is any evidence of a difference in the reporting 
of shortness of breath in the two treatment arms, or that the reporting of symptoms changed 
with time. 
5.4.1 Model parameterisations 
To demonstrate their differences, the results of the different models were compared in terms 
of their interpretations, as well as the validation of the model assumptions. For the marginal 
models, independence working correlation matrices were initially used. These results were 
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Table 5.2: Proportion of subjects in each response category over the entire 8 week follow-up. 
Category 
0123 
Split course 0.12 0.37 0.25 0.26 
Continuous course 0.13 0.45 0.24 0.1 8 
then compared with those from models with specification of the working correlation matrix 
more closely approximating that expected, as detailed in Section 5.3.1. For the multilevel 
model analyses, RIGLS PQL estimation was used. The four models used are defined below. 
Marginal cumulative odds 
log 
Nijk 
=aM+aM+a2+IMocc +8Mrt1 1-Nil,, 
Random effect cumulative odds 
log 
P', k 
=aRE+aRE+a2E+RREOCCrI+ýjRErli+ui 
1 -µi1k 
!' 
Marginal continuation ratio Random effect continuation ratio 
µiýk .M ýM 'M ßM6 *Mrt log 
µrjk 
_a *RE a . 
RE 
a; 
R£ n *RE000+8 -RE ýt + i0g * =ai +a2 +a3 + occij+ i1+2+3+r ui I -Pijk 1 PUk 
(5.10) 
Within the marginal models, the cut point parameters, ak and a; M, k=1,2 for the cumulative 
odds model and k=2,3 for the continuation ratio model were parameterised in terms of 
differences from am and a*M, respectively. Similarly for the random effect models. Inall four 
models, a linear occasion effect was parameterised as occý1=0,..., 7 for weeks 1,..., 8, and 
constant treatment effect, rt1, modelled with the split course as baseline. In each case, the 
proportional odds assumption was tested by fitting a covariate by cut point interaction and 
constructing the combined Chi-squared statistic for simultaneous contrasts on 2 df. 
5.4.2 Results - marginal model 
The results for the two marginal models are given in table 5.3. These should both reflect 
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Table 5.3: Results for marginal cumulative odds and continuation ratio models results for shortness of 
breath in the CRC NSCLC study as an ordinal response. 
Estimate Odds ratio 
(SE) [95% CI] 
Cumulative odds model 
aM (Category 0 or below) -2.62 (0.54) 
a; ' (Category I or below) 2.16 (0.34) 
aM (Category 2 or below) 3.34 (0.39) 
ß'N (OCC) 
&" (/f) 
Continuation ratio model 
.M 
a, 
.M 
a2 
"M ag 
0.09 (0.04) 
0.39 (0.44) 
(Category 1 given 0/1) 1.66 (0.54) 
(Category 2 given 0/1/2) -2.02 (0.43) 
(Category 3 given 0/1/2/3) -2.59 (0.45) 
a'M (occ) -0.06 (0.04) 
vu (rt) -0.27 (0.37) 
Proportional 
odds assumption 
(X2 on 2 df) 
1.09 8.64 
[1.01,1.18] p=0.01 
1.48 0.35 
[0.62,3.50] p=0.84 
0.94 7.91 
[0.87,1.02] p=0.02 
0.76 0.62 
[0.37,1.581 p=0.73 
The standard errors quoted are robust standard errors from a GEE with an independence working 
correlation matrix. 
The treatment effect is given with the split course group as baseline and the occasion effect modelled 
as week 1 to 8 by a linear effect from 0 to 7. 
the patterns in the proportions over time shown in figure 2.15. This is particularly relevant for 
the cumulative odds model in which the category cut point parameters can be transformed from 
log odds (and log odds ratios) to give an estimated intercept for each of the lines displayed in 
figure 2.15(a) for the split course. The estimated treatment effect in this model for the log odds 
ratio of being in category k or below (for all k) for the continuous course versus the split course 
was 0.39 (SE=0.44). Translated in terms of an odds ratio this implies that patients on the 
continuous radiotherapy course were 48% (95% CI=[-38%, 250%]) more likely to be in 
category k or below than those in the split course. There was no evidence to suggest this effect 
167 
The analysis of repeated ordered categorical data 
(a) 
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(c) 
12345678 
Week 
(b) 
12345678 
Week 
(d) 
12345678 
Week 
Figure 5.1: Observed and fitted profiles of proportion of patients reporting symptoms of shortness 
of breath in category k or below. The fitted profiles have proportional occasion effects for (a) 
intensive split course; (b) continuous course; and non-proportional occasion effect for (c) split 
course; and (d) continuous course in the CRC NSCLC study. 
was not due to chance (p=0.37) or of a violation of the proportional odds assumption (p=0.84). 
This was not so for the linear occasion effect which gave an estimated 9% [1%, 18%] increase 
in odds per week of being in category k or below. The test of the proportional odds assumption 
gave some evidence of an interaction between occasion and cut point (p=0.01). This is shown 
in figure 5.1 by the fitted profiles for the models with proportional and non-proportional 
occasion effect. They demonstrate that the non-proportionality derived as a result of a fall in 
the proportion of patients in category zero in both treatment arms. 
The interpretation of the parameters of the continuation ratiö are very different, although 
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they do reflect the raw data plotted in figure 2.15. The individual category effects give the log 
odds of being in category k conditional on being in category k or below (for week 0, split 
course). For category 1, the estimated odds was high suggesting that of the responses in 
category 0 or 1, a larger proportion were in category 1. As expected, the corresponding 
estimated odds fall for the higher categories. Their was no evidence that the estimated 
treatment effect varied across categories (p=0.73) and, consistent with the cumulative odds 
model, there was no evidence that the estimated overall treatment difference was not due to 
chance (p=0.77). The direction of this estimated effect was different to that of the cumulative 
odds model highlighting the very different interpretation of the parameters of the two models. 
For the continuation ratio parameterisation, the estimated treatment odds ratio gave the relative 
difference in odds of being in the highest category, given the response was in that category or 
below for the continuous versus split course radiotherapy. The estimate of 0.76 (95% 
CI=[0.37,1.58]) suggested that patients on the continuous course of radiotherapy had lower 
odds of responding in the higher of a set of categories than those on the split course. This was 
therefore consistent with the estimated effect of the cumulative odds model. A similar 
comparison occurs with the linear occasion effect which was estimated to fall over time. As 
with the cumulative odds model, there was evidence to suggest that this effect was not 
consistent over categories (p=0.02). 
The results from the marginal models reported above, were based on an independence 
working correlation matrix. Although inferences based on the robust standard errors from this 
model will be consistent, they may be inefficient because of the poor approximation of the 
working correlation structure to the true covariance structure of the data (Zeger et al., 1988). 
For improved efficiency a number of alternative working correlation structures were assumed. 
For the cumulative odds model, although the dependency between cut points has a known 
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form, the added complexity of the dependence between repeated measurements makes the 
correlation structure more difficult to specify. The matrices used here attempted to improve 
the approximation of the dependence between cut points, although they all incorrectly assumed 
independence between repeated observations on the same subject. They were therefore block 
diagonal with diagonal blocks Ru, j=1,..., 8, that is, 
(Rt, 0 ... 0 
R, = 
o. (5.11) 
0 Ri7 
00R, 
Four matrices were used. Each has been previously described in Section 5.3.1. The first, 
an empirical matrix, was based on the observed correlation between the Pearson residuals 
calculated from an independence model. For computational simplicity, this was based only on 
subjects who responded at all occasions and was assumed the same for all j. The second matrix 
was suggested by Kenward et al. (1994). It used a two stage process with the working 
correlation matrix based on the estimated cut point parameters of the marginal model. Since 
the occasion effect was assumed constant over k (k=O, 1,2), R. was therefore the same for all 
j= l ,..., 8. The two remaining matrices used the method of Clayton (1992) and were based on 
the observed proportions within each category: Clayton (1) combined data over all occasions 
and assumed the same structure for all j; Clayton (2) used the observed proportions at each 
occasion separately, and thus allowed R, to vary across j. A summary of these matrices and 
the results of the analyses are given in table 5.4. 
For the cumulative odds model these illustrated that the exact choice of working correlation 
matrix although making very slight changes to the parameter estimates of the model, did not 
affect the model conclusions. For this example, the Kenward and Clayton (1) working 
correlation matrices were very similar and so it was unsurprising that their results varied very 
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Table 5.4: Estimates (robust SE) {estimate/SE} for marginal cumulative odds with different working 
correlation matrices. 
Working correlation structure 
Empirical Kenward Clayton (1) Clayton (2) 
Category 0 or below -2.56 (0.52) -2.63 (0.54) -2.64 (0.54) -2.63 (0.53) 
(-4.90} (-4.87) (-4.89) (-4.96) 
Category I or below 2.16 (0.32) 2.16 (0.34) 2.15 (0.34) 2.13 (0.34) 
(6.75) (6.35) (6.32) (6.26) 
Category 2 or below 3.34 (0.38) 3.34 (0.39) 3.34 (0.44) 3.30 (0.39) 
(8.79) (8.56) (7.59) (8.46) 
Occasion 0.08 (0.04) 0.09 (0.04) 0.09 (0.04) 0.09 (0.04) 
(2.00) (2.25) (2.25) (2.25) 
Treatment 0.36 (0.45) 0.39 (0.44) 0.39 (0.44) 0.39 (0.43) 
(0.80) 10.89) 10.89) {0.91) 
For each case the (24x24) working correlation matrix, R,, was assumed block diagonal and the same for 
all i. For the Empirical, Kenward and Clayton(1) examples the diagonal blocks, Rd were assumed the 
same for all j, and took the values 
1.00 0.317 0.173 1.00 0.341 0.189 1.00 0.345 0.193 
0.317 1.00 0.243 , 0.341 1.00 0.556 , 0.345 1.00 0.560 
0.173 0.243 1.00 0.189 0.556 1.00 0.193 0.560 1.00 
II 
) 0.317 1.00 0.243 0.341 1.00 0.5561,1 0.345 1.00 0.560 
0.173 0.243 1.00 0.189 0.556 1.00 0.193 0.560 1.00 
respectively. For Clayton(2), Ri has the same block diagonal structure, but Re was varied across 
occasions j=1,..., 8. 
little. Allowing the diagonal blocks to vary over occasions (Clayton (2)) also made little 
difference to the results although it did exhibit a very slight gain in efficiency over the 
independence and the other three working correlation matrices (illustrated by slight reductions 
in the standard errors of the model parameters of interest). Given the simplicity of each of 
these structures, particularly the Kenward and Clayton (! ) working correlation matrices, it is 
recommended that such matrices be used for practical situations. 
For the continuation ratio logit, three different matrices were used. The first two had the 
exchangeable structure given in equation (5.5) with lag one correlation p chosen arbitrarily to 
equal 0.64 and 0.20 respectively. The third matrix had the autoregressive structure described 
in 
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in equation (5.5), with lag one correlation, again arbitrarily chosen at p=0.6. The results are 
given in table 5.5. 
In contrast to the results of the cumulative odds model, in this case the choice of working 
correlation matrix over an independence matrix had some impact on the estimated coefficients. 
This was particularly striking for the cut point parameters but did not alter the conclusions of 
the analysis. The most marked change was seen with the exchangeable matrix with lag one 
correlation, p=0.64. The parameter estimates from this model were also more inefficient than 
those of the independence matrix given in table 5.3 suggesting that this matrix was less 
appropriate than the independence matrix. The results of the model with the autoregressive 
working correlation matrix with p=0.64, were much more efficient, suggesting that the poor 
performance of this first exchangeable matrix, derived from an over specification of the 
correlation between distant occasions. The exchangeable working correlation matrix with lag 
one correlation p=0.2 illustrated the highest gain in efficiency over the independence model. 
Table 5.5: Estimates (robust SE) (estimate/SE) for continuation ratio with different working correlation 
structures. 
Working correlation matrix 
Exchangeable Exchangeable AR1 
(p=0.64) (p=0.2) (p=0.6) 
Category I given 0/1 2.73 (0.64) 1.95 (0.52) 1.86 (0.53) 
(4.27) {3.75) {3.51) 
Category 2 given 0/1/2 . 1.69 (0.49) -1.66 (0.40) -1.12 (0.40) 
(-3.45) (-4.15) (-2.80) 
Category 3 given 0/1/2/3 -3.76 (0.50) -2.78 (0.45) -3.00 (0.49) 
(-7.52) (-6.18) (-6.12) 
Occasion -0.09 (0.04) -0.08 (0.03) -0.08 (0.04) 
1-2.25) (-2.67) (-2.00) 
Treatment -0.25 (0.54) -0.31 (0.41) -0.33 (0.45) 
(-0.46) (-0.76) (-0.73) 
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5.4.3 Results - random effect models 
The results for the random effect models are given in table 5.6. Deriving from random 
effect models, the parameter estimates represent the effect of a particular covariate on a 
subject's underlying odds of being in category k or below for the cumulative odds model, or of 
being in category k given a response in category k or below for the continuation ratio model. 
Their results can therefore not be compared directly with the plots of proportions over time 
given in figure 2.15. As discussed in Section 4.2, the parameter estimates will be larger in 
absolute size than those of the marginal models with the relative difference proportional to the 
or a.. variance of subject specific (log) odds, aü 
2 
For the cumulative odds model, the variance in subject specific log odds of being in 
category k or below, was estimated as 14.0, indicating a large amount of variation between 
subjects. For example, this gave a 95% reference range for the subject specific probability of 
being in category 1 or below (for patients in the split course) of [0.0003,0.999]. The effect of 
treatment was consistent in sign with that of the respective marginal model and estimated a 
108% increase (95% CI=[-71%, +1370%]) in the subject specific odds of being in category k 
or below if treated with continuous versus a split course of radiotherapy. There was no 
evidence to suggest this was not due to chance or that it was dependent on the category k. Also 
consistent with the results of the marginal cumulative odds model, there was some evidence of 
an increase in the odds of being in category k or below over time. The estimated change in odds 
over one week was +23% (95% CI=[+10%, +39%]). There was also some evidence of non- 
proportionality of this effect over k. Given the estimated between subject variability and 
assumed Normality of the random effects, the expected ratio of the marginal (population 
average) parameter estimates to these random effect (subject specific) estimates was 0.41. 
Those observed (relative to the marginal model estimates of Clayton (2) in table 5.4) 0.33 and 
0.45 for the occasion and treatment effects respectively. 
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Table 5.6: Results for random effect cumulative odds and continuation ratio models for shortness of 
breath in the CRC NSCLC study as an ordinal response. 
Estimate Odds ratio 
(SE) [95% CII 
Cumulative odds model 
Fixed parameters 
a,, (Category 0 or below) -6.00 (0.85) 
aRE (Category I or below) 5.27 (0.46) 
aZE (Category 2 or below) 8.23 (0.54) 
ßRE (OCC) 
8RE (ri) 
Random parameters 
a2 ý 
Continuation ratio models 
Fixed parameters 
Proportional 
odds assumption 
(x2 on 2 df) 
1.23 8.51 
[1.10,1.39] p=0.014 
0.21 (0.06) 
2.08 1.32 
[0.29,14.7] p=0.52 
0.73 (1.00) 
14.0 (2.74) 
cc RE (Category I given 0/1) 5.65 (0.81) 
OGZRE (Category 2 given 0/1/2) -5.12 (0.46) 
a; RE (Category 3 given 0/1/2/3) -7.70 (0.54) 
0"" (OCC) -0.20 (0.05) 
8 "RS (rt) 
Random parameters 
aZ. 
0.82 8.55 
[0.74,0.911 p=0.014 
0.51 1.37 
[0.08,3.20] p=0.50 -0.68 
(0.94) 
12.5 (2.43) 
The treatment effect is given with the split course group as baseline and the occasion effect modelled 
as week 1 to 8 by a linear effect from 0 to 7. 
All estimates were obtained using RILLS with I st order PQL. 
For the continuation ratio model, there was similarly a high degree of variation between 
subjects in the underlying odds of responding category k given k or below. For category 2 
given 0,1,2, the estimated 95% reference range in terms of probability was [0.002,0.999]. In 
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terms of the estimated treatment effect, the estimated difference in subject specific log odds of 
a response in category k given a response in category k or below, for continuous radiotherapy 
versus a split course of radiotherapy, was -0.68 (SE=0.94). This translated to a 49% lower odds 
of being in the higher category if the patient was given continuous therapy versus a split dose 
(95% CI=[92% lower, +220% higher]). As for the population average effect estimated from 
the marginal continuation ratio model, there was no evidence to suggest this was not due to 
chance (p=0.77) or that the effect varied according to the category cut point (p=0.50). Based 
on the estimated between subject variance, and Normality of subject specific residuals, the 
expected ratio of the estimated parameters of the marginal model to its random effect 
counterpart was 0.43. Those observed (relative to the marginal model with exchangeable 
working correlation with p=0.20 given in table 5.5) were 0.46 and 0.40 for the occasion and 
treatment parameters respectively. Residual diagnostics for each of these random effect models 
are shown in figure 5.2. In both cases they showed no substantial deviation from Normality. 
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Figure 5.2: Standardised level three (between subject) residuals for the (a) cumulative odds; (b) 
continuation ratio random effect models for shortness of breath in the CRC NSCLC study analysed 
as an ordinal response. 
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5.4.4 Analysis conclusions 
In conclusion, each of these models gave evidence of a change in the odds of reporting 
symptoms over time, either as a population average effect, or in terms of a change in odds for 
a subject. The direction of this change was shown in all cases to be dependent on the category, 
k. There was no evidence of a difference in the odds in the reporting of the severity of 
shortness of breath between the two treatment groups, although patients on the continuous 
course were shown to have less severe symptoms than those on the split course. 
5.5 Summary and discussion 
As most quality of life measurement scales can, to some degree, be reduced to an ordinal 
scale, this work has assessed the use of two proposed models for such data. Their extensions 
for repeated measurement data using random effect (hierarchical) models and marginal models 
using GEEs for estimation have been explained and applied to the RSCL data in the CRC 
NSCLC study. Other approaches to both the model parameterisation and its extension for 
repeated measurement are possible, in particular the use of transitional models that allow for 
the dependence induced by the repeated measurements by conditioning explicitly on previous 
observations. Such models give a different interpretation again to both the marginal and 
random effect models and have been discussed by several authors, for example, Lindsey et al., 
1995, Follmann, 1994. In particular, Lindsey et al. (1995) use a transitional model in 
conjunction with a continuation ratio for a model that can be fitted using any conventional 
logistic regression software. In terms of parameter estimation, full likelihood parameter 
estimation approaches have been suggested by Grizzle et al. (1969) and Kenward et al. (1994). 
Unfortunately, these are restricted to cope with few repeated measurements and would therefore 
have been difficult to apply to the example data. As these data are typical of those generated 
within quality of life studies, the use of such models is perhaps restricted for this application. 
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An exception to this is, for example, in some breast cancer trials where patient life expectancy 
is relatively long and quality of life measured at a small number of infrequent occasions during 
this time (Fallowfield er al., 1987). 
Once again, within the example presented here, it has been assumed that missing data is 
unrelated to the response process and it has therefore been ignored. A more detailed discussion 
into the implications of this are provided in a Chapter 7. However, Mark and Gail (1994) 
demonstrated with a simple example, that a marginal model for the cumulative odds 
parameterisation with a generalised estimating equation and an empirical working correlation 
matrix gave relatively unbiased estimates even in cases when the missing data observed was 
informative of the underlying response. 
The motivation for analysing the data on its original ordinal scale rather dichotomising it 
to a binary response was to avoid the loss of information which may result from such a 
dichotomisation, the arbitrariness of choosing where to dichotomise and to increase the power 
of the analysis. The information gain of the analysis is unfortunately offset by the increased 
complexity in interpretation of these models. In terms of the gain in power, although this is 
apparent with the random effect analyses (seen by comparing tables 5.6 and 4.2), it was not the 
case for the marginal models (tables 5.4,5.5, and 4.2). This was almost certainly due to the 
loss of efficiency induced by a poorly specified working correlation structure in that they allow 
for the dependence between cut points rather than between repeated measurements. 
Introducing a second set of estimating equations to fully model this structure may help in this 
respect, but the added efficiency is again offset by the additional complexity (Kenward et at., 
1994). 
As with the analyses of Chapters 3 and 4, alternative methods of estimation are available for 
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the marginal or random effect analyses of ordinal repeated measurement data. Those presented 
here were chosen specifically for their application as limited programming is required in order 
for them to be applied, therefore making them accessible in practice. For random effect 
analyses, an equally accessible method is available using Gauss-Hermite quadrature which has 
been implemented by Hedeker and Gibbons (1994). The main problem with the models 
presented here is the unfamiliar interpretation of the covariate effects of both cumulative odds 
and continuation ratio models. Although the equally unfamiliar subject specific interpretation 
of the random effect model may deter application of these models, as for the binary case, it 
should be noted that, although unfamiliar, it is often these subject specific effects which are of 
interest in a clinical trial. 
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6 The Analysis of Quality of Life Censored by Death 
6.1 Background 
In many cancer studies treatment is given in order to improve the quality of a limited 
survival prognosis. In such cases it can be expected that patient death during follow-up will 
occur, leaving a truncated or censored quality of life profile for that individual. The 
consequences of such patient `dropout' when attempting to draw inferences about treatment 
efficacy may be great. This becomes a particular problem when there is a trade-off between 
quantity and quality of survival. Cox et al. (1992) suggest that in such cases, in order to aid 
clinical decision making, it may be best to report quality of life and survival outcomes 
separately, thus allowing the clinician and patient to weigh up the trade-off. Although initially 
appearing to be straightforward, considering quality of life and survival as two distinct 
outcomes is not altogether without problems. The potential for bias introduced as a result of 
early subject dropout has been well documented (Diggle and Kenward, 1994, Little, 1995) and 
a particular, perhaps philosophical, problem is whether the quality of life of patients who 
subsequently die should influence inferences about response beyond their time of death, or 
whether it is the quality of life of only surviving individuals at each time which is relevant. If 
it is the former, ignoring subjects who die and considering solely the remaining subjects may 
give misleading conclusions. 
As an alternative, much work has been done with methods of combining the two endpoints 
to give a quality adjusted survival analysis (Glasziou et al. 1990, Gelber et al. 1986, Korn 
1993). It has been suggested that these methods allow more insight into the quality of life and 
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survival trade-off. Until recently such quality adjusted techniques focused on defining a 
number of health states through which patients progress and summarising the weighted survival 
time which patients spend in each state for some arbitrary weights assigned to each state. This 
work has been used most extensively to analyse patient toxicity and disease progression data 
where health states are naturally defined, whereas their application to self assessed quality of 
life data, where state definitions are more arbitrary, has been extremely limited. Recent work 
by Glasziou (1995) has attempted to address this by considering the use of patient responses 
to self assessed questionaries over time as a weight for their survival, thus avoiding the 
definition of arbitrary health states, but as yet the method has not been tested in practical 
situations. 
The work within this chapter examines the use of both these approaches to quality of life 
data censored by death, contrasting a number of analyses of the quality of life and survival data 
from the CRC HAP trial restricted to that available at June 1st 1993 (described in Chapter 1). 
As full quality of life and survival are also available for all but three subjects in the full version 
of this data set, for some of the analyses presented, these data will also be analysed as a 
comparison. Section 6.2 considers treating death in quality of life studies as a dropout problem 
and discusses types of dropout model which are most appropriate for application to quality of 
life data. Quality adjusted survival techniques based on both health state and continuous 
quality of life responses are presented in Section 6.3. 
6.2 Modelling dropout mechanisms for informatively censored data 
The term dropout in repeated measurements is used to refer to the cessation of a subject's 
response for reasons which may or may not be related to that response. For example, when 
blood pressure is measured on patients being treated for hypertension, patients whose blood 
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pressure reaches a certain level may by design be excluded from the study as they undergo extra 
treatment (Murray and Findlay, 1988). Diggle and Kenward (1994) reported an alternative 
example where dropouts were not due to study design. In this example, which concerned 
measuring the amount of protein in the milk of cows receiving different feeds, dropout was due 
to cows ceasing to lactate before the end of the study. For self assessed quality of life data, the 
censoring or death of a patient are generally the reasons why a patient is regarded to have 
dropped out. 
If it is planned that subjects are to be observed over a predetermined time period, and 
interest lies in the nature of response over this entire period, inferences should naturally be 
based on the hypothetical complete data - that is the sequence of measurement which would 
have been observed in the absence of dropout. It is on such complete data inferences that 
interest in the literature has focused. This work has demonstrated that the complexity of the 
analysis required will depend on the relationship between this sequence of measurements (the 
measurement process) and the probability of patient dropout (the dropout process) (Little, 
1995). 
When the probability of a subject dropping out is unrelated to the observed responses of 
interest, the problem with the data analysis is simply one of being able to cope with unbalanced 
data, for which any of the techniques discussed in the Chapters 3,4 and 5 are appropriate. As 
it is usually reasonable to assume that such an assumption is valid for dropout which arises due 
to censoring because of staggered entry, subsequent discussion for quality of life data is 
focused purely on the problem of dropout due to patient death. 
When there are no a priori ties between the parameters which define the dropout process 
and those of interest for the measurement process, the parameters of the two processes are said 
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to be distinct. For example, supposing the measurement process can be parameterised in terms 
of a linear trend over time defined by ß=(a, ß), and the dropout process is defined by some 
underlying probability function with parameters 4. The two processes are said to be distinct 
if 4 and ß are a priori independent. When this assumption holds, and in addition the 
probability of dropout is related only to observed measurements, it has been well documented 
that, because it is possible to factorize the joint likelihood for the complete data and dropout 
process into two distinct parts, consistent estimates for the parameters of the measurement 
process may be obtained using likelihood analyses of the observed data ignoring the dropout 
process (Little and Rubin, 1977, Zwinderman, 1992, Diggle and Kenward, 1994, Little, 1995). 
This was the case in the example of Murray and Findlay (1988), where their study design 
determined that subjects were withdrawn and placed on an open program of treatment if their 
blood pressure at any time t was greater than 110mmHg. This defined a dropout process such 
that a patient is considered to have dropped out at time t if their measurement at time t-1 was 
greater than 110mmHg. 
When the dropout process does depend on the unobserved data or the parameters of the two 
processes are not distinct, this factorisation of the likelihood is not possible and explicit 
modelling of the dropout process is then required. The possible modelling strategies suggested 
can be separated into 3 classes: selection; pattern mixture; and informatively right censored 
models (Little, 1995). 
Selection and pattern mixture models evolve from different factorisations of the joint 
likelihood for the measurement and the dropout process. Selection models use a model for the 
hypothetical complete data along with one for the dropout process conditional upon the 
hypothetical data (Diggle and Kenward, 1994), whereas pattern mixture models stratify the 
population by the pattern of dropout (Little, 1993, Little, 1995). This is summarized in box 6.1. 
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Box 6.1 
Derivation of selection and pattern mixture models 
Dropping the subscript i, for y=(yl,..., y ), j=1,..., m, the complete data, made up of that 
observed, (y, a, ), and that missing due to dropout, (y,,,,, ), and r=(ri,..., r), a corresponding 
indicator such that r, =1, if y, is observed, 0 otherwise, the selection model factorises the 
joint distribution, fiy, r) as 
fy, r) =J(Y)jtrly) =fly,, y,,,;, )frly., y., ) ; 
whereas, for the pattern mixture model it is factorised as 
ly, r) =f(r)fylr)=fir)lyk, y_, I r) 
Both models rely heavily on assumptions about the relationship between the observed and 
missing responses and the dropout process which cannot be validated. For selection models 
this is done implicitly in modelling the dropout process and its relationship with the complete 
data. Most commonly used examples are probit or logistic models which relate the probability 
of dropout to the unknown observation at the time of dropout (Diggle and Kenward, 1994). For 
a pattern mixture model the assumptions are more explicit and concern how the observed data 
from complete `patterns' relate to the observed and unobserved data from different incomplete 
patterns. Under certain assumptions for the pattern mixture model, the two approaches will 
give equivalent results (Molenburghs et al., 1995). 
Unfortunately, since these models condition the dropout process explicitly on past, present 
or future responses, they require responses to be measured at the same times for all subjects and 
more inconveniently, that dropout also occurs at a small numbers of distinct occasions. This 
makes them impractical for the problem of dropout due to death in quality of life studies when 
measurement occasions may not be consistent across subjects, and dropout occurs at many 
different times. In addition, they attempt to make inferences about the complete data (that is, 
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in the absence of dropout). Philosophically, when the reason for dropout is itself is an outcome 
of interest, it is unclear whether such inferences are relevant. 
The third class of models, informatively right censored models, attempt to lessen these 
restrictions by assuming that dropout is a function of some latent variable for each subject. 
Examples have been restricted to the case where the outcome of interest is the rate of change 
in response over time, with dropout, in each case a result of patient death, assumed dependent 
on subject specific intercept and slope (Wu and Carroll, 1988, Wu and Bailey, 1988, Wu and 
Bailey, 1989, Schlucter, 1992). 
Wu and Carroll (1988) used a two stage iterative algorithm with a probit censoring model 
to combine subject specific intercept and slope estimates taken from a linear random effects 
model for the response over time to give a pseudo maximum likelihood estimate of an `average' 
rate of change over time. Wu and Bailey (1989) showed that, under this probit censoring 
model, the rate of change of the subject specific slope is a monotonic increasing or decreasing 
function of the dropout time (with the direction dependent on the sign of the dropout parameter 
of the probit model). By defining a model for the subject specific intercept and slope as a 
function of the dropout time, they derived a linear minimum variance unbiased and a linear 
minimum mean squared error summary estimates for the rate of change. Each use the 
conditional linear model to give an estimated slope for a subjects with an `average' survival 
time which can be compared across different patient groups. 
Although an improvement over pattern mixture and selection models, these models do still 
require that dropout occurs at a limited number of time points during the follow-up. They are 
therefore of restricted use when dropout is indeed due to death and therefore occurs at different 
times across all subjects. Further, subjects with fewer than two observations have to be 
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excluded for tractability. 
These restrictions are overcome by Schlucter (1992) who generalised the conditional linear 
models of Wu and Bailey (1989) to allow the analysis of more unbalanced data generally seen 
in clinical trials and as a result of dropout due to death. Assuming that individual intercept, 
slope and logarithm of survival time (which may also be censored) follow a trivariate Normal 
distribution, an E-M algorithm was used to estimate the covariance structure of the three 
components and, in turn, and give appropriately adjusted estimates for the average response 
pattern for a randomly chosen individual with mean survival. Further, by modelling the joint 
distribution of survival and response, the estimated covariance between response and survival 
allow the conditional expectation of these parameters for different survival times to be 
evaluated allowing inferences which may be particularly relevant for quality of life studies. 
Although Schlucter (1992) expressed his model in terms of its full likelihood and used an 
E-M algorithm to estimate its parameters, it may also be formulated as a multilevel model and 
fitted using the RIGLS algorithm described in Chapter 3 (Touloumi, 1996). This is 
demonstrated here using the restricted CRC HAP trial data. The transformation from the joint 
to the conditional model as a function of survival is also presented. These conditional 
inferences are then compared against those of a conditional linear model which simply includes 
known patient survival times in the multiple regression analysis. As this latter analysis is only 
possible when full survival data is available (that is, the time of death is known for all subjects) 
the CRC HAP trial full data are used for the second example. 
Given the nature of dropout due to death in quality of life studies, none of the other dropout 
models discussed here are considered appropriate and they will therefore not be discussed 
further. 
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6.2.1 Trivariate Normal model 
The multilevel version of Schlucter's log-Normal survival model treats the quality of life 
response and the survival as a bivariate problem. This gives a two level model for the quality 
of life response as described in Chapter 3, modelled alongside a log duration model for the 
survival outcome (Goldstein, 1995, Touloumi, 1996). 
A response yqk where y,,., is the jth quality of life response for the ith subject and yy2 (j=1 
for all i) is the single survival response for that subject defined as above. Two dummy 
variables, zip and zij2, define these responses with zij, =l for a quality of life response, 0 
otherwise, and zU2=1-ziý1. Given these definitions, a simple trivariate Normal model can be 
expressed as 
yijk fl(al+ßltiji+uil+vutijl+erjl). zijI + f2(a2+si2). Zlj2 (6.1) 
where f, is an identity link function giving the simple variance components model discussed 
in Chapter 3 for a trend over time. The timing of the jth measurement for the ith subject, 
j= 1,..., m. is denoted t,,,. As before, the subject level residuals, (u,,, v,, ), for the intercept and 
slope for subject i for this part of the models are assumed Normally distributed with mean 0, 
z 
and variance, Ei= 
oN °wV 
The level one residuals, denoted e, ý, 
for thejth measurement for 
° Qz 
V MV 
the ith subject are assumed to be Normally distributed with mean zero and variance a,. 
Patient survival is modelled using a log duration model denoted f2 which allows 
incorporation of censored individuals (Goldstein, 1995). Although the residual error for this 
part of the model may take a number of distributional forms (Normal, extreme value, Gamma), 
in this example a Normal distribution with zero mean and variance o; is assumed. As there is 
only one survival observation for each subject this varies only at the patient level with residual, 
denoted si2 for subject i. Although the survival part of the model in equation (6.1) does not 
include covariates, this is a simplification for clarity and not a model restriction. 
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Corresponding with the model used by Schlucter, these two parts of the model are combined 
and the level two residuals (uj1, vi,, s12) assumed to follow a trivariate Normal distribution with 
variance 
a' 
AZ on, 
aW 
(6.2) 
Although all survival data (censored or observed) is used in estimation of the fixed components 
of this model, only the uncensored individuals contribute information in estimation of the 
variance components relating to the survival outcome. 
Defining 3, )T and ab, =(o., a,, )T from multivariate Normal theory, the conditional 
distribution of ß, Is, for some known survival time s will also be Normally distributed with 
E(ß, is)=ßl+a3-2oý(s-a2) and var(ß, ls)=EI -as2o, U ab (6.3) 
giving explicit conditional estimates for describing quality of life conditional on a given 
survival time. These are given explicitly in box 6.2. 
As an application of this model, the restricted RSCL physical data from the CRC HAP trial 
Box 6.2 
Mean quality of life profiles conditional on survival 
E(a1ls)=ai+ 
0w(s-as) 
02 
o (s-a_1 
auv our 
2 
av am 
a. a, 
Q2 
vu(a, ls)=a; - "` 2 
of 
s a 
var(ßils)=oý- M 
Z a, 
E(p''S)=ýy'+ -vr- --iý 
YY2 
a, 
cov(a I, 
ß d=aM, - 
arraw 
a2 a_ 
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were analysed with the basic model of equation (6.1) extended to include a treatment covariate 
for both the quality of life (rt, 1) and the survival (rt12) outcomes . 
Each of these variables were 
defined to take the value 1 for patients in the control arm, 0 for those receiving an HAI. Mean 
profiles of these quality of life data were given in figures 2.8 and 2.9 and suggested a slight 
downward trend over time, with an apparent constant treatment difference. To investigate this 
behaviour in the light of patient death, three progressive models were used. The first model 
(model one) assumed the survival and quality of life endpoints were independent, or that 
dropout is uninformative. In the second model (model two) a dependence between survival and 
intercept residuals was allowed, whereas the final model (model three) allowed a full 
covariance structure between survival and both subject intercept and slope. In terms of the 
covariance parameters of equation (6.2), models one and two correspond respectively to 
assuming that o =o,,, =0 and o,,., =O respectively. The results of each model are given in table 
6.1. 
Model one (the independence model) gave some evidence of a small increase in physical 
quality of life score over time which translated to an 0.34 (95% CI=[0.13,0.56]) unit increase 
over a month. There was no evidence of a difference in level of quality of life between the two 
treatment arms (p=0.20). The survival coefficient gave an estimated mean log survival of 5.97 
for the HAI group, translating to a geometric mean survival of 393 (95% CI=[311,496]) days. 
The estimated relative survival difference was 0.64 (95% CI=[0.46,0.89]). These results 
corresponded well with those presented in Appendix 1.2 which gave an estimated median 
survival of 404 and 274 days in the HAI and control groups respectively. The random 
parameter estimates showed a large degree of variation both in patient quality of life intercept 
and slope, but there was no convincing evidence of an association between the two. 
The extension of the model to incorporate dependency between the subject intercept and 
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Table 6.1: Results of a trivariate Normal model for the RSCL physical quality of life scores in the CRC 
HAP trial. 
Model one Model two Model three 
Estimate (SE) Estimate (SE) Estimate (SE) 
Fixed parameters 
a, (cons, ) 10.7(l. 10) 9.88 (1.10) 9.83(l. 10) 
P, (time, ) 0.011 (0.004) 0.012 (0.004) 0.013 (0.004) 
b, (rt, ) -1.33 (1.54) -0.89 (1.55) -0.94 (1.55) 
a2 (con) 5.97 (0.12) 5.95 (0.11) 5.95 (0.11) 
82 (rte) -0.45 (0.17) -0.38 (0.16) -0.37 (0.16) 
Variance parameters 
Level two (12 43.0 (8.50) 44.5 (8.51) 43.4 (8.57) 
0,0.0004(0.0001) 0.0004(0.0001) 0.0005 (0.0001) 
aY 0.50 (0.09) 0.48 (0.08) 0.48 (0.08) 
aMý -0.024 (0.026) -0.025 (0.024) -0.017 (0.027) 
aµr - -2.66 (0.66) -2.52 (0.68) 
aVS -- -0.002 (0.003) 
a; Level two 15.72 (1.09) 15.64 (1.01) 15.60 (1.01) 
-2 log lh 3870.2 3849.4 3847.7 
Within these models, time was recorded in days since randomisation, and treatments (ri, t and rt;, ) 
were both coded with the HAI group as baseline (rt, t=0 for HAI group, I for control). 
their survival times made very little difference to the estimated survival parameter for the HAI 
group despite the slight change in interpretation of the coefficient now representing mean 
survival for subjects with an `average' quality of life score at the start of the study. Since the 
direct comparison being made is conditional on average patient quality of life, there was some 
reduction in the estimated relative difference between the two treatment groups (0.68,95% 
CI=[0.50,0.94]). Similarly the quality of life intercept parameter had a modified interpretation 
being the mean intercept for a randomly selected individual with average survival. This was 
reflected by a reduction in the parameter estimate from 10.7 (SE=1.10) units to 9.88 (SE=1.10) 
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units. There was little change in the estimated average slope which retained the interpretation 
of the previous model. Again there was no evidence of an absolute difference in the level of 
physical quality of life scores between the two groups, although that of the control group was 
again lower than in the HAI group. The random parameter of most interest in model two was 
that for the covariance between intercept and survival. The change in -2 log lh following the 
introduction of this additional parameter was 20.9 gave strong evidence of a negative 
association between the level of a subject's initial quality of life and their survival. This 
indicated that subjects with a lower than average initial quality of life score (better quality of 
life) tended to have a higher than average survival. The estimated correlation coefficient was 
0.58. There was very little change in all parameter estimates from model two to model three. 
This was not surprising given the size of the estimated covariance between survival and slope 
and the lack of evidence to support this as a real effect (change in -2 log Ih of 1.65). 
The basic assumption of this model is trivariate Normality of the level two residuals. 
Residual diagnostics to assess this assumption are shown in figure 6.1. Figures 6.1 (a)-(c) show 
Normal plots of each of the standardised level two residuals in turn showing little evidence of 
a deviation from Normality for each univariate distribution. A Gamma plot to test for trivariate 
Normality is shown in figure 6.1(g). This plots the Mahalanobis distances estimated for each 
subject using their level do_ residuals and the estimated correlation matrix from model 3 
against the quantiles of a Chi-squared distribution on 3 df. Like the univariate Normal plots, 
this gave little evidence of a deviation away from trivariate Normality. Bivariate plots of the 
possible pairs of residuals are given in figures 6.1 (d)-(f). The strong negative association 
between patient survival and intercept is highlighted in figure 6.1(e). 
An advantage of this model is that it allows estimation of the conditional distribution of 
response given survival time using equation (6.3). This was done using the results given in 
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Figure 6.1: Residual diagnostics for the level two residuals of the trivariate Normal model for the 
restricted data of the CRC HAP trial (a)-(c) give univariate Normal plots; (d)-(f) give bivariate scatter 
plots; and (g) a Gamma plot. 
model three for particular values of s corresponding to 6 to 30 months in 6 month intervals. 
The resulting expected conditional intercepts and slopes for each of these values are given in 
figure 6.2 for the HAI and control groups. The intercept and slope are plotted separately as a 
function of observed survival time in figures 6.2(a) and 6.2(b). Realisations of these average 
profiles for the HAI and control group respectively are shown in figures 6.2(c) and 6.2(d). 
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Figure 6.2: Quality of life profiles conditional on survival as estimated for the restricted physical 
quality of life from the CRC HAP trial from the trivariate Normal model summarised by (a) average 
intercept and (b) average slope as a function of survival time. HAI: ; control: --------- and 
average profiles for survival, s=6,12,18,24,30 months (c) HAI and (d) control. 
These figures clarified the relationships indicated by the covariance structure of the joint 
distribution showing lower initial physical scores (better quality of life) for patients with 
increased length of survival. Although there was not the same convincing evidence of a 
relationship between rate of change and survival, the same pattern of a lower rate of change for 
increasing survival was also illustrated. The realisations of these average profiles when plotted 
over time showed that, although starting from different points on the physical quality of life 
scale, by death the profiles had all tended to reach a similar point in the level of quality of life. 
This suggested that differences in quality of life for different survival times may be due simply 
to patients being at different states of their disease progression rather than an overall difference 
in their experience. An important feature highlighted by this analysis was the very different 
conclusions of the descriptive analyses of figures 2.8 and 2.9 which indicated slight downward 
trends in quality of life scores in contrast to the positive trends shown here. As such positive 
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trends were also seen from model one which did not condition on patient survival, this 
emphasises the need not only for analyses that adjust for patient survival, but more importantly, 
the problems associated with these descriptive analyses that ignore repeated measurement data 
structure. 
6.2.2 Conditional linear model 
If survival time was known for all subjects, the problem of obtaining the conditional 
inferences shown in figure 6.2 would be simple using a multilevel or random effect structure 
as discussed in Chapter 3. For example, a model to examine the rate of change in response y. 
for subjects i, i= 1,..., n over time, tU for j=l,..., m1, dependent on survival s, could simply be 
written 
yu=a + ßt,, +Zs, +ýsýtu+u, `+eü (6.4) 
where { is the difference in the intercept and t is the difference in rate of change of response 
for each additional day of survival. This model can then be fitted as demonstrated in Chapter 
3. 
The fundamental difference between this model and the conditional transformation of the 
trivariate Normal model is that within the conditional linear model, the distribution of the 
survival times is left unspecified whereas in the trivariate Normal model they are assumed to 
follow a log Normal distribution. To assess the implications of this difference, both were 
applied to the full data from the CRC HAP trial. In these full data, survival times were known 
for all but three patients who were therefore necessarily excluded. The trivariate Normal model 
used corresponded to model three of the previous section and fitted a full covariance structure. 
For the conditional linear model, the model of equation (6.4) was extended to include a 
treatment coefficient. For consistency with the trivariate Normal model, survival was modelled 
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Table 6.2: Results for a trivariate Normal versus a conditional linear model for the RSCL physical 
quality of life data in the CRC HAP trial full data. 
Trivariate Normal model Conditional linear model 
Estimate (SE) Estimate (SE) 
Fixed parameters 
a] (cons) 10.52 (1.09) a (cons) 10.83 (0.97) 
ßi (time) 0.018 (0.004) ß (time) 0.015 (0.003) 
61 (rti) -1.57 (1.57) 6 (rt) -1.55 (1.54) 
a2 (cons2) 5.89 (0.10) { (surv) -3.99 (1.04) 
62 (rt2) -0.34 (0.15) (time. surv) -0.019 (0.006) 
Variance parameters 
Level two aw 43.8 (8.47) 34.7 (7.00) 
0ý 0.0005 (0.0001) 2 0.0003 (0.0001) 
0; 0.50 (0.08) 
o"v -0.002 (0.003) OM'v, -0.02 (0.02) 
0, -2.09 (0.62) 
0, -0.007 (0.003) 
Level one a; 16.13 (1.05) a; 16.18 (1.05) 
-2 log Ih 3849.6 3663.6 
on the log scale as a deviation from the estimated group mean from the trivariate Normal model 
for these data (5.89 and 5.55 for the HAI and control groups respectively (table 6.2)). The 
parameterisation of the model in this way enables a direct comparison of the parameters ( (, l; } 
of the conditional linear model and (a; 2c , o-2a} used 
in the transformation from joint to 
conditional inference for the trivariate Normal model. 
Comparing the results for the trivariate Normal model using the full data and those for the 
restricted data given in the final column of table 6.1 showed a number changes although none 
194 
The analysis of quality of life data censored by death 
were substantial. These may be attributed both to the difference in samples, and more 
importantly, because the fixed parameters (al, ß) represent estimated effects for subjects with 
mean survival (and vice versa) some deviation can be expected. 
Given the parameterisation of survival times which has been used, it is possible to compare 
the parameter estimates of the two models. For instance, the estimates of ß, and ß are directly 
comparable and give the average rate of change for survival times equal to the respective group 
means. Similarly, the intercept terms al and a correspond. In both cases, good agreement 
between the estimates was seen (10.5 versus 10.8 for the intercepts, and 0.018 versus 0.015 for 
the slopes). Estimates of (a; 2o ,, 0; 
-2a. ) from the results in table 6.2 were 1-4.18, -0.014). 
Again these were in good agreement with those of the conditional linear model for (r, ý) of 
( -3.99, -0-019). The estimates of the covariance structure of the conditional model calculated 
from the trivariate Normal model (using the equations given in box 6.2) corresponded well with 
those of the conditional linear model with ew=35.1,02, =0.0004 and 0. cvý=-0.04. from the 
trivariate Normal model versus 34.7,0.0003 and -0.02 from the conditional linear model. 
As in the previous section, realisations of the conditional model for a number of survival 
times have been plotted. Figure 6.3(a) and (b) give the results for the trivariate Normal 
conditional transformation, (c) and (d) give the equivalent figures for the conditional linear 
model. These highlight a substantial difference between the inferences drawn form the two 
models with figures 6.3(a) and (b) showing less variability with changing s than those of the 
conditional linear model in figures 6.3(c) and (d). This is thought to be due to the assumption 
of log Normality of survival times restricting the behaviour of the estimates of the trivariate 
Normal model. In terms of the conclusions of the analyses for the data, these analyses gave 
very different quality of life profiles for different survival times to those of the restricted data. 
In contrast to the respective plots for the restricted data shown in figure 6.2, they do not suggest 
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Figure 6.3: Average quality of life profiles for survival of 6,12 , 18,24,30 months, (a)-(b) as 
estimated from the trivariate Normal model for the HAI and control groups and (c)-(d) as estimated 
from the conditional linear model for RSCL physical quality of life in the CRC HAP trial. 
a similar profile of quality of life for different survival times. Rather, they show the longer 
term survivors to have a more gradual decline in quality of life than the short term survivors 
(from the conditional linear model, p=0.002). 
6.2.3 Conclusions 
These analyses have demonstrated the use of a trivariate Normal model to analyse quality 
of life and survival data together to obtain inferences about the joint distribution of the two 
outcomes, or inferences about patient quality of life conditional upon survival times. The 
analysis performed well and gave clear and comprehensive representation of the data which 
could be fairly easily explained to a clinician or patient. 
In comparison with the conditional linear model which may be seen as a simple solution to 
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analysing quality of life data alongside survival, the trivariate model performed well although 
more work is needed to determine the properties of this model particularly when a substantial 
amount of data are censored. As the analysis can be easily extended to include more covariates 
than have been considered here, can be fitted easily even when some subjects are censored, and 
may be applied to continuous, binary or ordinal data, it may serve as a useful tool in future 
practical data analysis of quality of life data. 
6.3 Quality adjusted survival analysis 
Rather than considering quality of life and survival as separate endpoints, quality adjusted 
survival analyses have also been proposed (Schumacher et al., 1991, Korn, 1993, Glasziou, 
1995). The combination of quality of life and survival outcomes to give a quality adjusted 
survival was first, and still is commonly, used in health economics for decision making 
(Weinstein and Stason, 1977). In its most simple form, it is assumed that patient quality of life 
may be divided into distinct health states (s=1,..., S) which are assigned weights, w=(w1,..., ws), 
reflecting the value of survival spent in each state. Applying these weights to the time spent 
in each state, denoted t. for subject i in state s, a patient's quality adjusted life years (QALYs) 
is then defined as the sum of the weighted times spent in each state 
S 
QALYr=E wJt. (6.5) 
S-1 
These weighted times are then summarised and compared across different patient groups of 
interest. In recent years, such methods have been adapted and used for the analysis of patient 
toxicity data in cancer and AIDS research under the name of TWIST, that is Time Without 
Symptoms and Toxicity (Gelber and Goldhirsch, 1986, Gelber et at., 1991, Gelber et al., 1992). 
In its original form, the TWIST metric combined patient survival and toxicity data by 
subtracting periods of time during which the patient experiences toxic effects of treatment or 
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symptoms of disease recurrence from overall survival (Gelber and Goldhirsch, 1986). In 
addition, for some side effects or symptoms additional survival time was subtracted to allow 
for recovery. It was therefore equivalent to QALYs where the specific symptoms represented 
the health states with the weights assigned to these health states being less than or equal to zero. 
When survival times are complete for all subjects, a comparison of QALYs across patient 
groups is straightforward using usual methods for continuous outcome data to compare the 
mean QALYs across patient groups. When some survival times are censored, as is often the case 
in clinical trials, survival analyses techniques have been used. It has been shown however, that 
such techniques can lead to biased estimation of the true distribution of QALYs in the form of 
overestimation of the survival function. This is caused by the weighting of individual survival 
times because patients who have poorer quality of life accumulate quality adjusted time very 
slowly, and are therefore more prone to early censoring leading to an underestimation of the 
hazard function, and an overestimation of the survival function (Gelber et at., 1989). The 
problem can be reduced to some degree by restricting the follow-up period by some upper limit, 
L, and focusing the analysis on QALY(L), the amount of QALY accumulated within L time units. 
This has the effect of reducing the extent of censoring, and in turn the extent of bias. 
Unfortunately simulation studies have shown that the degree of bias still remains fairly high 
even when the amount of censoring is low (Gelber et al., 1989). An alternative solution which 
has been shown to perform better is to impute QALYs for censored individuals and then to 
perform an analysis as for uncensored data. This is discussed in more detail in Section 6.3.1. 
In the light of these problems with survival analyses for censored QALYs, the TWIST metric 
was redefined using a partitioned quality adjusted survival analysis (PQAS). Rather than 
weighting individual patient TWIST, a PQAS analysis weights the estimated group means for 
time spent in each health state. Its limitation is that it requires that the health states are 
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progressive, with the final state defined as patient death. For each other state, the 'survival' 
event of interest is defined as an individual progressing from that state to the next. The analysis 
is then performed by estimating the survival for each state in turn. By restricting survival by 
some upper limit L, the restricted mean survival for each state is estimated by the finite area 
under each survival curve. The mean time spent in each state is then calculated by subtracting 
the observed mean survival in state s from that observed in state s+l. Q-TWIST is then defined 
as the weighted sums of these restricted mean survival times for some weights w=(wl.... , ws). 
Although a simple formula for the variance of the estimates is not available, variances can be 
obtained by bootstrapping, thus enabling formal comparisons of Q-TWiST across patient 
groups (Glasziou et al., 1990). 
Since the quality adjusted techniques outlined so far have relied on the existence of 
definable health states they may be inappropriate for the analysis of continuous self assessed 
quality of life. As an alternative, Glasziou et at. (1995) note that a possible definition of the 
rate of gain of QALYs at time t is simply the product of the proportion of people still alive at 
time t multiplied by the average quality of life of the survivors at time t. The integrated 
survival-quality product or mean QALYs over some time period bounded by an upper limit L, 
is then estimable by calculating the area underneath this profile. A similar analysis has also 
been suggested by Korn (1993) in which, rather than summarizing the quality of life at each 
time point for the group as a whole, individual patient profiles are first summarized by 
calculating the area underneath the profile, where the profile is bounded by either the patient's 
survival or censoring time. These potentially censored quality of life summaries for each 
individual are analysed for the group as a whole. Unfortunately, in the same way as for the 
quality adjusted times from health state models, conventional survival estimates for the 
distribution of these individual summaries will be biased because of induced informative 
censoring on the quality adjusted time scale. Although Korn (1993) gives an adjusted survival 
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estimation algorithm which reduces this bias to some degree, the method can be 
computationally intensive and can cope only with quality of life measured at a limited number 
of occasions. Its practical application to the much quality of life data in cancer trials is 
therefore limited and its use will not be pursued further here. 
Although the use of these quality adjusted survival techniques have been much discussed 
in the quality of life literature (Cox et al., 1992, Fayers and Jones, 1983, Schumacher et al, 
1991) very little practical application of use with self assessed quality of life data in clinical 
trials has been reported. Indeed only two practical applications have been found (Allen-Mersh 
et a!, 1994, Korn, 1993). The aim of this section of work is therefore to assess the methods 
outlined above to determine whether they are appropriate for future reporting of self assessed 
quality of life data where large numbers of individuals have died during the measurement 
process. To do this the RSCL physical scores from the CRC HAP trial are analysed using 
modifications to TWiST, PQAS and the integrated quality-survival product in turn. Along with 
each example, the particular analysis is discussed in more practical detail than given so far. 
Results for both the restricted and full data sets will be given. For the two health state methods, 
states were defined on the basis of the recommended RSCL `normal' physical score 
classification, that is a score of less than 20 units. For both the restricted and full data, 
approximately 13% of total follow-up time was classed as abnormal. A discussion of the 
problems and advantages of each analysis is given in Section 6.3.4. 
The lack of practical application of all these methods has meant that software is not 
available. S-Plus (Becker et al., 1988) functions have therefore been written for each case. 
These are listed in Appendix 3. 
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6.3.1 Time with normal quality of life 
Time with normal quality of life (TNQOL) is here defined as that period of a patient's 
survival spent with `normal' RSCL scores. Its definition is based on that of the TWIST metric 
but is more specific to patient quality of life as evaluated by self assessed questionnaires rather 
than patient symptoms and toxicity. In similar notation to that of Gelber et al. (1989) it was 
defined as TNQOL, =TR, -AQOL, where TR, is the time from the start of treatment to death and AQOL, 
is the amount of time of abnormal quality of life patient i experiences during this time. 
Although these quantities may or may not be observed because of censoring, given U,, the 
follow-up time for patient i, their observed values can be obtained by OTR, =U,, and 
OTNQOL, =OTR, -OAQOL, where OAQOL, is the observed amount time spent with abnormal 
quality of life. The censoring variable for OTR, andOTNQOL, is given by 8, =1 if a death is 
observed, 0 otherwise. 
In their published report of the CRC HAP data, Allen-Mersh et al. (1994) analysed such 
OTNQOL, for i= 1_. ^ using Kaplan-Meier estimation of the survival function, and comparing 
the two treatment arms with a log rank test. They concluded that there was a "significant 
prolongation in normal (... ) survival for physical symptoms (p=0.04)" in HAI treated patients 
compared with controls. However, as discussed earlier, the discounting of patient time with 
abnormal quality of life results in informative censoring. This requires some refinement to 
these simple survival analyses to assess the robustness of conclusions to varying severity of 
plausible bias. Based on the work of Gelber et al. (1989) this was done by defining a bounded 
TNQOL, OTNQOL(L),, defined as the amount of TNQOL accumulated within L days from the 
start of treatment. This was given by OTNQOL(L)r=OTR(L)i-OAQOL(L), where 
OTR(L), =min(L, U, ) and OAQOL(L)t is the length of time spent with abnormal quality of life 
within L time units. The censoring variable for OTR(L), and OTNQOL(L), is then 8(L)= 1 if OTR(L), =L 
or the patient has died, 0 otherwise. Thus a patient is only considered censored if they are still 
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alive, but have not been observed for L time units. 
With the exception of the first and last recorded measurements, when 0 and the time of death 
or censoring were used, it was assumed that the transition between quality of life states took 
place midway between the current and the previously observed measurement time. Based on 
these assumptions, the definitions above are illustrated by a hypothetical example in table 6.3. 
As the choice of L influences the results of the analysis, a range of values were used with 
their results plotted against the value of L thus giving an indication whether the analysis 
conclusions change with increasing L, as well as assessing the possible extent of bias. For the 
illustrated example the bounds were chosen at 6,12,18 and 24 months, as well as for the 
maximum follow-up within the sample which was 1273 days (42 months). These bounded times 
were then analysed either by Kaplan-Meier estimation of the censored OTNQOL(L), or by a two 
sample t-test of an uncensored data set with maximum, minimum or mean values imputed for 
censored individuals. These were again based on the definitions of Gelber et a!. (1989) and are 
summarised in box 6.3. These authors noted that for values of L no larger than median follow- 
Table 6.3: Hypothetical example illustrating accumulation of TNQOL. 
Time of measurement 
A 
B 
Quality of life score OAQOL OTNQOL 8 OAQOL(L) OTNQOL(L) 6(L) 
23 51 79 107 135 
21 24 12 14 16 
42 70 98 116 154 
15 14 18 21 16 
65 85 0 65 75 1 
28 143 1 28 112 1 
Within the body of the table the numbers given in bold type refer to the time of quality of life 
measurement in days since randomisation with the quality of life scores given in normal font. 
Patient A was censored at 150 days, and patient B died at 171 days. In the case of the definitions 
requiring an upper bound for survival, L=140 days was assumed. 
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Box 6.3 
max (OTNQOL(L), ) =L-OAQOL, 
min (OTNQOL(L), ) =Ui-OAQOL, 
mean (OTNQOL(L)i) = Ui -OAQOLi +i (L - U, ). 
up, all four methods performed very well. As median survival in the restricted CRC HAP trial 
data were 404 and 274 days for the HAI and control groups respectively, it was expected that 
estimation beyond 18 months may not perform as well as that at 6 and 12 months. 
The Kaplan-Meier estimated survival curves for censored TNQOL for the restricted data 
are shown in figure 6.4 and shows a very slight early advantage for the control group which was 
reversed later in follow-up. Within these data, 22% and 15% of the HAI and control groups 
0 200 400 Soo am 1000 1200 
TNOOI (day. ) 
Figure 6.4: Kaplan-Meier TNQOL based on the RSCL physical scores for the restricted data of the 
CRC HAP trial. HAI: ; control: --------. Censored observations are marked +. 
Definition of Imputed OTNQOL(L)1 for censored individuals 
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respectively were censored. Although these proportions were not high, it was observed by 
Gelber et al. (1989) that even when the degree of censoring was only 10%-20%, the Kaplan- 
Meier derived estimates may still be subject to an unacceptably large bias. The truncated and 
imputed methods to approximate for the bias are given in table 6.4 for L=1273 days (42 
months). Mean survival for the former was estimated by calculating the area under the 
respective truncated Kaplan-Meier curves. Standard errors for these estimates were obtained 
by bootstrapping. A simple bootstrap was used which repeatedly re-sampled from the data with 
replacement and estimated the area under the curve for the resulting sample. This was done 
separately for each treatment group. The number of repeated samples was arbitrarily chosen 
to be 2000. The confidence intervals for the estimated mean difference were calculated 
assuming unequal variances with the degrees of freedom based on Welch's test. The final 
column of the table gives a p-value for an alternative test to Welch's test in each case. For the 
Table 6.4: Mean TNQOL(L) in days over a 42 month period (1273 days) estimated using Kaplan-Meier 
(K-M) and three different imputation methods (detailed in box 6.3) for the RSCL physical scores for 
the CRC HAP trial. 
Mean TNQOL(L) (SE) Mean difference p value p value 
[95% CI] (Welch's (alternative 
HAI Control test) test) 
Restricted data 
K-M area 441.7 326.6 115.1 0.141 0.120 
under curve (62.7) (45.1) [-38.9,269.1] 
Maximum 475.7 380.8 95.0 0.230 0.230 
imputation (56.7) (54.3) [-63.3,251.31 
Minimum 366.1 290.8 75.3 0.215 0.216 
imputation (45.5) (39.6) [-44.8,195.4] 
Mean 461.2 361.0 100.2 0.148 0.148 
imputation (49.8) (47.1) [-36.2,236.6] 
Full data 
K-M area 448.1 310.7 137.4 0.031 0.033 
under curve (47.8) (40.5) [12.8,262.01 
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Kaplan-Meier analysis, a log rank test comparing the survival curves was used, and for the 
imputation methods, an unpaired two sample t-test assuming equal variances. At 1273 days (42 
months) 9 subjects in the HAI group and 6 in the control group were censored. Also given in 
the table are the results from an analysis of the full data over the same 42 month period. These 
results are also presented over time in figure 6.5 which shows the estimated mean difference 
from each of the analyses of the restricted data for all values of L plotted against L. 
Naturally there was some difference in the point estimates for each of the four estimation 
procedures, but all the analyses of the restricted data in table 6.4 gave consistent results with 
an estimated treatment difference in mean TNQOL accumulated within 42 months in favour of 
the HAI group. Although these were results were based on a slightly smaller data set, they were 
consistent with the conclusions of Allen-Mersh et al. (1994). The strength of evidence for all 
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Figure 6.5: Mean difference in TNQOL(L) (HAI-Control) estimated for restricted data using K-M 
following truncation (O), maximum (o), minimum (0) and mean (e) imputation with the observed 
TNQOL(L) for the full data (+). Vertical bars show the lower bounds of a 95% CI for the full data. 
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of the analyses using the restricted data was, however, not convincing in the restricted data. 
At 42 months the difference between the results of each of the three imputation methods and 
that of the truncated Kaplan-Meier for the restricted data was at its greatest and may indicate 
bias in the latter analysis as a result of censoring. At earlier time points (when censoring was 
naturally lower) the differences between the four methods were much reduced. This replicates 
the findings of Gelber et al. (1989). Over the 42 month period, although never reaching 
statistical significance, all of the results for the restricted data showed better quality of life for 
patients receiving HAI over the controls. Such behaviour was also seen with the analyses of 
the full data. 
A possible criticism of this analysis, is the choice of definition for `normal' quality of life. 
Although the chosen cut-off in score was that recommended by the RSCL developers, the 
sensitivity of the results to the cut-off were assessed by lowering the cut off to 16. These 
results are presented in table 6.5 for each of the 4 approximate methods for the smaller data as 
well as for the full data. Although obviously reducing the estimated mean TNQOL, in the HAP 
trial example, changing the cut off in this way did not change the conclusions of the analysis 
that the HAI patients had a longer TNQOL(L) than the control patients although without the full 
data, which is now available, there was no convincing evidence to conclude that this was due 
to a real treatment effect rather than due to chance. 
6.3.2 Partitioned quality adjusted survival analysis 
A partitioned quality adjusted survival (PQAS) analysis assumes that patient quality of life 
moves progressively through a number of defined health states and thus requires the definition 
of appropriate progressive health states. Given the invasive nature of the HAI treatment and 
thus the early expected poor quality of life, improving later in follow-up, for a PQAS analysis 
of the CRC HAP trial data three progressive states (s=1,..., 3) were defined as `treatment related 
206 
The analysis of quality of life data censored by death 
Table 6.5: Mean TNQOL(L) in days over a 42 month period (1273 days) estimated using Kaplan-Meier 
(K-M) and three different imputation methods for a 'normal' quality of life cutoff of 16 units. 
Mean TNQOL(L) (SE) Mean difference p value p value 
[95% CI] (Welch's (alternative 
HAI Control test) test) 
Restricted data 
K-M area 399.4 314.6 84.9 0.273 0.316 
under curve (62.6) (45.9) [-68.1,237.91 
Maximum 44.3 368.5 74.8 0.358 0.359 
imputation (58.9) (55.4) [-86.2,235.8] 
Minimum 322.1 277.8 44.3 0.461 0.462 
imputation (44.5) (40.1) [-74.9,163.51 
Mean 417.2 348.0 69.1 0.319 0.319 
imputation (49.5) (47.9) [-68.0,206.3] 
Full data 
K-M area 393.1 291.3 101.8 0.102 0.100 
under curve (46.1) (40.8) [-20.7,224.2] 
abnormal quality of life', `normal quality of life' and 'quality of life deterioration'. These 
definitions are described in table 6.6 and give a conservative estimate of the amount of time 
spent with normal quality of life scores. This is because once a patient had recorded a quality 
of life deterioration, all remaining survival time was classed as abnormal regardless of whether 
Table 6.6: Partitioned quality adjusted survival state definitions for PQAS analysis of the CRC HAP 
RSCL physical data. 
State name Definition 
Treatment related abnormal Abnormal quality of life immediately following treatment. A 
quality of life patient is deemed to have left this state on the first occurrence 
of a normal quality of life score. 
Normal quality of life Periods of normal quality of life scores. The time of leaving 
this state is defined by the first occurrence of an abnormal 
quality of life score following at least one normal score. 
Quality of life deterioration Periods of abnormal quality of life following periods with 
normal scores. A patient leaves this state at death regardless of 
their quality of life score. 
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Table 6.7: Hypothetical example illustrating transition times for a PQAS. 
Treatment related Normal quality of Quality of life 
abnormal quality life deterioration 
Time of measurement of life 
Quality of life score Survival Status Survival Status Survival Status 
23 51 79 107 135 
A 65 1 150 0 150 0 
21 24 12 14 16 
42 70 98 116 154 
B01 107 1 171 
15 14 18 21 16 
Within the body of the table the numbers given in bold type refer to the time of quality of life 
measurement in days since randomisation with the quality of life scores given in normal font. Patient 
A was censored at 150 days, and patient B died at 171 days. 
normal scores were subsequently recorded. This is illustrated by patient B in the hypothetical 
example given in table 6.7. As with the TNQOL(L) example, the cut-off for a normal score was 
taken according to the RSCL guidelines at 20 units and the time of state to state transitions, if 
they occurred, were taken as midway between the time of current and the previously observed 
measurement. 
Having determined the survival and censoring indicator for each patient and each state, the 
mean quality adjusted survival time was estimated as described by Glasziou et al. (1990). 
Survival curves, S,. (t), for the survival in state s or worse, were estimated for each state 
separately. Given 5 (t) (s=1,..., 3) and an upper bound, L, the restricted mean survival, ps(L), 
was then estimated by calculating the area under S, (t) bounded by L. The restricted mean time 
spent in each state, T, (L), was then estimated by 
T (L) =µ, (L) -µ, _ 1(L) 
(6.6) 
Assuming that 11o(L)=0, this difference gives the estimated mean time spent in each adjacent 
states. Finally, for some vector of weights, w=(w,,..., w3), the restricted mean quality adjusted 
survival, QAS(L), was estimated by the weighted sum of these differences, 
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3 
QAS(L)=E wsTs(-) 
S-1 
(6.7) 
The variance of this quantity, var(QAS(L))=w'rVw, where V=var(T(L)) for T(L)=(TI(L),..., T3(L)) 
and was obtained by bootstrapping. Again this was a simple bootstrap of size 2000 in which 
subjects within each treated group were repeatedly re-sampled with replacement. The empirical 
estimate of the variance of 
f(L) estimated for each sample was then used as an estimate for V. 
For the analyses presented, a range of upper bounds for survival corresponding to 6,12,18, 
24 and 42 months were used in order to check for consistency in the analysis conclusions for 
increasing L. The estimated restricted mean times spent in each state for the restricted and the 
full data are shown in table 6.8 for L=1273. The partitioned estimated survival curves for the 
restricted data are shown in figure 6.6. 
As expected, the analysis showed that patients who received the HAI treatment spent on 
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Figure 6.6: Partitioned quality adjusted survival analysis for the restricted CRC HAP trial RSCL 
physical quality of life data: (a) HAI; (b) control. Censored observations are marked +. 
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Table 6.8: Restricted mean (SE) survival time (days) in each progressive health state based on 42 months 
(1273 days) follow-up for both the full and the restricted CRC HAP trial RSCL physical quality of life 
data. 
State Restricted data Full data 
HAI Control HAI Control 
Treatment related 17.8 7.36 22.0 7.01 
abnormal quality of life (7.29) (4.24) (7.98) (4.02) 
Normal quality of life 
322.2 306.4 349.1 290.7 
(52.2) (46.6) (47.9) (40.9) 
Quality of life 142.9 36.6 123.7 36.2 
deterioration (46.8) (12.7) (38.7) (12.. 2) 
In order that the area underneath each survival curve is defined, an upper bound for survival was 
required. For the data presented in the table this was 42 months (1273 days) for both the restricted 
and full data. 
average a greater length of time with abnormal quality of life following treatment with 17.8 
days versus 7.36 in the control group. The mean time spent with normal quality of life scores 
was also greater in the HAI group, although the relative difference between the groups was 
much less than that seen for the first state. Similarly, the mean survival following a 
deterioration in quality of life was greater in the HAI group. Over the entire follow-up period, 
this implies that for any given positive weights less than one assigned to each state, the overall 
Table 6.9: Estimated mean QAS for HAI and control groups for different choice of weights for a PQAS 
analysis of the restricted RSCL physical data of the CRC HAP trial. 
Weights QAS (SE) 
1 w2 w3 HAI Control Difference [95% CI] p value 
010 322.2 (52.2) 306.4 (46.6) 15.8 [-123.5,155.1] 0.822 
0.5 1 0.5 402.5 (50.0) 328.4 (44.5) 74.1 [-59.2,207.4] 0.272 
0.25 1 0.75 366.8 (49.3) 319.2 (45.2) 47.6 [-85.6,180.7] 0.479 
0.75 1 0.25 371.2 (49.0) 321.0 (44.9) 50.2 [-82.1,182.5] 0.755 
0.9 1 0.9 466.8 (56.2) 345.9 (43.5) 120.0 [-20.7,262.5] 0.093 
111 482.9 (58.6) 350.3 (43.4) 132.6 [-12.7,277.9] 0.073 
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weighted restricted survival time will always favour the HAI treated arm of the study. 
Although the direction of effect was not altered by the choice of weights given to each state, 
obviously the size of the effect is still dependent on the choice and hence also the level of 
statistical significance. This is illustrated in table 6.9 for different choices of weight. The 
extremes of reasonable positive weights are shown in the first and sixth row of this table and 
corresponding to counting only time with normal quality of life and discarding the quality of 
life states and recognising all accumulated survival time. From these limits it is demonstrated 
that any reasonable choice of positive weight will not only favour the HAI group in terms of the 
estimated difference in mean QAS(L) as was already known, but that there will be no 
convincing evidence of a treatment difference for any given weights as shown by the lack of 
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Figure 6.7: Surface of the realised values of the lower limit of 95% confidence interval for mean 
QAS(L) for all possible combinations of w, and w3 in the interval [0,1]. 
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evidence from the two extreme cases. This is also shown in figure 6.7 which shows the surface 
of 95% lower bounds for mean QAS(L) for all combinations of w, and w3, with w2 always 
equal to one. The figure shows that for all possible combination of weights, the lower 
confidence bound was always less than 0, implying that the 95% confidence interval included 
the null value of no difference. The maximum lower bound shown on the figure corresponds 
to the final row of table 6.9 when total survival in each group is compared. 
As with the TNQOL analysis, a similar picture was also seen at the shorter restricted time 
points as shown in figure 6.8. One exception to this was at 24 months at which time the control 
group had a very slightly higher estimated restricted mean time spent with normal quality of 
life. 
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Figure 6.8: Estimated QAS(L) and 95% Cl for L=6,12,18,24,42 months with weights given by: 
(wi, w2, w3)= (0,1,0): "; (0.5,1,0.5): m; and (1,1,1): " for the restricted RSCL physical quality of life 
scores of the CRC HAP trial. 
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6.3.3 Integrated quality-survival product 
The integrated quality-survival product was outlined by Glasziou (1995) as an alternative 
to health state based models. The basis of the analysis is the observation that the rate of gain 
of quality adjusted life years at times t, denoted qaly(t), may be expressed as the product of the 
survival function and the average quality of life of survivors at that time, 
galy(t)=Q(t)S(() (6.8) 
This then allows the mean quality adjusted life years gained up to some time limit L, denoted 
QALY(L), to be estimated as the area under this quality-survival product 
L 
QALY(L) =f Q(t) S(t) dt 
0 
(6.9) 
A Kaplan-Meier estimate is the obvious estimator for the survival function, but estimation 
of Q(t) has more options. Glasziou (1995) suggest this could be done by simply estimating 
group means at fixed time points, t, and then interpolating between distinct times using either 
a step function assuming quality of life changes at these fixed times or by linear interpolation. 
Alternatively they suggest that the order of estimation could be reversed, such that quality of 
life measured at distinct times for individuals is interpolated to continuous time, with Q(t) 
estimated as an average of these continuous functions. Such an approach is particularly helpful 
when measurement of quality of life takes place at very different times for each subject. 
In the subsequent application, three alternative methods of extrapolation were considered. 
The first used the most simple formulation possible, and assumed a simple group specific linear 
regression model through all the available data. This was then evaluated at all observed 
measurement occasions across subjects. The second analysis used a lowess smoother for an 
average quality of life which was not necessarily of a linear form. The third analysis first 
obtained subject specific quality of life profiles in continuous time. These were obtained by 
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first evaluating quality of life at the planned 30 day measurement times for each subject using 
the mean of the two closest measurements at days 0,30,60, ... etc, and then 
interpolating 
between these points using a step function. 
Although the idea of integrated quality-survival product was to solve the problem of 
subjectively chosen weights by using patients' quality of life scores to weight survival, the 
scores resulting from typical quality of life measurement instruments still may not give ideal 
weights. For example, the RSCL is scored such that low scores indicate a better physical 
quality of life. In order to obtain a reasonable weighting some transformation of this score is 
obviously needed. This gives a similar arbitrariness problem for choice of weights. For 
example, for the RSCL physical score, the percentage of the total score calculated as 
w, =icould be used. Alternatively, to give a weighting which recognises the small 
clinical differences between low scores in contrast to the large clinical differences between 
Figure 6.9: Profile of weight versus quality of life response as used for the continuous quality 
adjusted survival. 1-(score/40): -; 1-(score/40)2: --------. 
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Table 6.10: Estimation of Q(t) for an integrated quality-survival product analysis of the restricted CRC 
HAP trial data. 
Analysis Weighting 
I WI 
2 WI 
Method of estimation 
A linear function of time evaluated at all observed 
measurement times 
A lowess smoother evaluated at all observed measurement 
times 
Mean of the subject specific quality of life evaluated at the 
3 w1 planned 30 day measurement occasions, t=(0,30,60,... ' 1260) 
4 W2 
A linear function of time evaluated at all observed 
measurement times 
5 
6 
w2 
W2 
A lowers smoother evaluated at all observed measurement 
times 
Mean of the subject specific quality of life evaluated at the 
planned 30 day measurement occasions, t=(0,30,60, ..., 1260) 
high scores, the transformation w2=1-( 40 
2 could be used. Both of these weighting functions 
are shown in figure 6.9 and were used for the analysis of the restricted RSCL physical scores 
of the CRC HAP trial giving six analyses in total which are outlined in table 6.10. All analyses 
were restricted to L=42 months follow-up. 
Following estimation of Q(t)and S(t), the quality-survival product, Q(t)S(t), was simply the 
product of Q(t) and S(t) evaluated over t. This is shown in figure 6.10 for the CRC HAP trial 
RSCL physical data for analyses 1,..., 3. Figure 6.10(a) shows S(t), 6.10(b), (d) and (f) give the 
estimated Q(t) for analyses 1,2 and 3 respectively. The product of the survival curve and these 
respective estimated quality of life functions is given in figure 6.10(c), (e) and (g). 
These figures highlight the different degrees of smoothing used in each estimation of Q(t), 
ranging from the linear function in figure 6.10(b), to that based on the subject specific means 
at each planned 30 day interval in figure 6.10(f) which was very noisy. The interesting thing 
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to notice from these figures, is that the degree of smoothing had little impact on the final results 
of the analysis in this example with figures 6.10(c), (e) and (g) all showing very similar 
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Figure 6.10: Estimated (a) survival S(t); and quality of life function Q(t) and quality-survival 
product for (b) and (c) analysis 1; (d) and (e) analysis 2; (f) and (g) analysis 3. HAI: 
control: --------. 
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Table 6.11: Integrated quality-survival product for the restricted RSCL physical data from the CRC HAP 
over a 42 month period. 
Mean (SE) 
Analysis HAI Control 
Difference [95% Cl] p-value 
1 346.7 (54.4) 258.2 (32.7) 88.5 [-38.3,215.3] 0.168 
2 353.4 (58.6) 265.9 (32.5) 87.5 [-46.5,221.4] 0.196 
3 353.2 (47.6) 276.5 (40.1) 76.7 [-47.2,200.6] 0.222 
4 420.1 (58.9) 302.9 (40.4) 118.0 [-24.5,260.5] 0.103 
5 433.8 (65.6) 319.5 (38.3) 114.3 [-37.5,266.1] 0.137 
6 431.6 (55.0) 322.2 (42.2) 109.4 [-28.7,247.5] 0.119 
behavioural patterns. This is further demonstrated by the estimated integrated quality-survival 
products for the three example over the 42 month period which are given in the first three rows 
of table 6.11. Although the smoothed estimates of Q(t) gave slightly increased points estimates 
of the difference between the two groups, there was little to suggest a difference between these 
estimates. Similar results were seen for the alternative transformation of quality of life scores. 
6.3.4 Conclusion 
The aim of this section of work was to assess a number of quality adjusted survival methods 
proposed for the analysis of self assessed quality of life data. Three alternative analyses were 
used. The first two analyses were based on health state models, and although they have been 
extensively used in toxicity studies, their application for self assessed quality of life data has 
been limited. Practical application of the third analysis, although specifically designed for such 
data, has yet to be reported in the quality of life literature. The aim of this work was therefore 
to assess the practical use of these analyses for the analysis of self assessed quality of life data 
and to highlight the issues which they generate. 
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The main problem with the TNQOL analysis (based on TWiST as defined by Gelber et al., 
(1989)) is that of bias induced by the informative censoring of discounted survival times. 
Because of this issue, which lead to the method being abandoned for the analysis of toxicity 
data, it is concluded that, if used, results obtained using Kaplan-Meier estimation of the 
survival curve in analyses in the light of a moderate or large degree of censoring, should be 
presented alongside those of the imputation methods suggested by Gelber et al. (1989). This 
enables the consistency of conclusions over a range of approximate methods to be assessed. 
As demonstrated in these analyses however, although these will give a range of possible values 
for patient group estimated mean TNQOL, differing degrees of bias in these estimates may 
result from the different quality of life behaviour in the two groups. A range containing all 
possible differences may be achieved by comparing the minimum imputed mean in one group 
with the maximum imputed mean in the second group and vice versa. However, unless there 
is very strong evidence of a difference it is unlikely that these estimates will give results on 
which strong inferences can be made. 
A further problem with this analysis is that it is impossible to determine whether any 
apparent advantage in TNQOL(L) for the one group over another is due to the previously 
established survival benefits or indeed a superior quality of life. This has been one of the major 
criticisms of the use of quality adjusted survival techniques in the literature and it is difficult 
to see how it may be overcome. 
The main restriction of the partitioned quality adjusted survival (PQAS) analysis is that it 
requires that the health states defined for the analysis are progressive. Such are inherent for 
the analysis of toxicity data where states of toxicity, TWiST and disease recurrence occur 
naturally. Self assessed quality of life data however can fluctuate throughout treatment and 
follow-up, particularly when periods of treatment are repeated several times during follow-up 
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as is often the case with treatments of chemo- and radio- therapy. This can be overcome to 
some degree by careful definition of states, and incorporation of additional states which allow 
a little more movement in the quality of life profile to occur. For example, `poor quality of life 
after treatment' and `poor quality of life after good'. However, this requires some knowledge 
about the expected behaviour of quality of life within a study, and will not always be 
practicable. In such cases, a partitioned quality adjusted survival analysis will not be feasible. 
The method does have an advantages over the TNQOL (TWiST) analysis in that it overcomes 
the main criticism of such methods in the literature by having a clear interpretation of the 
results in terms of it being possible to determine how the estimated weighted quality adjusted 
survival is made up in terms of time spent in each state. Perhaps more importantly, it is also 
not subject to bias as a result of informative censoring. 
The integrated quality-survival product was suggested specifically as a quality adjusted 
survival analysis for self assessed quality of life data, (Glasziou, 1995). Like TWIST however, 
it suffers from an interpretational problem as it is difficult to understand how the quality 
adjusted survival time has been accumulated and the presentation of the individual components 
of the quality-survival product (Q(t) and S(t)) is vital to facilitate interpretation. Although the 
main aim of this analysis is to eliminate the need for a researcher to subjectively assign weights 
for survival, it is unclear whether the scores obtained from quality of life measuring instruments 
define a reasonable weighting system for the analysis. Transformations of the scores to achieve 
more realistic weights from the scores may be applied, but these suffer from the same 
subjectivity as choosing weights in the first place. 
An unfortunate feature that all these analyses share, is the large number of assumptions or 
subjective decisions that have to be made by the researcher. These include: the definition of 
health states (TNQOL and PQAS); the choice of weighting for each state (PQAS and weighted 
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TNQOL); the choice of transformation of quality of life scale (integrated quality-survival 
product); and the length of time over which quality adjusted survival is evaluated (TNQOL, 
PQAS and integrated quality-survival product), and demand that a number of sensitivity 
analyses are presented along with the study results in order to study the robustness of 
conclusions drawn. These need to include presenting the results over a range of restricted times, 
L and varying the choice of weights. Within an analysis of the integrated quality-survival 
product, the impact of the choice the transformation of the quality of life scores needs also to 
be investigated. 
If feasible, it is concluded that the PQAS based analysis is the most favourable as a quality 
adjusted survival analysis of self assessed quality of life data. The basis of this conclusion is 
its ability to overcome the interpretational criticisms these analyses have faced in the literature. 
When extensive censoring occurs within the data TWiST based analyses like TNQOL, although 
simple to apply, are best avoided. Although the integrated quality-survival product has some 
potential, its lack of an intuitive interpretation of its results may limit its application as a 
reasonable alternative to PQAS. Whatever analysis is finally chosen though, possibly the most 
important part of a quality adjusted survival analysis is an extensive sensitivity analysis to 
accompany any results to support the conclusions in the light of the many arbitrary assumptions 
which all of the analyses require. 
6.4 Summary and discussion 
This work has examined alternative analyses for self assessed quality of life data which are 
censored as a result of patient death. Two very contrasting approaches were considered. The 
first included models for the analysis of data which are incomplete as a result of patient 
dropout. It was concluded that, of the three general classes of such models which have been 
220 
The analysis of quality of life data censored by death 
discussed in the literature, those termed informatively right censored models are the most 
appropriate in relation to the problem at hand. This conclusion was made on the grounds that, 
both pattern mixture models (Little, 1993) and selection models (Diggle and Kenward, 1994) 
rely on measurement (and therefore dropout) occurring at unique time points which is not 
guaranteed in quality of life studies. In addition they attempt to make full data inferences - that 
is, inferences based on expectation in the absence of dropout. This was not regarded as 
appropriate in the context of quality of life data and patient death, since it is the expectation of 
quality of life conditional on a patient being alive which is of interest. For such inferences, two 
different models were presented. Both gave very similar results. The trivariate Normal model, 
attributable to Schlucter, (1992), modelled the joint distribution of patient quality of life and 
survival, which could then be transformed to give inferences for the conditional distribution 
of quality of life given a particular survival time. In the second model, this distribution was 
modelled directly. The latter was unfortunately restricted to circumstances when survival times 
are known for all subjects, whereas the former incorporates censored survival times within the 
analysis. Although both analyses were presented with quality of life modelled in terms of a 
linear trend over time, more complex patterns of response over time may be incorporated. In 
addition, the analyses are not restricted to continuous outcomes, and may be used as extensions 
of the models for the random effect binary or ordinal outcomes discussed in Chapters 4 and 5. 
Further work is however needed in order to fully determine the properties of these models and 
their robustness to differing degrees of censoring. 
The second analysis options considered were different methods for quality adjusted survival 
analyses. Such analyses have been used successfully for the analysis of toxicity data, but have 
been criticised in the quality of life literature as they make it impossible to determine how 
quality adjusted survival has been accumulated, for instance whether patients have a short 
survival with good quality of life or a long survival with poor quality of life. Of the three 
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different quality adjusted survival analyses evaluated, it was concluded that the partitioned 
quality adjusted survival (PQAS) (Glasziou et al, 1990) was the most useful. Unfortunately, 
the analysis requires that progressive quality of life health states are definable, which may make 
it infeasible in many practical situations. In addition, as bootstrapping is required in order to 
obtain measures of precision for estimated effects, they are also computer intensive. 
A third analysis option which has not been considered here is the use of multi-state models. 
These models have been used to study disease progression (Kay, 1986, Andersen et al., 1991) 
where survival and disease development are modelled in the setting of a Markov chain, 
estimating transition intensities (or instantaneous hazard rates) between health states. It has 
been suggested (Olschewski and Schumacher, 1990, Abrams, 1992) that by defining 
appropriate quality of life states with death as a final absorbing state, such analyses could be 
useful for the analysis of self assessed quality of life data. Since there has been no application 
of such models in the quality of life literature, it is unclear how useful they may prove to be, 
and it is an interesting area of research in which further work is needed. 
It should be noted that all of the work included in this chapter once again ignored the 
problem of intermittent missing data. This is a very different problem to that of censored 
quality of life responses due to death that discussed in the following chapter. 
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7 Missing Data in Quality of Life Studies 
7.1 Introduction 
Missing data is a common problem in studies measuring quality of life. In all of the work 
covered so far in this thesis it has been assumed that the implications of some of the data being 
missing can be ignored and it has been considered simply as a problem which generates 
unbalanced data rather than a source of potential bias. The implications of this assumption will 
depend on the reasons underlying the missing data, or more formally the missing value process. 
If responses are missing simply because subjects forget to complete or return questionnaires 
and is not related to the underlying level of quality of life at that time then, although reducing 
the precision of estimates, it is reasonable to assume that the occurrence of missing data will 
not introduce a bias. On the other hand if the reason underlying the incidence of missing 
responses is in some way related to the underlying level of response, for instance if subjects 
tend not to respond when they are depressed or when they are feeling particularly well, 
inferences from analyses that ignore the missing data may be subject to bias. 
Even within a randomised controlled trial, when it is believed that the underlying reasons 
for missing responses are the same across the two treatment groups, a bias in the estimate of a 
treatment comparison may occur if indeed there is a difference in the underlying level of 
response in the two groups. For example, if the probability of subject non-response is related 
to an underlying high level of response, and if one group of patients experience higher 
underlying levels of response than the other, then this group will be more susceptible to missing 
data and the observed crude mean difference in response between the groups will be an 
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underestimation of the true underlying difference. 
Although the implications of missing data have been well documented in terms of missing 
data due to dropout or attrition, very little has been written relating to intermittent missing data. 
In one of the few references to address the problem, Diggle et al. (1994) have suggested that 
if data is intermittently missing, "it may be reasonable to assume that they arise from 
mechanisms unrelated to the measurement process and are therefore missing completely at 
random". Intuitively, this does not seem reasonable for quality of life data. The work in this 
chapter investigates this explicitly and attempts to determine how missing data typical of that 
seen in quality of life studies may affect the conclusions of an analysis. This is done by 
developing two models to investigate how the observed missing data relate to the observed 
quality of life response. These are exemplified using the data from the CRC NSCLC study. 
Before these models are developed however, Section 7.2 describes the notation and well known 
classification of missing response processes as defined by Little and Rubin (1987). This is 
followed by a simulation exercise to exemplify these definitions and their implications for 
particular intermittent missing value processes. The current literature on examining the nature 
of the missing value process within a data set is then discussed and two models that extend this 
work are developed. Using the results of both the simulation exercise and these two models, 
some conclusions as to the effect of missing data on the inferences already drawn from the CRC 
NSCLC study are then discussed. A more general discussion is given in Section 7.4. 
7.2 Missing value processes 
7.2.1 Notation 
The classifications of missing value processes defined by Little and Rubin (1987) will be 
used throughout using the following notation. 
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The vector, y; =(y; 1,..., yim), is the vector of underlying responses for subject i over occasions, 
j=l,..., m. The components of this vector which are observed are denoted y. with those that are 
missing denoted y,.. As such these two sub-vectors form a partition of yi=(yo, yim) 
xi is a design matrix of known covariates which relates y, to 0, a vector of unknown 
parameters describing the relationship of x, and y, about which inferences are to be made. For 
example, x, may be a (mx2) matrix to model 0=(a, ß), an intercept and slope to examine how 
the quality of life response changes over time. 
A second (mx 1) vector, rj=(rýý,..., rrm) denotes the missing value process, where rU=1 if yu 
is observed, 0 if it is missing. The design matrix z, relates ri to 40, a vector of unknown 
parameters for the missing value process where xi and zi may or may not be distinct. For 
example, both the missing data process r, and response y, may change with respect to time. 
The density of y, given 0 and xi is written f, (y, le, x1). Similarly the density of rj given 40, z, 
and y, is given by f2(rrI4 , zi, yj). The joint density of the observed data (yb, r, ) can then be 
obtained by integrating the joint distribution of (y,, r, ) over the sample space of the missing data 
Yin - 
f(ym, rjl9, W, xj, zj) =ff, (yjl6, xj)fz(rjlý, zj, yj)dyjo 
, ý, 
(7.1) 
It is the partitioning of the joint density in equation (7.1) that is critical in defining the 
implications of particular missing data processes. 
7.2.2 Missing completely at random 
An observation is said to be missing completely at random (MCAR) if missingness is 
completely independent of the underlying measurement process. That is 
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fZ(ri4, ZVy, ) _ . 
f(ri'O, Z; ) (7.2) 
Since yj and r, are independent, y10 can be seen as a random sample from y,, and thus 
inferences based only on the observed data (y, a, rt) are valid. 
Further, substituting equation 
(7.2) into equation (7.1) illustrates that ignoring a missing value process that is MCAR will 
introduce no bias although there will be a loss of precision in the analysis because of the 
reduced data size. Treating the missing data as simply a problem of unbalanced data is 
therefore valid under such a missing value process. 
7.2.3 Missing at random 
An observation is defined as missing at random (MAR) if missingness is related to the 
observed data, y, 0. 
Formally 
f2(r, 1 40, zi, yi) = f(rý1 (ý, zr, yro) (7.3) 
Combining this with equation (7.1), the joint density of the observed data (y, 0, r, 
) reduces to 
f2(rjl40, Z,, yjo) A (yilA, xj) d. Yi. =f2(rrl40, Zj, Yio)f3(Y; o19, x; 
) 
r,. 
(7.4) 
Following this partitioning, Rubin (1976) showed that if 0 and (0 are distinct, likelihood 
based inferences about 0 can be made based only on yk and x,. Hence, for continuous 
outcomes, variance component models which use the full available data, such as those used in 
Chapter 3, will be valid. Alternative models are also available. In particular, Zwinderman 
(1992) discussed alternative models for continuous outcomes subject to missing data classed 
as `dropout'. Also, the Dale model proposed by Kenward et al. (1994) for the analysis of 
ordinal data will also be valid under MAR. 
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It should be noted however, that unlike the MCAR process, equation (7.4) shows that y, and 
ri are not independent. This implies that the sampling properties of maximum likelihood 
estimates will depend on the missing value process and thus precision estimates based on the 
expected information matrix will be incorrect. It has been suggested therefore, that under 
MAR, precision estimates and test statistics should be based on the observed rather than 
expected information (Laird, 1988). A further problem with all likelihood based analyses is 
that, they implicitly impute missing data, and can therefore be sensitive to model 
misspecification. 
As an alternative, a weighted GEE for binary and continuous outcomes have also been 
shown to perform well for the MAR case. The basis for this proposed model is a note 
identifying the source of bias in the GEE analysis under MAR and adjusting for this accordingly 
(Rotnitzky and Wypij, 1994, Robins et at., 1995, Robins and Rotnitzky, 1995). 
7.2.4 Not missing at random 
Finally, an observation is said to be not missing at random (NMAR) if given observed 
measurements, there is some residual association of the missingness to the realised value of the 
missing observations. That is 
f2(rj1 10. zO, YI) = f(ri1 4, zt,. Yio, Ym) (7.5) 
In situations where data are NMAR, inferences drawn from an analysis ignoring the missing 
data will be biassed. Simulation exercises by many authors have attempted to address the 
extent of the problem. Wang-Clow at al. (1995) saw that when the missing data process was 
non-ignorable but the same in both treatment groups, non-likelihood based approaches tended 
to do generally better than those based on likelihood. However, in practical situations, in the 
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event of non-ignorable non-response it is impossible to determine the extent of possible bias. 
Given this, the most satisfactory way to determine the implications of the missing data on 
parameter estimation has been suggested to be a combination of pattern mixture models using 
plausible missing data processes and multiple imputation (Laird, 1988, Glynn et al., 1993) to 
give a sensitivity analysis for the different missing data assumptions. 
7.2.5 Two simulated illustrations 
To illustrate the problem of intermittent missing data for analyses of typical quality of life 
data, two simulated examples were performed. Although a number of simulated examples to 
illustrate the problems of the different missing value processes have been recently presented 
in the literature (Wang-Clow et al, 1995, Wu and Carroll, 1988) these have concentrated on the 
problem of patient dropout rather than intermittent missing data which is an additional problem 
in quality of life studies. It was therefore hoped that this exercise with simulation parameters 
typical of those seen in quality of life data, may give more information about the problems that 
intermittent missing data may cause in quality of life studies. 
In each scenario, full data were simulated for eighty-two subjects on eight occasions with the 
subjects split equally between two groups. In the first example, it was assumed that both groups 
had the same underlying response, constant through time. In the second example, the mean 
response, again assumed constant through time, was different in the two groups. In both cases, 
responses for each subject i were generated from a Normal distribution with mean µ, and 
variance oe . These subject specific means were then in turn assumed to be Normally 
distributed with mean µ and variance o,,. The values taken for these parameters are defined 
in table 7.1. The choice of parameters was based on previous experience with the results of the 
NSCLC CRC study reported in Chapter 3. 
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Table 7.1: Simulation parameters for two intermittent missing value simulations. 
Missing data process 
Marginal Variance 
parameters parameters MCAR MAR NMAR 
Ni P2 axi=Q2z Q. t=ä 2 Pr(r, O) Pr(rý=Oly;;. >l8.33) Pr(r,; =OIy>18.33) 
1 16 16 10 4 
0.20 0.55 0.75 
2 14 17.5 10 4 
For the MAR process missing data is assigned with a probability of 0.55 on the basis of the last 
observed measurement, yü.. 
The impact of missing data for three methods of data analysis were was assessed: an 
unweighted mean of subject specific parameters obtained by least squares (UWLS) (Wu and 
Carroll, 1988); a generalised estimating equation with an exchangeable correlation structure, 
(GEE) (Liang and Zeger, 1986); and full random effect analysis using multilevel models to give 
REML estimates (MLn) (Goldstein, 1995). For the UWLS analysis, subjects who following 
the assignment of missing data had less than three observations overall were excluded. 
Consistent with the simulated data structure, the parameter of interest, the mean response in 
each group was assumed constant over time. Separate variance parameters were estimated for 
each group using MLn thus giving an estimate of the intraclass correlation in each group. A. 
single estimate of the intraclass correlation was used for the GEE analysis. 
The results using each of these methods for the 300 simulated full data sets are given in 
tables 7.2 and 7.3 for the marginal and variance parameters respectively. These very closely 
reflected the simulation parameters used and were the same regardless of estimation method. 
Responses within this full data set were then designated to be missing according to each of the 
missing data processes defined above. For the MCAR case a value was designated missing with 
a probability of 0.2. Under MAR, missingness was determined on the basis of the previously 
observed measurement such that a response was assigned missing with a probability of 0.55 if 
the value of the last available observation was greater than 18.33. For example, if the second 
0.20 0.55 0.75 
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Table 7.2: Estimated marginal parameters (SD) of the full data simulated for missing data simulations. 
Method of analysis 
UWLS GEE MLn 
Simulation one : N1=16, N2=16,8=0 
µ1 16.03 (0.51) 16.03 (0.51) 16.03 (0.51) 
µ2 16.01 (0.51) 16.01 (0.51) 16.01 (0.51) 
6 -0.018 (0.72) -0.018 (0.72) -0.018 (0.72) 
Simulation two : N1=14, P2=17.5,6=3.5 
Ni 
P2 
8 
14.03 (0.51) 14.03 (0.51) 14.03 (0.51) 
17.51 (0.51) 17.51 (0.51) 17.51 (0.51) 
3.48 (0.72) 3.48 (0.72) 3.48 (0.72) 
The mean and standard deviation of the estimates from the 300 simulations are given as the estimate 
in each case. 
Table 7.3: Estimated variance parameters (SD) of the full data simulated for the missing data 
simulations. 
MLn GEE 
Variance estimates p 
Group 1 Group 2 Overall 
Simulation one : aa, =0u2=10; o, '=ai2=4; p=0.71 
02 9.97 (2.36) 9.80 (2.35) 
0,3.99 (0.34) 3.99 (0.32) 0.70 (0.04) 
Intraclass correlation 0.71 (0.05) 0.70 (0.05) 
Simulation two : aäß=022=10; a; 1=a. 2=4; p=0.71 
o. 9.97 (2.36) 9.80 (2.35) 
0,3.99 (0.34) 3.99 (0.32) 0.70 (0.04) 
Intraclass correlation 0.71 (0.05) 0.70 (0.05) 
The mean and standard deviation of the estimates from the 300 simulations are given as the estimate 
in each case. 
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observation was designated missing on the basis of the first, missingness of the third 
observation was also based on the value of the first. Being impossible to determine the value 
of the previous measurement, no dataweredeleted at the first measurement occasion. For the 
NMAR process, a value was designated missing on the basis its own value. If the value 
exceeded 18.33 it was assigned missing again with a probability of 0.75. The observed mean 
proportion of missing data for each simulation are shown in table 7.4. Given the simulation 
parameters, this was approximately 20% overall for the MCAR and NMAR analyses. Under 
MAR the overall proportion of missing data in simulation one was slightly lower at 16%, and 
for simulation two slightly higher at 22%. The distribution of proportion of missing data by 
treatment group and overall for each individual simulation within simulations one and two are 
shown in figure 7.1 along with a summary of the numbers of subjects omitted from the UWLS 
analysis in each case . 
For the MCAR cases, all the distributions were the same. This was because the assignment 
of missing data in both simulations was set to start from the same random seed. For simulation 
one where both groups had the same underlying parameters the distributions of missing data 
Table 7.4: Observed mean proportion of missing data in missing data simulations one and two by group 
and overall. 
Group 1 Group 2 Overall 
Simulation one 
MCAR 0.20 0.20 0.20 
MAR 0.16 0.16 0.16 
NMAR 0.20 0.20 0.20 
Simulation two 
MCAR 0.20 0.20 0.20 
MAR 0.18 0.25 0.22 
NMAR 0.09 0.31 0.20 
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'Figure 7.1: Missing data summary box plots and histograms for simulations one and two showing 
the distribution of the proportion of missing data ((a) & (c)) and the number of subjects who were 
omitted from the UWLS analysis because they had less than three observations ((b) & (d)) for each 
of the 300 simulations. 
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were very similar in terms of the proportions missing as well as the number of subjects with less 
than three observations who were omitted from the UWLS analysis. For simulation two where 
the different group means were used, in line with their expectations, the distribution of missing 
data between the two groups was different for the MAR and NMAR cases where the missing 
data process was related to the underlying response. This was also reflected in the distribution 
of the number of subjects with less than three observations who were omitted from the UWLS 
analysis. 
The results of the three different analyses of these data following the different missing data 
simulations are given in table 7.5 for the fixed (marginal) effects and table 7.6 for the random 
(variance) components. A series of one sample t-tests were used to test for bias in these 
estimates following data deletion under the various missing value procedures with the original 
simulation parameters. All estimates have been rounded to 2 decimal places which accounts 
for some apparent discrepancies of p-values in the tables. 
All three analysis methods performed well for the MCAR case, and gave no evidence of any 
bias in the estimation for both simulations. For simulation one, in the MAR case the UWLS 
analysis produced estimates lower than the true mean effects in each group, although the 
evidence for this as a real effect was not convincing. These were both consistently estimated 
in the GEE and MLn analyses. For all three analyses, the estimated group difference was still 
consistently estimated. However, for simulation two the UWLS analysis overestimated the true 
mean effects in each group, although it did consistently estimate the group difference. 
Although not to the same degree, the estimated group means from the GEE and MLn analyses 
were greater than the true effects. Again-the estimated group difference was still consistently 
estimated. In the NMAR case, the mean parameter estimates were underestimated in both 
simulation examples. 
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Table 7.5: Estimated marginal parameters (SE) (two sided p-value} for simulations one and two 
following the assignment of missing data. 
Method of analysis 
UWLS GEE 
Simulation one : µ, =16, P2=16,6=0 
Missing completely at random (MCAR) 
Ni 
N2 
8 
16.03 (0.03) (0.31) 16.03 (0.03) (0.31) 
16.01 (0.03) (0.74) 16.01 (0.03) (0.74) 
-0.020 (0.04) (0.64) 0.020 (0.04) 10.62) 
MLn 
16.03 (0.03) (0.31) 
16.01 (0.03) (0.74) 
-0.020 (0.04) (0.62) 
Missing at random (MAR) 
N, 
NZ 
6 
15.97 (0.03) (0.28) 16.01 (0.03) {0.83} 
15.96 (0.03) {0.19) 16.00 (0.03) (0.99) 
-0.020 (0.70) (0.981 -0.019 (0.71) (0.981 
16.01 (0.03) (0.76) 
16.00 (0.03) {0.93} 
-0.007 (0.04) (0.87) 
Not missing at random (NMAR) 
Ni 
N2 
8 
15.25 (0.02) (<0.001 } 15.45 (0.03) (<0.001) 
15.22 (0.03) (0.08) 15.43 (0.03) (<0.001 } 
-0.026 (0.04) (0.45) -0.019 (0.04) 10.611 
15.48 (0.03) (<0.001) 
15.46 (0.03) (<0.001) 
-0.023 (0.04) (0.59) 
Simulation two: µi=14, µl=17.5,8=3.5 
Missing completely at random (MCAR) 
Ni 
Pi 
8 
14.03 (0.03) {0.74} 14.03 (0.03) {0.74} 
17.51 (0.03) {0.74} 17.51 (0.03) {0.74) 
3.48 (0.04) (0.48) 3.482 (0.04) (0.48) 
14.03 (0.03) (0.74) 
17.51 (0.03) (0.74) 
3.482 (0.04) (0.48) 
Missing at random (MAR) 
NI 
N2 
6 
14.24 (0.03) (<0.001) 14.08 (0.03) (0.01) 
17.74 (0.03) (<0.001 } 17.58 (0.03) (0.01) 
3.50 (0.04) (0.97) 3.49 (0.04) 10.89) 
14.07 (0.03) (0.02) 
17.57 (0.03) (0.02) 
3.50 (0.04) (0.90) 
Not missing at random (NMAR) 
Ni 
P2 
8 
13.66 (0.03) (<0.001) 13.72 (0.03) (<0.001) 
16.31 (0.03) J<0.001) 16.74 (0.03) 1<0.001) 
2.65 (0.04) J<0.001) 3.01 (0.04) 1<0.001) 
13.73 (0.03) 1<0.001) 
16.77 (0.03) (<0.001 } 
3.04 (0.04) 1<0.001) 
The standard error of the estimates from the 300 simulations is given for each case and used to 
construct a one sample t-test comparing each estimate with the simulation parameter. 
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For the random parameters, the full random effects analysis using MLn performed 
reasonably well in the both MCAR and MAR cases in simulation one. For the latter, the 
estimated between subject variances were slightly lower than the full data example, but there 
Table 7.6: Estimated variance parameters (SE) (two sided p-value) for simulations one and two 
following the assignment of missing data. 
MLn 
Variance estimate 
Group 1 Group 2 
Simulation one : a,, =o4=10; a,, t=a, ==4; p=0.71 
Missing completely at random (MCAR) 
oN 9.98 (0.14) (0.71) 9.79 (0.14) 10.13) 
o; 4.01 (0.02) (0.81) 4.00 (0.02) (1.00) 
Missing at random (MAR) 
oM 9.81 (0.14) (0.18) 9.78 (0.13) (0.08) 
o; 4.00 (0.02) (0.88) 4.01 (0.02) (0.60} 
Not missing at random (NMAR) 
a; 7.66 (0.13 ) (<0.001) 7.44 (0.14) J<0.001) 
a; 3.55 (0.02) (<0.001) 3.54 (0.36) (0.20) 
Simulation two : apt=a =10; a<<=a 2-4; p-0.71 
Missing completely at random (MCAR) 
v; 9.98 (0.14) (0.86) 9.79 (0.14) {0.87) 
o; 4.01 (0.02) {0.83) 4.00 (0.02) 11.00) 
Missing at random (MAR) 
a, ý, 10.13 (0.14) 10.37} 9.72 (0.14) 10.04} 
o; 3.99 (0.02) (0.51 1 4.00 (0.02) 10.91) 
Not missing at random (NMAR) 
W., 8.02 (0.12) (<0.001) 8.02 (0.15) (<0.001) 
o; 3.65 (0.02) {<0.001) 3.52 (0.02) (<0.001) 
GEE 
P 
Overall 
0.70 (0.002) {0.33} 
0.69 (0.002) (0.03) 
0.62 (0.004) (<0.001 ) 
0.70 (0.002) (0.37) 
0.67 (0.003) (<0.001) 
0.63 (0.003) (<0.001) 
The standard error of the estimates from the 300 simulations is given for each case and used to 
construct a one sample t-test comparing each estimate with its simulation parameter. 
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was no evidence to suggest this was not due to chance. For simulation two, although the 
parameters were consistently estimated, under the MAR process estimates for the between 
subject variance were slightly greater than their true values for group 1 and slightly lower for 
group 2. The evidence was, however, not convincing. For the NMAR case, all the parameters 
were under estimated. This is consistent with what was expected, as removal of the larger 
observations will have the effect of drawing the available data for all subjects closer together, 
thus lowering the between subject variance, as well as reducing the variance around a subject's 
fitted parameters. 
Overall these analyses have shown that under an MCAR process, the method of analysis is 
not important in order to avoid biased estimation. They also highlighted that for an NMAR 
process, bias is unavoidable. The most interesting scenario for which some information is 
retrievable is under an MAR process. As expected, the UWLS analysis showed most bias, 
however, although to a smaller degree, some was also seen in estimates using GEE and MLn. 
When compared to the parameter estimates of the full data (tables 7.2 and 7.3) however, the 
extent of this bias was reduced somewhat. 
7.2.6 A third simulated example 
Since in practical situations it may be expected that the level of response will change over 
time a third simulation which allowed a fall in the level of response of time was also performed. 
Its simulation parameters are given in table 7.7. In this example, a fall in the level of response 
over time has been assumed. This has been allowed to vary across subjects. The variation 
between individuals in the underlying level of response has also been increased in this example. 
The missing data processes assumed in each case were the same as in the two previous 
examples. The observed proportions of missing data for each missing data process are shown 
in table 7.8. The distribution of observed proportions for each 300 simulations, as well as the 
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Table 7.7: Simulation parameters (2). 
Missing data process 
Mean Variance 
response (random effects) MCAR MAR NMAR 
PI N2 ß Ei=E2 0e1=0; 2 Pr(rr; =0) Pr(rr/=0y/1. >18.33) Pr(rr1=Oy>18.33) 
17 14 -0.7 
35 -0.9 
-0.9 0.8 10 0.20 0.55 0.75 
For the MAR simulation, data was designated missing with a probability of 0.55 on the basis of the 
last observed value denoted ye.. 
number of subjects which were omitted from the UWLS analyses due to an excess of missing 
data are shown in figure 7.2. As expected, these show a higher proportion of missing 
observations in group 1 for both the MAR and NMAR cases. Similarly, for the UWLS analysis, 
the distribution of number of subjects removed because of lack of data was different in the two 
groups. 
Table 7.8: Observed proportions of missing data in a third missing data simulation exercise. 
Mean proportion of missing values observed 
Group 1 Group 2 Overall 
MCAR 0.20 0.20 0.20 
MAR 0.19 0.12 0.16 
NMAR 0.25 0.14 0.20 
The results for the full data and those following the application of each of the missing data 
processes are shown in table 7.9 for the marginal parameters and table 7.10 for the variance 
parameters. For the marginal parameters, as for the previous two examples, parameter 
estimation with MCAR missing data was consistent for all analysis methods. When data was 
MAR, the UWLS analysis consistently estimated the group difference, but its performance in 
estimating the group intercepts and slopes was poor. For GEE, although the group means were 
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Figure 7.2: Missing data summaries for simulation three showing (a) the distribution of the 
proportion of missing data; and (b) the number of subjects who were omitted from the UWLS analysis 
because they had less than three observations for each of the 300 simulations. 
again consistently estimated, there was some evidence of a bias in the estimate for the slope 
which was greater in absolute size than the true simulation parameter. Estimation of the fixed 
parameters using MLn was much better with no evidence of a bias for any of the parameters. 
When the data were NMAR all analyses performed badly. With the exception of the slope 
estimated with the GEE analysis, all parameter estimates were significantly lower than their 
respective underlying parameters. 
Estimation of the variance parameters using MLn indicated a bias in estimation of the 
variance between subject intercepts and the covariance between slope and intercept under all 
three missing value processes. However, when compared to the estimates of the full data the 
NMAR 
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Table 7.9: Estimated marginal parameters (SE) {two sided p value) following missing data simulation. 
Method of analysis 
UWLS GEE 
Simulation parameters : N, =17, N2=14,6=-3, ß=-0.7 
Full data (Estimate (SD)) 
III 
112 
8 
ß 
17.06 (1.00) 
14.04 (0.96) 
-3.03 (1.38) 
. 0.70 (0.12) 
17.07 (1.01) 
14.03 (0.98) 
-3.03 (1.42) 
-0.70 (0.12) 
MLn 
17.07 (0.99) 
14.04 (0.95) 
-3.03 (1.34) 
-0.70 (0.12) 
Missing completely at random (MCAR) 
NI 
N2 
8 
a 
17.05 (0.06) (0.40) 
14.02 (0. (6) (0.72) 
-3.04 (0.08) (0.64) 
-0.69 (0.007) (0.30) 
17.05 (0.06) 10.40) 
14.03 (0.06) 10.60) 
-3.02 (0.08) 10.811 
-0.69 (0.007) (0.37) 
17.05 (0.06) (0.41 ) 
14.02(0.06) (0.73) 
-3.03 (0.08) (0.81) 
-0.69 (0.007) (0.35) 
Missing at random (MAR) 
NI 
Ns 
8 
P 
16.87 (0.06) (0.03) 
13.90 (0.06) {0.08) 
-2.97 (0.08) (0.72) 
-0.66 (0.007) 1<0.001) 
17.01 (0.06) (0.89) 
14.02 (0.06) (0.77) 
-2.99(0.08) (0.92) 
-0.74 (0.007) (<0.001) 
17.02 (0.06) (0.78) 
13.99 (0.06) (0.80) 
-3.02 (0.08) (0.78) 
-0.69 (0.007) (0.18) 
Not missing at random (NMAR) 
Al 
P2 
a 
15.41 (0.05) 1<0.001) 15.89 (0.05) (<0.001) 
13.26 (0.05) (<0.001) 
-2.64 (0.07) 1<0.001) 
15.79 (0-05) (<0.001) 
13.13 (0.05) (<0.001) 
-2.65 (0.07) (<0.001) 
13.03 (0.05) (<0.001) 
-2.38 (0.08) 1<0.001) 
0 -0.68 (0.007) (0.01) -0.70 (0.007) (0.81) -0.64 (0.007) (<0.001) 
The standard error of the estimates from the 300 simulations is given for each case and used to 
construct a one sample t-test comparing each estimate with their simulation parameter. 
rating of its performance under MCAR and MAR was improved. Again in the NMAR case, all 
the estimated parameters were further away from their true values than in the MCAR and MAR 
examples with substantial evidence of bias. 
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Table 7.10: Estimated variance parameters (SE) (two sided p value) following missing data simulation. 
Simulation parameters : a; =35, o , =0.8, a,,, =-0.9 a ; -10 
Full data 
Estimate (SD) MCAR MAR 
NMAR 
o2 37.02 (6.91) 37.03 (0.42) (<0.001) 36.90 (0.42) (<0.001) 29.16 (0.004) 1<0.001) 
aý 0.80 (0.16) 0.79 (0.01) (0.60) 0.79 (0.009) (0.48) 0.69 (0.43) (0.001) 
awv -1.68 (0.87) -1.68 (0.05) (<0.001) -1.72 (0.05) (<0.001 } -1.39 (0.009) (<0.001) 
or 9.98 (0.63) 10.02 (0.04) (0.60) 10.05 (0.04) {0.22} 9.24 (0.04) (<0.001 } 
The standard error of the estimates from the 300 simulations is given for each case and used to 
construct a one sample t-test comparing each estimate with the respective simulation parameter. 
7.2.7 Conclusion 
These simulations have illustrated some elements of the discussion of the previous section. 
Primarily, they have shown that under MCAR missing data processes the choice of estimation 
procedure was not crucial in avoiding bias in the parameter estimation. As expected, under 
MAR the MLn estimated parameters showed little evidence of bias. Surprisingly however, 
GEE, a non-likelihood approach, also performed well. This was not so for the UWLS analysis 
which is some degree is due to the need to exclude completely, all subjects with less that three 
responses. As expected, under NMAR, without taking into account the missing data process 
explicitly in the analysis, all analyses performed badly in all but the most simple case of 
estimating a group difference of zero. 
7.3 Determining the nature of a missing value process 
As is evident from the previous section, the type of analysis required to make valid 
inferences about parameters of interest will always depend on the missing value process. For 
instance, an ignorable process which is MCAR rather than MAR will allow full flexibility in 
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the analysis procedure, whereas a non ignorable (NMAR) process as distinct from an ignorable 
one (MCAR or MAR) will give rise to potentially biased parameter estimation. Methods to 
assess the nature of the missing data process are therefore an important part of any applied 
analysis of data which are subject to missing data. 
Some work has been reported in the literature discussing possible approaches in this area. 
In particular, Diggle (1989) proposed a non parametric test assessing whether missing data due 
to dropout occurred at random within distinct groups of the sample. Rideout (1991), in 
response to Diggle's paper, showed how using a logistic regression model for the odds of 
dropout for a given mean level of response gives an equivalent test for MCAR versus MAR 
processes. Other more recent work in the area has involved stratifying the population 
according to their observed pattern of missing data and then testing for the equivalence of 
response in each stratum (Park et al. 1993, Dawson 1994). 
Unfortunately, the basic nature of missing data means that a robust test to highlight an 
ignorable (MCAR or MAR) process from a non ignorable one (NMAR) is impossible. Diggle 
and Kenward (1994) presented a model which related the odds of dropout to the observed 
measurement history and the conditional expectation of the unobserved response at the time of 
dropout. Essentially the method involves evaluating the expectation of the missing response 
at the time of dropout conditional on the observed responses and an underlying missing value 
process (based on the logistic regression model) in a full data likelihood model. Using these 
conditional estimates, the missing value process is then updated. The procedure continues 
iteratively until convergence. Naturally the results are very sensitive to the model 
Specification for which no possibility of validation is available. 
All of this work to be found in the literature refers to the missing data due to dropout as 
241 
Missing data in quality of life studies 
opposed to intermittent missing values. Particularly when the proposed methods involve 
stratification by the observed pattern of missing data the extension of the methods for the 
intermittent case is not feasible. The remaining work in this chapter discusses an extension of 
the logistic regression model to help distinguish an MCAR from an MAR process for 
intermittent missing values in a repeated measurement problem. This is then extended and 
modelled alongside the quality of life measurement process to model jointly missing data and 
quality of life. 
The first model is a multilevel logistic regression that is an extension of Rideout's logistic 
regression model for the intermittent missing values in a repeated measurement analysis. The 
model is a first order transition model with a random effect which relates the subject specific 
odds of missing responses to the underlying level of response observed at the previous 
measurement occasion (if available). Before applying this model to the missing data problem 
in the CRC NSCLC study, an exploratory data analysis of the missing data in this study is 
performed in more detail than given previously in Chapter 2. 
7.3.1 The data 
A description of the extent of the missing data within the CRC NSCLC study was given in 
tables 2.1 and 2.2. They showed that on a weekly basis, a little over 50% of data was available 
each month. Ignoring the complete non-responders and those subjects who responded only at 
pre-treatment, as they can offer nothing to any data analysis of post treatment response, 57 
subjects remained. The amount of missing data among these subjects is summarised in table 
7.11. Missing data that was due to patient death during follow-up was ignored in the analysis 
the reasoning for this is discussed in the subsequent sections. A 75% to 80% response rate was 
seen overall which was very evenly distributed between treatment groups and over time. 
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Table 7.11: Number of missing data each week in the CRC NSCLC study taken as a proportion of those 
subjects giving at least one post baseline response. 
n Week 
1234S678 
Overall 57 0.28 0.21 0.19 0.25 0.26 0.19 0.18 0.23 
Continuous 
course 
Split 
course 
29 0.21 0.17 0.17 0.28 0.24 0.14 0.14 0.24 
28 0.36 0.25 0.21 0.21 0.29 0.25 0.21 0.21 
Further, in a logistic regression analysis of the proportion of responses given by each 
subject against several baseline covariates (table 7.12) it was seen that women tended to give 
a larger proportion of possible responses. There was also evidence of relationships with 
subject weight and Karnofsky performance score at baseline. The relationship with weight 
suggested that heavier subjects tended to complete a smaller proportion of responses. It was 
felt that this was likely to be confounded with the sex relationship. However, in a multiple 
regression analysis it was the relationship with weight that retained significance rather than 
Table 7.12: Examination of patterns of missing data in the CRC NSCLC study: a logistic regression of 
number of responses recorded on baseline variables. 
Uoharlate analyses 
Partial regression 
coefficients 
Baseline variable Estimate (SE) 95% CI Estimate (SE) 
Abe (years)' -0.08 (0.10) (-0.28.0.118] - 
Weight (kgs) -0.21 (0.09) [-0.3g. -O. 041 -0.22 (0.09) 
Sex (M-0. F-I) 0.35 (0.17) (0.009.0.68] -0.09 (0.22) 
Karnofsky 0.35 (0.08) (0.20.0.501 0.42 (0.11) 
PEV1 (I)' 3.31(l. 85) (-0.30.6.94] - 
Treatment 0.026(0.15) (-0.26.0.32] - 
(short-0. Ions I1 
Results given per 10 unit increase. 
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that of sex. The relationship with Karnofsky performance indicator was as expected: subjects 
with the lower scores at baseline tended to complete a smaller proportion of their responses. 
This was relatively unchanged in a multiple regression analysis. No evidence of a relationship 
was seen with age, FEV 1 (as a marker for disease severity) or treatment. 
7.3.2 Logistic regression model for MCAR versus MAR 
In Chapter 4a random effects logistic regression analysis for repeated measurements was 
introduced which assumed that each subject has an underlying propensity of a positive response 
which was modelled as an odds on the log scale. Within this model, the coefficients of 
covariates in the model represent the absolute changes in this subject specific log odds for unit 
changes in the covariate value. 
The first model presented here to investigate the nature of the missing data process 
investigates the dependency of missing data on the value of the previously observed 
measurement, if available, using this two level logistic regression model with binomial error eÜ 
at level one for a response i, =1 if data is available, 0 if missing for j=2,..., m: 
ru=pu+eu 
with 
log 
pal 
=a+yprevnaýý+6prevobsýý+ui I -PU 
(7.6) 
(7.7) 
where prevna, =1 if 0 otherwise (ie prevnaj=1 if the previous observation is available, 
0 otherwise), prevobsL=yj_l if rij_t=1,0 otherwise (ie prevobsj is the value of the previous 
observation when available). The random effect u1 is assumed Normally distributed with zero 
mean. 
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Under this parameterisation exp(a+u, ) is the subject specific log odds of having a response 
available at occasion j when the response at the previous occasion j-1 is missing. Within 
subject this is assumed constant over all j. The covariate effect y has little interpretable value 
representing the modification on the log scale in subject specific odds of response when the 
previous observation is available and takes the value zero. The parameter of particular interest 
is 8 which give the change in the subject specific log odds for each unit change in the previous 
response when observed. Although not a full test (as the missing value process may be related 
to more observations than simply that observed at the previous measurement occasion), a 
simple test for Ho: MCAR versus H,: MAR is Ho: 6=0. 
It is worth noting that these covariate effects, although giving the same relative changes in 
the odds between subjects, absolute changes in odds for equivalent levels of response at 
occasion j-1 will differ in accordance with each subject's underlying propensity for missing 
data given by u1 . As 
discussed Chapter 4, these subject specific parameters ur are not estimated 
explicitly. Instead we estimate their variance and thus the extent of variation between subjects 
in terms of this underlying propensity. 
An assumption of the model is that within subject, the incidence of missing data is constant 
over time. A relaxation of this assumption involves incorporating an occasion covariate into 
the model. It may also be possible that variation between subjects may be explained by 
measured baseline covariates. By introducing these as additional covariates into the model of 
equation (7.7) and examining their effect on the extent of variation in the random effect u1 this 
may be examined. Similarly, this may help explain any dependency of the missing value 
process on available responses. 
Within their analyses of dropout data, Diggle and Kenward (1994) observed in many of their 
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examples the incidence of dropout appeared related to changes in the level of response. Their 
model involved investigating changes between the conditional expectation of the unobserved 
response and the observed response at the previous measurement occasion. The role of changes 
in level can also be easily examined by a simple extension of the model of equation (7.7). This 
is done simply by changing the definition of the indicator prevna, to take the value I only when 
the previous two observations are available (and hence a change in response can be calculated) 
and 0 at all other times with this modelled alongside the difference between these two 
measurements. For clarity this model is represented in equation (7.8) with the redefined 
variables denoted chok,, and changed respectively. In order that it is possible to measure the 
change in the previous two responses, with this parameterisation, measurement occasions are 
limited to, j=3,..., m. 
log pal =a +y chok, +8 change, +ui 1-p, (7.8) 
Estimation of the model parameters can be done as an iterative process using RILLS 
(Goldstein, 1995) and a first (or second) order Taylor series expansion to linearise the logistic 
model. As discussed in chapter 4, if only the fixed parameter estimates are used to formulate 
the Taylor series expansion (marginal quasi-likelihood (MQL) estimation) all the parameters 
in the model will be subject to a downward bias which is proportional in size to var(u, ). 
Therefore penalised quasi-likelihood (PQL) estimation, which uses the estimated residuals from 
the model in addition to the fixed effects in evaluating evaluate the Taylor series expansion is 
used here. 
To demonstrate the use of this model and its extensions, an analysis was carried out using 
quality of life responses from all 57 patients in the CRC study who had at least one post 
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treatment quality of life response available. Baseline responses were included in the analysis 
in the same way as those taken post baseline, giving j=1,..., 8 for the model of equation (7.7) 
and j=2,..., 8 for that of equation (7.8). Of these 57 patients, two died during the eight-week 
follow-up and hence the responses for these individuals were truncated at time of death. 
The final data set analysed therefore contained 452 observations consisting of 55 patients 
each contributing eight observations and 2 patients contributing seven and five observations 
respectively. Out of these 452 observations, 102 were classified as missing on the HAD scale. 
Of the 102 missing observations, 47 responses were available at the previous measurement 
occasion. The mean anxiety score at this previous occasion was estimated at 5.66 (SD=4.10). 
The corresponding mean for available observations was 5.14 (SD=4.68). This information is 
summarised in table 7.13 along with the same information for the RSCL. A comparison of the 
two questionnaires shows that overall there were slightly fewer missing responses on the RSCL 
than on the HAD scale. There was some indication that the mean level of previous physical 
Table 7.13: Crude summary of the missing data for the HAD scale. 
Overall 
By previous value 
Previous Previous 
available missing 
Mean (SD) of available 
previous scores 
Hospital anxiety and depression scale Anxiety Depression 
Available 350 298 52 5.14 (4.68) 5.94 (4.31) 
n 
Missing 102 47 55 5.66 (4.10) 6.70 (4.87) 
Odds missing 0.29 0.16 1.06 
Rotterdam Symptom Checklist Physical Psychological 
Available 369 324 45 13.56 (7.91) 12.13 (7.24) 
a 
Missing 83 39 44 17.26 (9.72) 14.69 (7.22) 
Odds missing 0.23 0.12 0.98 
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scores was higher when subsequent responses were missing than when available. 
Initially the relationship of missing data and anxiety response was examined using the basic 
model given in equations (7.6) and (7.7). The results for this model are given in the first 
column of table 7.14. Within the text they have been transformed to refer to the odds of 
missing data by taking the reciprocal of the estimated odds. For a more natural interpretation 
of the parameter of the prevobsj variable, it was modelled as a deviation from the observed 
mean response for the whole data set. In the case of anxiety responses this was 7.03 units. 
This model gave no evidence to suggest that the incidence of missing responses was related 
to the value of the previous anxiety response when available was given. The estimated within 
subject odds ratio and confidence interval for each unit in the value of the previous response 
was 1.03 [0.95,1.10]. This was consistent with the summary results in table 7.13 where the 
mean anxiety response was slightly higher on occasions when the subsequent response was 
missing than when it was available. 
The estimated variance of the random component uj expresses how the underlying (log) 
odds of missing data varied across subjects. From this, a 95% reference range for the subject 
specific odds of missing data was calculated to give ranges on the odds scale of [0.14,3.45] 
where previous values were missing and [0.03,0.62] when previous values were available. On 
a probability scale these ranges correspond to [0.12,0.72] and [0.03,0.26] respectively. These 
intervals signified a large degree of variation between subjects and suggested that the incidence 
of missing data is to a large degree a subject specific phenomena. 
The results for the remaining quality of life dimensions in the CRC NSCLC study are also 
given in table 7.14. Again, the prevobs, variable was modelled in terms of a deviation from the 
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Table 7.14: Estimated coefficients (SE) for the basic model for each quality of life dimension estimated 
by PQL. 
HAD scale RSCL 
Anxiety Deoression Physical Psychological 
Fixed parameters 
a (cons) 0.35 (0.24) 0.40 (0.25) 0.54 (0.27) 0.55 (0.27) 
y (prevna) 1.57 (0.28) 1.53 (0.28) 1.78 (0.32) 1.74 (0.31) 
8 (prevobs) -0.028 (0.040) -0.056 (0.039) -0.059 (0.024) -0.051 (0.027) 
Random parameters 
oý 0.65 (0.30) 0.77 (0.33) 0.81 (0.38) 0.81 (0.38) 
-2 log lh 312.2 322.3 172.1 175.9 
sample mean. For the depression, physical and psychological scores these were 7.90,15.45 and 
14.0 units respectively. Again, estimation used PQL with a second order Taylor series 
expansion. 
There was little evidence of a relationship between missing data and the level of previous 
depression scores also obtained from the HAD scale, (exp(-E)=1.06., 95% CI=[0.98,1.18] for 
each unit score increase in the depression response). However, some evidence of a relationship 
of subsequent missing data with previous quality of life scores on the Rotterdam Symptom 
Checklist was seen. The estimated relative changes in subject specific odds were 1.06 (95% 
CI=[ 1.01,1.11] and 1.05 (95% CI=[ 1.00,1.11]) for each unit increase in the score for physical 
and psychological dimensions respectively. Such relationships corresponded to an increase in 
the incidence of missing data for higher levels of response (lower levels of quality of life). The 
lower limits of the respective confidence intervals for the confidence intervals were both very 
close to one demonstrating that this evidence was not strong. Fitting both dimensional 
responses simultaneously showed the information of the responses on the psychological 
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dimension could be explained by that in the physical dimension with a resulting change in 
deviance on adding the previous psychological scores of 0.4 (on 1 df). Again, these results 
were consistent with those seen in table 7.11. 
Normal plots of level two residuals for each of the four models in table 7.14 are given in 
figure 7.3. These were all very skewed at the upper tail of the distribution signifying an upper 
constraint on the odds of missing data due to the short follow-up period and restricted number 
of possible responses. Given a longer follow-up or more measurement occasions, these 
distributions could be expected to improve. 
The basic model for the relationship of missing data and previous physical quality of life 
responses was then extended. These results are given in table 7.15 to model changes in 
previous responses. Also presented is a repeated analysis for the level of previous observation. 
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Figure 7.3: Normal plots of standardised level two residuals for the (a) anxiety; (b) depression; (c) 
physical; and (d) psychological quality of life responses. 
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Table 7.15: Parameter estimate (SE) for modelling changes in the previous two responses for physical 
quality of life estimate by PQL. 
Estimate (SE) 
Previous response Change in previous two 
response 
Fixed parameters 
a (cons) 0.54 (0.37) 1.65 (0.40) 
y (prevnalchok) 2.85 (0.66) 1.36 (0.46) 
8 (prevphy/change) -0.049 (0.032) -0.015 (0.022) 
Random parameters 
02 1.91 (0.76) 3.040.07) 
-2 log Ih -12.76 -13.00 
These results differ slightly from those given in table 7.14 as the analysis was based on a 
slightly smaller data set with j=2,..., 5 (as opposed to j=1,..., 8 in the previous model). 
There was evidence of an obvious reduction in power for this analysis shown by the ratio 
of parameter estimates to their standard errors being reduced in all cases. In particular the 
analysis failed to give as much evidence for the relationship between the incidence of missing 
data and previous physical response seen previously (p=0.13). Similarly, the lack of evidence 
to support a relationship between the incidence of missing data and changes in the previous two 
responses may have been be due to a lack of statistical power as only 28 cases of missing data 
with a change in previous level of quality of life responses were available. Indeed lack of 
power is a problem in all of the models in this section. 
In the first analyses, a relationship was seen between the incidence of missing data and the 
level of physical quality of life observed on the previous measurement occasion. This gave 
evidence that the underlying missing data process was not missing completely at random. 
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(MCAR). However, if it were possible to explain the observed association by other known 
covariates at baseline, this conclusion may be revised. In the following analysis, the Karnofsky 
performance indicator, a measure of a patient's overall physical condition as judged by a 
clinician, was included in the basic model to assess this. The Karnofsky scale is scored in units 
of 10 between 0 (dead) and 100. Within the CRC NSCLC study data the lowest Karnofsky 
score reported was 50. For modelling purposes, the data were considered as (observed 
Karnofsky score - 50). Treatment and measurement occasion were also considered as 
potentially important covariates of interest. 
Due to missing covariate measurements, 17 patients for whom the Karnofsky score was 
missing were excluded from the analysis. Within this smaller data set there were 319 
observations that consisted of 71 missing values. Of these 71,33 (46%) had a previous 
observation available versus 213 (86%) of the 248 available responses. This was in contrast 
to 46% and 85% in the larger data set. There was very little difference in the summary of 
previous observations in this reduced data set compared to that given in table 7.13. 
The impact of the inclusion of each of the three variables was considered separately (table 
7.16). In each case inclusion of the extra covariate changed the interpretation, and therefore 
estimates, of the intercept parameter. For each model the parameter represents the log odds of 
an available response when the previous response is missing and the covariate of interest takes 
the value zero for a subject with a random effect of zero. For the model parameterisation used 
here, this represents a pre-treatment Karnofsky=50 and split course radiotherapy group. The 
occasion effect was modelled as a linear term with j=2,..., 8 modelled as j=0,..., 6. 
The relationship seen with baseline Karnofsky performance indicator was similar to that 
seen in the earlier model (table 7.12) and gave some evidence that subjects with a lower 
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Table 7.16: Fixed parameter estimates (SE) for a logistic MCAR versus MAR model for previous 
physical quality of life scores extended for baseline covariates (PQL estimation). 
Estimate (SE) 
a (cons) y (prevna) 8 (prevobs) a'. 
Univariate 
extensions to 
the baseline 
model 
Baseline model 
Karnofsky 
Treatment 
Occasion 
0.61 2.88 . 0.053 
(0.43) (0.77) (0.036) 
0.062 -0.87 2.80 -0.047 
(0.026) (0.69) (0.74) (0.034) 
-0.27 0.78 2.89 -0.055 
(0.68) (0.53) (0.79) (0.037) 
-0.034 0.69 2.92 -0.055 
(0.11) (0.50) (0.78) (0.036) 
1.77 
1.24 
1.96 
1.77 
performance score at baseline tended to have a lower proportion of responses. There was a 
little evidence of confounding between this relationship and that observed with previous 
physical quality of life scores with only a small reduction in the estimated effect of the previous 
scores. The main effect of adding the Karnofsky indicator to the model was the noticeable 
reduction in the between subject variance from 1.77 to 1.24. Consistent with the results of the 
preliminary analyses there was no evidence to suggest a relationship of treatment group and the 
missing data. Similarly there was little evidence of a linear trend over time. 
From these series of analyses it may be concluded that the prevalence of intermittent missing 
data in the NSCLC study was related to the patients underlying condition at the start of the 
study (given by their Karnofsky score) as well as their physical recorded physical quality of life 
during the study. It would therefore not be realistic that the missing data in study were missing 
completely at random. 
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7.3.3 Joint modelling of the quality of life and missing data process 
The model in the previous section explicitly conditioned the missing data process on the 
observed data in an attempt to determine the nature of the missing data process. Such a model 
stems from the background of selection and pattern mixture models discussed in Chapter 6. As 
discussed in that chapter, an alternative way of approaching the problem of missing data is to 
condition not on the actual measurements, but some latent variables determining the underlying 
patient response (Wu and Carroll, 1989, Schlucter, 1992). This was demonstrated in Chapter 
6 when patient survival was modelled alongside their quality of life in a multivariate model 
which enabled estimation of the joint distribution of survival and quality of life. A similar 
model may be applied to the intermittent missing data problem. Such a model assumes that 
missing data is not due to the level of observed quality of life at a particular time, but on a 
patient's underlying quality of life response as well as their own propensity for non response. 
The type of inferences this allows are as to whether a subject who has a higher than average 
intercept and slope tends also to have a higher than average propensity for missing data. The 
model therefore does not concentrate on the particular instances of missing data, it focuses 
more on the overall level of missing data for each subject and addresses the question as to 
whether the parameters underlying the quality of life (response) and missing data processes may 
be assumed distinct. 
Unlike the survival model of Chapter 6, the model is a three level model. This difference 
arises because in the case of missing data, there exists random variation both within and 
between subjects for both outcomes of interest. The variation at level three is between subject 
and at level two between occasions. No variation is modelled between dimensions (quality of 
life and missingness) at level one. The response yjk is made up of the quality of life responses y, 
and missing data process rU such that yuk=yj for k= 1, r, j 
for k=2. Given this, the most simple 
model is then expressed as 
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yuk-zrp (a1+ß ixýjr +uir +yirxui '11i111) 
+z2{[1+exp(-a2-uJ2)]-'+e} (7.9) 
where zij, =1 for all ye,, 0 otherwise and z. 2 =1-z,, =1 
for all y. 2,0 otherwise. This gives a 
model for the quality of life responses corresponding exactly to the simple variance components 
model of equation (3.1), where xU, denotes the time of measurement, and one for the missing 
data process that is analogous to the multilevel binary response model of equations (4.14) and 
(4.15). In the latter, the subject residual un denotes the deviation from the average log odds 
of missing data for the ith subject assumed to be Normally distributed with zero mean and 
variance a2 . 2. 
The residual component of this model, eu2, is assumed to come from a binomial 
distribution and has with mean 9U and variance 6. (1-Os), where 9U=E(rr) and may or may not 
vary with j. 
The extra variance components of this model over and above those of two separate models 
represent the associations at level three between (u,,, uf2) and (u12, v7, ) denoted aw/2 and aav12 
and at level two between (e fl, eU2) 
denoted ac12 " 
When all of these covariance terms are fitted, 
the model coefficients for the quality of life response give the mean intercept and slope for a 
subject with an underlying mean propensity for missing data (as given by the missing data 
coefficient a2 ). On the other hand, constraining these covariances to be equal to zero, will give 
results exactly comparable with fitting two univariate models. 
An extension to the model of equation (7.9) including additional covariates was fitted to the 
CRC NSCLC physical quality of life data. The extra covariates were fitted within the quality 
of life response part of the model included a treatment covariate denoted rte, =1 for the 
continuous course, 0 for the intensive split course, and a baseline response, base,, which was 
centred around the overall mean of 15.45 units. The data set used therefore consisted only of 
the 42 subjects who responded at baseline and at least one post treatment follow-up. Out of 
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these 42 subjects, the proportion of missing data in each treatment arm was 15% overall, and 
14% and 16% for the long and short courses respectively. 
Three successive models were used. The first assumed independence between the two 
outcomes, with all the covariances between them constrained to be zero. The second model 
allowed a dependency between the two intercept terms, and the final model had a full 
covariance structure. The results are given in table 7.17. 
The results from model one are analogous to those of two separate models: for the quality 
of life response there was some evidence of a slight fall in the level of physical quality of life 
over the period, but no evidence of any difference between the two treatment groups. There 
was a large degree of variability between the subject specific profiles. The missing data part 
of the model fit only an intercept term therefore assuming the same constant level of missing 
data over the period in the two treatment arms. The fitted intercept term of 1.77 (95% 
CI=[1.30,2.24]) gave an estimate of the overall proportion of missing data of 0.15 (95% 
CI=[0.10,0.21]). Again there was a large amount of variation between subjects with a 95% 
reference range for the subject specific proportion of missing data of [0.02,0.55]. 
On extending model one to allow covariance between the level of quality of life and the log 
odds of missing data, the intercept parameter a2 may be interpreted as the log odds of available 
data for a subject with average (baseline adjusted) intercept. Similarly the quality of life 
intercept term a, reflects the average baseline adjusted intercept for a subject with 15% missing 
observations. Very little change in any of the parameter estimates was seen. This was 
indicative of the small estimated correlation between the two intercept terms with very little 
evidence of a real effect with a change in -2 log lh of 0.5 on 2 df for the addition of two extra 
parameters. This was also true for the estimated covariance between the odds of missing data 
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Table 7.17: Parameter estimate (SE) for modelling changes in the previous two responses for physical 
quality of life. 
Estimate (SE) 
Gu12 
Fired parameters 
a, (cons, ) 15.15 (1.41) 
ß, (occ) -0.61 (0.18) 
Ti (base) 0.68 (0.13) 
6, (rt) 1.64 (2.09) 
a2 (cons2) 1.77 (0.24) 
Random parameters 
Level three 0.11 36.7 (9.92) 
awl 
2 av, 
2 a 
r2 
Level two 
Qrvl2 
z all 
Model one 
-1.02 (1.23) (-0.19) 
0.81 (0.27) 
1.01 (0.47) 
10.1 (1.07) 
0,12 
-2 log Ih 1667.0 
Model two 
15.01(1.40) 
-0.61 (0.18) 
0.67 (0.13) 
1.56 (2.08) 
1.77(0.24) 
36.4 (9.86) 
-1.02 (1.23) (-0.19) 
0.81 (0.27) 
1.00 (0.47) 
-0.93 (1.47) 1-0.15) 
10.3 (1.10) 
0.49 (0.23) (0.15) 
1666.5 
Model three 
15.03 (1.40) 
-0.62 (0.18) 
0.68 (0.13) 
1.56 (2.08) 
1.78 (0.24) 
36.5 (9.90) 
-1.04 (1.23) (-0.19} 
0.81 (0.27) 
1.01 (0.47) 
-1.05 (1.56) (-0.17) 
0.06 (0.27) (0.07} 
10.3 (1.10) 
0.48 (0.23) (0.15) 
1666.5 
Standard errors are given on the variance parameters only as an indication of their variability. The 
estimated correlations are given within the curly brackets( ) for the covariance estimates. No estimate 
is given for oi2=var(eu2) as in all cases this has been constrained to be equal to one for binomial 
variation. 
and the rate of change in quality of life - the extension of model two to model three. 
Residual diagnostics for model one are shown in figure 7.4. These show a very poor validity 
of the main Normality assumptions of the model, particularly in respect to the missing data part 
of the model. This is the result of the restricted possible available responses per subject and 
indicates that the model is perhaps more suited to data with a longer follow-up period with more 
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Figure 7.4: Residual diagnostics for joint quality of life and missing data model showing univariate 
Normal plots for (a) ui,; (b) v// ; and (c) u12 ; bivariate plots of (d) (ui1, v1, ) ; (e) (u11, ui2) ; f) (v11, ui2) ; and 
(g) a Chi-squared plot of the Mahalanobis distances. 
measurement occasions. 
7.3.4 Conclusions 
Two models have been used to help determine how the intermittent missing data relates to 
the response process which is observed in a study. The first model examined the relationship 
between the incidence of missing data and previous responses either observed or missing using 
a two level repeated measurement model which considers each subject to have an underlying 
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propensity to miss responses. This subject specific odds is assumed to be acted on in the same 
relative way by covariates in the model for all subjects. For the CRC NSCLC study, this model 
gave some evidence to suggest that missing data was related to the previously observed score 
from either dimension of the Rotterdam Symptom Checklist. This relationship was slightly 
more pronounced for the physical quality of life score, suggesting that subjects with missing 
responses tended to have recorded higher scores (poorer quality of life) in their previous 
response. No similar evidence was seen for the anxiety and depression scores of the HAD scale 
although the observed relationships in the data were in the same direction as those for the 
physical and psychological dimensions. The lack of evidence to support these relationships 
may have been due to a lack of statistical power. In addition, although a relationship between 
missing data and baseline Karnofsky performance was also seen, this did not seem to detract 
substantially from the quality of life association. Therefore, assuming the missing data was 
ignorable (MCAR or MAR) these analyses have given some evidence against the assumption 
of MCAR particularly in terms of patient physical well being. 
In the second model, rather than conditioning on the level of the observed response, the 
model considered allowed the underlying propensity for missing data to be related to the 
underlying level of response characterised by subject specific random effects rather than the 
actual level of observed responses. It therefore addresses the question whether the parameters 
underlying the quality of life (response) process may be assumed distinct from those of the 
missing data process. For the CRC NSCLC RSCL physical data, little evidence of a 
dependence both in terms of underlying level and rate of change of response over time was 
seen. However, residual diagnostics of the model put its conclusions into doubt. This poor 
performance was thought to be due to the small number of measurement occasions in the data 
set. 
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From these results it must be concluded the missing data in the study could not be 
considered as missing completely at random with missingness showing at least some 
relationship to observed physical well being. 
7.4 Summary and discussion 
Intermittent missing data has been reported as a problem in most cancer clinical trials with 
quality of life assessment. Although clear definition of how theoretically the relationships 
between missingness and response may affect analysis options, little practical experience in 
terms of the performance of different methods of estimation has been reported for intermittent 
missing data (as opposed to dropout). In the first half of this chapter, a simulation exercise was 
therefore performed to investigate the performance of three methods of analysis suitable for the 
analysis of continuous outcomes: subject specific analyses with unweighted combination 
(UWLS); generalised estimating equations with an exchangeable correlation structure (GEE); 
and random effect (or hierarchical) models using MLn. Data were simulated under three 
different underlying response processes, and missing data assigned under MCAR, MAR and 
NMAR missing value processes. The results showed that, with approximately 20% of data 
missing, all three analyses performed well under MCAR. When data were MAR, estimates 
from the UWLS analyses were always biassed, with MLn performing best of all. Under NMAR, 
when the underlying response process and missing data processes were the same across patient 
groups, although the estimated patient group means were biased, the estimated group 
differences were unbiased. This was not the case when group differences did exist and 
evidence of bias was seen in the parameter estimates. The GEE analysis performed best of all 
in this situation. The main conclusion to be drawn from these simulations is that, missing data 
(and more particularly the type of missing value process) has a large impact on the choice of 
analysis highlighting the importance of investigating the nature of missing value process. 
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Although some work has been presented in the literature in this area, much of it has dealt 
with the special case of missing data due dropout (or 'monotonic' missing data) rather than that 
which is missing intermittently. The second half of this chapter concentrated on developing 
such models that may help in this process when data is missing intermittently. The first model 
looked at determining whether subsequent missing data was related to previously observed 
quality of life. The model is similar to that suggested by Rideout (1991) for investigating the 
nature of a dropout process. The major difference is that for intermittent missing data, repeated 
missing responses for subjects required the problem to be set in a repeated measurement 
framework. There are a number of drawbacks with this model however, in particular its 
potential lack of power which will be inversely related to the extent of the missing data 
problem, such that the greater the missing data problem, the lower the power of the analysis. 
This in turn means that relationships between missing data and underlying response in small 
data sets should not merely be ruled out on the basis of a lack of statistical evidence. In 
addition, the results are all very model dependent. For instance, in the example given, there 
may have been a relationship with missing data and subsequent response which would never 
have been determined from the series of models fitted here. 
Under the assumption that missing data is MAR, Rubin (1976) showed that inferences based 
on likelihood analyses would be valid provided the parameters which define the missing data 
process and measurement process are distinct. Although a fundamental assumption for Rubin's 
assertion, little work has been done to verify the assumption in practice. The second model 
presented here attempted to do this. Unfortunately in the example here the data set was too 
small to justify the assumptions made. However, with a larger data set the model may be useful 
although more work is needed to truly assess the properties of the model and determine in what 
circumstances its performance is maximised. 
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The type of missing data process which presents the greatest analysis problem is a non- 
ignorable or NMAR process which the work in this chapter has not directly addressed. The 
fundamental problem with such a process is that the validity of any models which are developed 
are impossible to verify due to the very nature of the process one is trying to determine. The 
best current solution to the problem, suggested by Glynn et al. (1993) is that a combination of 
pattern mixture models (Little, 1994) and multiple imputation (Rubin, 1987) be used under 
reasonably assumed non-ignorable processes. This produces a series of sensitivity analyses 
such that the robustness of estimates made ignoring the process can be explicitly assessed. 
Their examples related to survey data and it was suggested that follow-up surveys of non- 
respondents could be used to help decide on reasonable missing data processes. This will not 
be feasible in quality of life assessment in clinical trials studies where the number of missed 
assessments per individual is great and often patients have died by the time of analysis. In 
many studies quality of life assessment, however, often takes place at a similar time to clinical 
follow-up so that some information about a patient's general condition may be available to aid 
in the definition of appropriate missing data processes. 
One of the main limitations of the work in this chapter is that it is focused on the analysis 
of continuous outcomes. Given the amount of data in quality of life studies which is measured 
on an ordinal scale (which may then be dichotomised), further work is needed to asses the ways 
in which intermittent missing data will affect the types of models discussed in Chapters 4 and 
5 for the analysis of such data. A particular example is the case of missing item response for 
which the multivariate binary model of Section 4.5 may be of great help when missingness is 
MCAR. It is unclear however how this model will perform under MAR or NMAR missingness 
processes. 
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8 Discussion and Recommendations 
The assessment of quality of life as a primary outcome in cancer clinical trials is now almost 
universal. To date, its reporting in the applied literature has generally used simple descriptive 
summaries. This means that the statistical inferences that can be drawn about differences in 
quality of life between patient groups, as well as changes in quality of life over time, can be 
limited. Further, as these analyses often ignore many natural characteristics of the data, their 
conclusions could be misleading. There is therefore a definite need to improve the analysis of 
such data. For this end, the aim of this thesis was to assess the practical application of recent 
developments in statistical methodology to handle the problems faced in the analysis of self 
assessed quality of life data from cancer clinical trials. Those of particular concern were 
highlighted in a review paper by Cox et at. (1992) relating to the analysis of typically 
unbalanced repeated measurement data, multiple dimensional outcomes and missing data, 
where the latter may be in the form of censoring of the quality of life response due to patient 
death, or simply because patients have failed to complete questionnaires. 
Descriptive analyses that have been typically used to present quality of life data in the 
applied literature were reviewed in Chapter 2, and it was concluded that, given the quantity of 
data that a quality of life study generates, these are essential in the analysis process. However, 
they should concentrate not only on examination of average behaviour over time, as has 
generally been done to date, but also consider individual patient data, as well as distributions 
of summary statistics calculated for each subject. Additionally, in the light of missing data, 
patterns of missingness both in relation to observed quality of life and disease characteristics 
need to be examined. Given the frequency of missing data as well as the repeated 
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measurements and multiple dimensionality typical of quality of life data, these analyses should 
not constitute the whole data analysis and the use of statistical models that account for the data 
structure and allow solid conclusions to be drawn need to be encouraged. It was on such 
analyses that the remainder of this thesis was focused. 
Essentially two classes of model that appropriately allow for the dependence between 
repeated measurements within subjects were considered: random coefficient (or hierarchical) 
and marginal models. The fundamental difference between the two models is the way in which 
they incorporate this dependency into the modelling framework. In Chapter 3 it was seen that 
the dependency within subjects can be accommodated by incorporating a subject specific 
random effect into the model. In turn, such random coefficient models then allow examination 
of the components of variance of the data. In the most simple case, this is the variance within 
and between subjects. These models were shown also to offer the ability to examine this 
variance structure further in terms of its relationship to other patient characteristics, as well as 
treatment. Further, they can be extended to incorporate the assessment of multiple dimensions 
of quality of life which not only allows estimation of inter-dimensional correlations within and 
between subject, but permits overall covariate effects (for example the effect of treatment) to 
be estimated if appropriate. 
Although the work of Chapter 3 concentrated on the analysis of continuous outcomes, it was 
shown in Chapter 4 that these random coefficient models can also be used for the analysis of 
repeated binary outcomes that arise from arbitrary dichotomisation of the ordinal scales of 
individual items on a questionnaire. This not only allows the pattern of behaviour of specific 
aspects of patient quality of life to be examined using the most basic model, but also a 
multivariate model can be used to obtain an overall analysis of patient quality of life which has 
more intuitive appeal than the more conventional summary scores. Again the associations 
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between the individual symptoms are also examinable in this model. Further, it also offers a 
simple solution to the problem of missing item responses (Fayers, 1996) - that is, when patients 
fail to answer individual questions on a questionnaire as opposed to missing the whole 
questionnaire. Missing items usually result in the loss of the occasion response for a subject 
as they mean that a summary score cannot be evaluated for the questionnaire. However, since 
the random coefficient model can easily handle unbalanced data, if it can be assumed that the 
reasons underlying the missing item are ignorable such missingness is a trivial matter in the 
analysis. 
Marginal models, the second class of models used, treat the dependency between repeated 
observations as nuisance parameters. The resulting parameter estimates have a very different 
interpretation to those of the random coefficient model - they give the estimated effect of 
covariates of interest on the response of population as a whole, whereas those of the random 
coefficient model are estimated in terms of their impact on a subject specific response. It was 
demonstrated in Chapter 4 that, although this distinction is not important when a identity link 
function is used (as is generally done with continuous outcomes), it can be vital when a logit 
link function is used with binary outcomes and can lead to large differences in the resulting 
parameter estimates. In this case, it is therefore important to determine whether it is the 
population average or subject specific covariate effects that are of interest prior to deciding on 
the analysis strategy. In terms of a treatment covariate, this relates to whether it is a general 
public health perspective that is of interest (population average) or simply the effect of 
treatment on an individual patient's quality of life (subject specific). 
Because of the way both of these models incorporate the variance structure into the analysis 
procedure, they can easily be extended to incorporate dependency arising from alternative 
sources. One such additional source variance arises when logistic regression models are used 
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for the analysis of repeated ordinal data following transformations from the ordinal scale to a 
series of correlated binary responses (McCullagh and Nelder, 1983). The application of both 
the marginal and the random coefficient model for two such transformations - cumulative 
probability and continuation ratio - were discussed in Chapter 5. The models presented have 
the same properties as those of Chapter 4 with an important distinction needed between the way 
in which they incorporate the dependency between repeated measurements (as random effect 
or nuisance parameters). In addition, the two transformations presented also result in very 
different parameter interpretations between which a clear distinction is needed. Unfortunately, 
this can make the models difficult to interpret and their practical use may therefore be more 
limited than that of the more simple binary models for chosen dichotomies, despite their often 
arbitrary choice. 
The application of many of the models in Chapter 3 to 5 was demonstrated assuming the 
response to be a simple linear function of time. The exception to this was the use of natural 
cubic splines for the analysis of complex patterns of response due to transient symptoms 
following treatment (Chapter 4). Such behaviour is common in cancer clinical trials, 
particularly involving chemotherapeutic treatment (MRC lung cancer working party, 1991 a). 
Although the application demonstrated the cubic spline within a marginal model, when the 
timing of treatment varies across patients it may also be possible to incorporate such complex 
patterns at a subject level within a random coefficient model. Since this is a feature which can 
frequently occur within cancer clinical trials, it is a particularly relevant, and very interesting, 
area of further research. 
Another important consideration in the analysis of quality of life data is the problem of 
informative censoring of patient quality of life as a direct result of patient death. Two different 
classes of models to address this issue were reviewed in Chapter 6. Dropout models (Little, 
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1995) attempt to obtain correct inferences about the response in the light of such patient 
dropout whereas quality adjusted survival techniques combine the quality of life and survival 
endpoints to give a quality adjusted survival about which inferences are then made. Although 
the latter have been applied extensively and successfully for toxicity data, their use in self 
assessed quality of life data was shown to be problematic and it was concluded that only a 
partitioned quality adjusted survival (PQAS) (Glasziou et al., 1990) analysis is currently 
useful. Unfortunately, this analysis is restricted to instances when progressive quality of life 
states can be defined which somewhat limits their use for self assessed quality of life data that 
is often seen to fluctuate between states. In terms of the three classes of dropout models that 
have been discussed in the literature (Little, 1995), it was concluded the informatively right 
censored dropout models (Wu and Bailey, 1988) and in particular, the trivariate Normal model 
(Schlucter, 1992) is the most suitable for application with quality of life data. Although this 
latter model considers quality of life and survival together, it treats them as a multivariate 
problem estimating their joint distribution, from which their conditional distribution can also 
be determined. This is an area in which more work is needed. In particular, with the 
application of such models to binary outcomes, and their behaviour when many survival times 
are censored. A further class of model, that has not been addressed here, is multi state models 
(Kay, 1985). These are transitional (Markov) models that incorporate death as an absorbing 
state and present a further area of interesting research in this area. 
The value of all of these models for analysing self assessed quality of life data depends on 
their ability to cope with the presence of intermittent missing data during follow-up. This is 
a particular problem in quality of life studies and was discussed in Chapter 7. In the notation 
of Little and Rubin (1987), since the marginal model analyses presented in Chapter 4 and 5 for 
binary and ordinal outcomes used quasi-likelihood estimation procedures, these assume data 
are missing completely at random (MCAR), as do the quality adjusted survival analyses of 
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Chapter 6. Although the random coefficient models presented in Chapters 3 and 6 make the 
assumption that the data are missing at random (MAR), it is unclear under what conditions the 
random coefficient binary models, used in Chapters 4 and 5, will be valid (whether just MCAR 
or MAR). This needs to be assessed with a simulation exercise similar to that presented for 
continuous outcomes in Chapter 7. For such data, these confirmed that under MCAR the choice 
of analysis procedure makes little difference to the analysis conclusions. Under MAR, the 
random coefficient models which used RIGLS (Goldstein, 1986) estimation or the marginal 
models using GEE (Liang and Zeger, 1986) performed adequately, with an unweighted least 
squares analysis leading to estimation bias. When data were not missing at random (NMAR) 
all analyses performed badly, although those using GEE still gave unbiased estimation of rate 
of change and group differences within one example. 
Because of the differential bias of different analysis strategies in the light of missing data, 
investigation of the nature of a missing value process is important. Unfortunately, by definition 
it is impossible to identify a missingness process that is (NMAR) purely on the basis of the 
observed data. Although a number of models to distinguish between MAR and MCAR 
processes have been applied in determining the nature of dropout processes (Rideout, 1991, 
Park et at., 1993, Dawson, 1994), these are generally unsuitable for application with 
intermittent missing data. Two alternative models were suggested in Chapter 7 and, when 
applied to data of a recent cancer clinical trial, gave some evidence of an MAR process as 
opposed to MCAR. However, caution is needed in interpreting these models as they may lack 
power and so be prone to false negative results. Further, as it is impossible to determine 
whether a process may be NMAR, the best current solution seems to be that offered by Glynn 
et al. (1993). This work, however, is little developed in terms of practical application, and is 
an area which offers much scope for interesting and challenging further research. 
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All of the analyses of the work presented in the thesis were performed using MLn (Rasbash 
and Woodhouse, 1995) or S-Plus (Becker et al., 1988) software. MLn has been specifically 
written to estimate the parameters of random coefficient models using (restricted) IGLS. Other 
packages can also fit such models (Kreft et al, 1994), in particular, all the analyses presented 
could be performed using HLM (Bryk et al., 1988), VARCL (Longford, 1988) and BUGS 
(Thomas et al., 1992). In addition, two level models for continuous outcomes can be fitted 
using SAS Proc Mixed (SAS Institute Inc., 1992), S-Plus (version 3.3) and BMDP-5V 
(Zwinderman, 1990). For each case, different estimation procedures are used: for instance, 
HLM uses the EM algorithm (Dempster et al., 1977), and BUGS uses Markov Chain Monte 
Carlo methods (Gilks et al., 1993). Marginal models can be fitted using most software 
packages, although the choice of package will determine the ease in which robust standard 
errors are obtained. The models that were presented here used a first order generalised 
estimating equation (GEE1) which can be fitted using OSWALD (Smith and Diggle, 1994), a 
library of S-Plus function. These functions also allow the alternating logistic regression (ALR) 
models, that were outlined in Chapter 4, to be fitted. Macros which fit models using GEE1 are 
also available for SAS software. Alternatively, robust standard errors can be obtained for the 
simple repeated measurement model by bootstrapping or jack-knifing (Efron and Tibshirani, 
1993) where the individual forms the experimental unit. STATA (StataCorp., 1995) also has 
facilities to obtain Huber (1967) estimates of the standard errors for both continuous and binary 
outcomes that will be very close to those of a GEE1 with an independence working correlation 
matrix. As software to perform the quality adjusted survival analyses is not generally available, 
a number of S-Plus functions were specifically written for the analyses performed here. These 
are listed in Appendix 3. 
This thesis has shown that there exist a number of recently developed statistical methods 
that can be very successfully used to tackle the major issues that have been raised concerning 
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the analysis of quality of life data. Essentially, the central feature required of such models is 
their ability to handle unbalanced repeated measurement data and appropriately adjust for the 
dependence between observations measured on the same subject. Since all the examples in the 
thesis gave evidence of a large degree of between subject variation, the impact of ignoring the 
repeated measurement structure for these data would have been great. As it is believed that 
these data are typical of quality of life studies in general, it is concluded that the use of 
statistical models, such as those presented here, are not only essential for the analysis of quality 
of life data in general, but that they are generally accessible and should therefore be encouraged 
within the applied quality of life literature. This requires not only that the methods themselves 
are communicated within the quality of life research field, but also that the limitations of the 
simple descriptive analyses are highlighted. There are however a number of areas which do 
require further attention, the most challenging of which relate to coping with non-ignorable 
intermittent missing data and the informative censoring of response as a result of patient death. 
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Al Study Description 
A1.1 CRC non-small cell lung cancer study (CRC NSCLC) 
The Cancer Research Campaign, Clinical Trials Centre (CRC CTC) non small cell lung 
cancer trial (NSCLC) was designed to `compare the results of palliative radiotherapy to the 
mediastinum in patients with previously untreated bronchial carcinoma using either an 
intensive short course (a 2-week split course, with the second week of treatment given only to 
well patients randomised to receive it) or a continuous 4-week treatment'. The major outcomes 
of interest in the study were patient survival, measured in days from randomisation; local 
control, as shown by serial chest X-rays; symptomatic relief; and self assessed quality of life. 
Quality of life was measured pre-treatment and then weekly for the 8 weeks following the 
start of treatment. The measuring instruments used were the Hospital Anxiety and Depression 
(HAD) scale and, with slight amendments to incorporate some disease specific items of interest, 
the Rotterdam Symptom Checklist (RSCL). Questionnaires were sent to patients through the 
post to be returned to the trials office using pre-paid envelopes. 
82 patients were randomised into the study, 42 to receive the continuous 4 week treatment 
and 40 to receive the split course. At the one month assessment of patients on the split course, 
15 were subsequently randomised to the one week course, 13 to the two week course. 12 
patients were not re-randomised. Table Al. 1 shows baseline patient characteristics in each arm 
of the study in terms of age, sex and Karnofsky performance measure (Karnofsky et al. 1949). 
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Table Al.!: Baseline patient characteristics for the CRC NSCLC study. 
Continuous course Split course 
Number of patients 42 40 
Sex n (%) male 33 (81) 27 (68) 
Age (yrs) mean (SD) 65.0 (7.11) 67.18 (7.29) 
Weight (kgs) mean (SD) 65.6 (9.99) 62.6 (11.3) 
Karnofsky median (IQR) 70 (10) 70 (10) 
Survival data for the two treatment arms are given in table A1.2 and figure A1.2. These give 
no evidence of a survival difference between the two groups. 
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Figure Al.!: Kaplan-Meier survival curves for the CRC NSCLC study. Split course 
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Table A1.2: CRC NSCLC study: patient survival. 
Survival rate 
Median survival [95% CI] 
(days) 
6 month 12 month 
Split course 223 0.58 0.30 
[0.44,0.75] [0.19,0.48] 
Continuous 239 0.57 0.36 
course [0.44,0.74] [0.24,0.54] 
Log rank test 
2 (p value) 
0.0 (0.922) 
A1.2 CRC Hepatic Artery Pump Trial (CRC HAP) 
This was a randomised multi-centre trial based in four geographical areas: London, the 
Midlands, the South West and the North. The objectives of the study were to `assess the 
quality of life and tumour response in patients with colorectal hepatic metastases treated by 
infra-hepatic arterial fluro-deoxyuridine (FUDR) infusion with that in patients with 
comparable metastases who received the conventional symptomatic treatment' (HAI versus 
control). 
The trial had three principal outcomes of interest: survival, measured in days from the time 
of randomisation into the trial until death; tumour response, as given by the percentage tumour 
involvement measured by a CT scan at 4 monthly intervals; and quality of life, measured by 
patient self assessment using the Sickness Impact Profile (SIP), the Rotterdam Symptom 
Checklist (RSCL) and the Hospital Anxiety and Depression (HAD) scale. These questionnaires 
were completed prior to randomisation and then monthly at the time of the regular monthly 
clinical follow-ups. 
Study descriptions 
100 patients were recruited to the study, 51 to the HAI group and 49 to the control group. 
The results of the study, published elsewhere (Allen-Mersh et al, 1994) showed some evidence 
of a survival advantage for patients undergoing pump implantation. Since publication of these 
results, more complete data has become available. These data are shown in figure A1.2 and 
strengthened the evidence for a survival difference. For the purpose of the examples in the 
thesis, the complete data set was restricted to include only information available as of June 1st, 
1993. This was done to reproduce the situation seen for the initial analysis of the quality of 
life data in the study where differential death rates in the two treatment groups meant that 
standard methods of analysis could not be used to analyse the quality of life data. At this time 
only 79 patients had been randomised into the study, 40 to the HAI group, 39 to the control. 
Survival data for this `restricted' data are shown in figure A 1.3. Survival rates for both the full 
and restricted data are given in table A1.3. 
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Table A1.3: Survival comparisons for the full and restricted data from the CRC HAP trial. 
Median survival 
(days) 
Full data 
HAI 334 
Control 214 
Restricted data 
HAI 404 
Control 274 
Survival rate 
[95% Cl] 
6 months 12 months 
0.83 0.51 
[0.72,0.95] [0.37,0.70] 
0.58 0.33 
[0.44,0.76] [0.20,0.53] 
0.76 0.49 
[0.66,0.891 [0.37,0.651 
0.53 0.27 
[0.41,0.69] [0.17,0.42] 
Log rank test 
X, (p value) 
4.0 (0.05) 
5.5 (0.02) 
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A1.3 MRC Lung Cancer working party (MRC LU07) 
This was a randomised multi-centre trial comparing two policies of palliative thoracic 
radiotherapy. The aim of the trial was to assess whether a shorter dose of two fractions each 
of 8.5 Gy given one week apart was as effective as the conventional longer dose of a typically 
30 Gy in total given in ten fractions over two weeks. Palliation and disease response were 
assessed monthly by clinicians for the first twelve months and every three months thereafter. 
Daily assessments of palliation were made by the patients using the daily diary card (Fayers and 
Jones, 1983). 
374 patients were initially recruited into the trial. Following the exclusion of 5 patients later 
discovered to have been ineligible on entry, 369 patients remained with 184 receiving the 
shorter dose (F2) and 185 the longer dose (FM). 
The results of the trial reported elsewhere (MRC lung cancer working party, 1991b) showed 
no evidence of a survival differences (table A 1.4 and figure A 1.4) between the two treatment 
groups. Performance status on entry was shown to be related to survival in both groups. 
Descriptive analyses of symptomatic quality of life data highlighted transient dysphagia 
Table A1.4: Survival data for the MRC LU07 study. 
Survival rate 
Median [95% CI] 
survival (days) 
6 months 12 months 
FM 178 0.47 0.21 
[0.40,0.55] [0.16,0.28] 
F2 178 0.46 0.20 
[0.40,0.54] [0.15,0.27] 
Log rank test 
X, (p value) 
0.1 (0.74) 
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following treatment in both groups. No evidence of a palliative gain of the conventional longer 
dose to the shorter dose was reported. 
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A2 Description of the Quality of Life Measuring Instruments 
A2.1 Hospital Anxiety and Depression (HAD) scale 
The Hospital Anxiety and Depression (HAD) scale was originally developed to aid the 
detection and management of emotional disorders in patients under investigation and treatment 
in medical and surgical hospital departments. It consists of 14 items measuring patient anxiety 
and depression. The items on the questionnaire are clearly divided into the two subscales and 
rated on a 4-point scale. 
The items comprising the depression subscale are based largely on the an hedonic 
depressive state - that is, an inability to derive pleasure from day to day activities that the 
normal person finds pleasurable. This is because it is believed to be the central 
psychopathological feature of that form of depression that responds well to anti-depressant drug 
treatment, therefore providing useful information to the clinician. The items for anxiety were 
chosen following a study of the Present State Examination (PSE) (Fallowfield, 1990). 
Box A2.1 
Example items from the HAD scale 
I feel tense or 'wound up' I get sudden feeling of panic 
(3) Most of the time (3) Very often indeed 
(2) A lot of the time (2) Quite often 
(1) From time to time (1) Not very often 
(0) Occasionally (0) Not at all 
Description of the Quality of Life Measuring Instruments 
Items are scored from 0-3 or 3-0 depending on the direction of the wording which is 
alternated in order to avoid responder bias. High scores indicate emotional problems. Based 
on psychiatric diagnosis as a gold standard, the scores can be categorized as: s7 - normal; 8-10 
- possible case of clinical anxiety or depression; z 11 - definite cases of clinical anxiety or 
depression. 
It has been suggested that for use in cancer clinical trials, a cut-off of 10 or 11 can 
distinguish between patients who are coping well with their disease and those who have 
developed morbid anxiety or depression (Maguire and Selby, 1989). 
Validity of the instrument was assessed with over 100 general medical outpatients and 
hospital staff. Sensitivity tests using PSE as the gold standard showed high correlation between 
the HAD scores and the interviewers' assessment. The scale scores were not shown to be 
affected by physical illness. 
A2.2 Rotterdam symptom checklist (RSCL) 
The Rotterdam Symptom Checklist (RSCL) was developed primarily as a tool to measure 
symptoms reported by cancer patients in clinical research (de Haes et al., 1990). The original 
list of items included in the instrument was based on previous analyses done using alternative 
checklists not specifically designed for cancer patients. A selection of the items from three 
such lists was taken on the basis of factor loadings of principal components analyses, relevance 
according to oncology specialists, and the distribution of the response to the questions (very 
skewed responses were omitted). This gave an initial list of 34 items with an additional eight 
items referring to activities of daily living (ADL). On the basis of further research, the 
checklist was amended in terms of the recommended length of time between repeated 
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administrations and in the inclusion/omission of a number of items. The resulting instrument 
now has 30 items (plus 8 for ADL) which can be efficiently summarised into a psychological 
and physical dimension both of which show good reliability. 
The items are scored on a four point scale: not at all; a little; quite a bit; very much. 
Examples are given in Box A2.2. Normal scores for the physical and psychological dimensions 
have been defined as <20 and <10 respectively. 
Box A2.2 
Example items from the RSCL 
Lack of appetite Sore muscles Nausea 
(1) not at all (1) not at all (1) not at all 
(2) a little (2) a little (2) a little 
(3) somewhat (3) somewhat (3) somewhat 
(4) very much (4) very much (4) very much 
An advantage of the RSCL is its flexibility in allowing the inclusion of relevant disease 
specific items. For instance, in studies of ovarian cancer, the inclusion of items which refer to 
hair loss and sexual interest at the expense of items which were not relevant to the disease, gave 
great insight into the distinction of treatment regimens at no expense of reliability (Maguire and 
Selby, 1989). 
A2.3 Daily diary card 
The daily diary card was originally developed by the Medical Research Council, 
Tuberculosis and Chest Diseases Unit and has been used in several MRC cancer treatment 
studies. The cards are completed each day by the patient and require no assistance. They 
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consist of 5 items to which a patient gives a graded response 1-5. The items which are used on 
the cards may vary according to the nature of the study. For example, in a study of patients 
receiving chemotherapy treatment, an item referring to vomiting may be useful, whereas in a 
study using radiotherapy to treat lung cancer, an item asking about difficulties swallowing are 
more applicable. Extra information about patient quality of life can also be obtained in an open 
free format comments box for each week of the card's use. Example questions from the card 
are given in box A2.3. 
Box A2.3 
Example questions and responses for the daily diary card 
Overall condition Activity 
(1) very well (1) normal work/housework 
(2) well (2) normal work but with effort 
(3) fair (3) reduced activity but not confined to home 
(4) poor (4) confined to home or hospital 
(5) very ill (5) confined to bed 
The advantage of the cards are the speed with which they can be completed. This allows 
their use on a daily basis without putting an excessive burden on the patient. This in turn gives 
a clear picture of the patient quality of life over treatment and follow-up, and can highlight 
transient side effects which may be missed by less frequent follow-up. Unfortunately, as with 
many quality of life instruments, their compliance rate can be poor as patients tire of 
completing the card over too long a follow-up period. 
In terms of validity and reliability, very little has been written about the cards, although they 
have been shown to display the expected features of symptomatic quality of life in the days 
following traumatic treatment. 
300 
S-Plus functions for quality adjusted survival analyses 
A3 S-Plus Functions for Quality Adjusted Survival Analyses 
A3.1 Introduction 
The following series of S-Plus functions were written in order to perform the quality 
adjusted survival analyses for the RSCL physical data of the CRC HAP trial. In Section A3.2, 
the three main functions used to perform each analysis are broadly described in terms of their 
practical use, arguments and returned value. Listings of the function code are given in Section 
A3.4. Secondary functions which are called by the functions are described in the same way in 
the second half of each section. 
Each of the main functions require the same basic arguments: a patient identifier (Id); 
patient survival (survival); a censoring indicator (status); patient quality of life (qol); and the 
timing of each quality of life measurement (gol. time). These arguments all have the same 
length and are defined with one row of data for each unique gol. time of a patient. 
Table A3.1: Main and secondary functions used for the quality adjusted survival analyses in Chapter 
6. 
Analysis Main unction Calls 
TWIST (TNQOL) TWIST. f QAS. f 
PQAS PQAS. f PQASTIMES. f, QAS. f 
Integrated quality-survival product glaszlou. f glas. f, AUC. f 
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A3.2 Function descriptions and their use 
A3.2.1 TWIST. f 
The function TWiST. f performs a TWIST based analysis (Gelber et al., 1989) to estimate 
the time spent with normal quality of life (TNQOL) where normal quality of life is defined by 
a user specified cutoff for the quality of life dimension of interest. By default, the function 
performs an analysis which uses the censored quality of life times using a log-rank test to 
compare patient groups. Alternatively, when many subjects are censored, it is possible to 
truncate the follow-up time by some time L. Alternatively, TWIST can be imputed for censored 
individuals, as defined by Gelber et a!. (1989), and patient groups compared using arithmetic 
means of the resulting uncensored data. If required, the function provides variance estimates 
for the means calculated as the area underneath the survival curves for censored or truncated 
analyses by resampling with replacement from the group data. 
TWiST. f (id , survival , status , qol , gol. time , group , cut. off , plotit=F , group. names=NULL 
, method = 
'censored' ,L= max(survival) , what = 
'max' 
, 
boot=F, R=NULL ) 
where 
id, survival, status, qol, gol. time are as defined in the introduction 
group defines the patient groups and is of the same length as 
id 
cut. off defines the cut off for normal quality of life 
plotit is an indicator as whether results should be plotted 
group. names patient group names for the plotted data 
method method of analysis required: 'censored', 'truncated', 
'imputed' 
L maximum follow-up for truncated or imputed analyses 
what method of imputation: 'max', 'min', 'mean' 
boot, R indicator whether bootstrapped variances are required 
and number of samples 
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A3.2.2 PQAS. f 
PQAS. f, directs the analysis for a partitioned quality adjusted survival analysis, (Glasziou 
et al., 1990). Within the function, three health states are determined according to the 
definitions in table 6.4 and a userspecifiedd cut. off for normal quality of life. The function 
returns a summary of the time spent in each of the states for each group separately. If a vector 
of weights for each state are given, a weighted quality adjusted survival time is also returned. 
PQAS. f (id , survival , qol, gol. 
time, status, group=rep( 1, length(id) ), cutoff=19.5 , 
weight=NULL, L=max(survival) , leg=NULL, boot=F, R=NULL, plotit=F, ... ) 
where 
id, survival, qol, qol. time, status are specified as defined in the introduction 
group defines the patient groups and is of the same length 
cutoff 
weight 
L 
leg 
boot, R 
plotit 
as id 
defines the cutoff for normal quality of life 
a vector of length 3 defining the weights for each 
health state 
upper boundary for the length of follow-up 
a vector of the same length as the number of patient 
groups required for plotting the partitioned quality 
adjusted survival curves if plotit=T 
indicator whether bootstrapped variances of mean 
time in each state are required and the number of 
samples if required 
indicator whether partitioned quality adjusted 
survival curves should be drawn 
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A3.2.3 glasziou. f 
This function perform an integrated quality-survival product analysis Glasziou (1995). If 
bootstrapped variances are not required, it returns a list containing a matrix for each group 
which, in the notation of Section 6.3.3, correspond to t, Q(t), S(t) and Q(t)*S(t). If 
bootstrapped variances are required, a matrix is returned which has estimates of the integrated 
quality-survival product in each group on the first row, with their corresponding standard errors 
as the second. Three different methods of evaluating Q(t) are possible: linear; smooth; and 
mean. These correspond to the analyses described in Section 6.3.3. 
glasziou. f ( id , survival , status , qol , qol. time , group=rep(1, length (survival)) , days=seq( from=0 , to=max(survival) , by=20) , method='smooth' , boot=F , R=NULL ) 
where 
id, survival, status, qol, qol. time 
group 
days 
method 
boot, R 
are as defined in the introduction 
is a group indicator the same length as id 
gives the days for which Q(t) is to be evaluated. This 
needs only to be specified if method='mean' 
method to be used to evaluate Q(t) : 'linear', 'smooth', 
'mean' 
indicator whether a bootstrapped variances are 
required, and number required 
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A3.2.4 PQASTIMES. f 
This function takes patient details of patient quality of life in terms of the actual value and 
timing, and calculates the amount of time each patient spends in each state along with a 
censoring indicator for each state according to whether patients have left that state, or are 
censored whilst remaining in the state. It returns a matrix with 5 columns containing a patient 
identifier, time of exiting each state for each subject and each state, the censoring status of each 
subject on exiting each state, a state identifier and a patient group indicator. 
PQASTIMES. f (id, survival , qol , qol. time, status, group=rep( 1, length(id)) , L=max(survival) , cutoff=19.5 
) 
where 
id, survival, qol, gol. time, status specified as defined in the introduction 
group defines the patient groups and is of the same length 
as id 
L upper boundary for follow-up time 
cutoff defines the cutoff for normal quality of life 
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A3.2.5 QAS. f 
This function calculates the area underneath a survival curve as given by survival and status 
which have one record for each patient. It returns a vector containing the area underneath the 
survival curve defined for each state as well as the overall survival curve. 
QAS. f( survival , status, state=rep( 1, length(survival) ), plotit=F , L=max(survival) , leg=NULL , ... ) 
where 
survival 
status 
state 
plotit 
L 
leg 
patient survival with one observation per patient per 
state 
survival censoring indicator, one observation per 
patient per state 
state indicator of the same length as survival 
indicator to determine whether the survival curves 
are plotted 
upper bound on follow-up 
legend required as a label for the required survival 
plot 
any plotting arguments 
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A3.2.6 glas. f 
This function calculates the quality-survival product. It uses a Kaplan-Meier estimate for S(t) 
and estimates Q(t) according to either a linear function through all the data, a lowess smooth 
of all the data, or subject specific means at specified days. It returns either a summary of the 
quality-survival product (a matrix containing t and Q(t)*S(t)) or full details (t, Q(t), S(t) and 
Q(t) *S(t) ). 
glas. f ( sam , qt, times, survival, status, comment=F, summary=T, ld=NULL, method) 
where 
sam identifies which rows of qt are to be used 
qt 
times 
survival, status 
comment 
summary 
id 
method 
gives the data to be used to evaluate Q(t). If 
method='mean', this is a matrix where each row is 
the mean quality of life for each subject evaluated at 
each time point. Otherwise, it is simply the observed 
quality of life listed for each subject in a vector of 
the same form as qol described in the introduction 
times at which Q(t) is to be evaluated. It is only 
required if method='mean' 
survival time and censoring indicator for each 
subject. If method='mean', these have one 
observation per subject. If method='smooth' or 
'linear', they are of the same form as survival and 
status described in the introduction 
an indicator whether comments as to the progress of 
the function should be printed 
an indicator whether a summary of the quality- 
survival product is required or full details 
patient identifier. Required only if method='linear' 
or 'smooth'. It should be of the same form as id as 
defined in the introduction 
method of analysis: 'linear', 'smooth' or 'mean' as 
described above 
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A3.2.7 AUC. f 
Calculates the area underneath a curve defined by the two columns of a given matrix, y. It 
returns either the cumulative area underneath the curve at each value of the second column of 
y, or a summary giving the total area underneath the curve. 
AUC. f ( y, cummulative =F) 
where 
y 
cummulative 
is a matrix with two columns. The first corresponds 
to a response y, the second a covariate x. It is 
ordered in ascending x and defines a curve under 
which the area is to be calculated 
an indicator whether the cumulative sum of the area 
is required, or just simply the overall area underneath 
the curve 
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A3.3 Function listings 
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A3.3.1 TWiST. f 
TWiST. f <- function( id , survival , status , qol , qol. time , cut. off , group , plotit=F , 
group. names=NULL, method ='censored' ,L= max(survival) , what ='max' , 
boot=F, 
R=NULL)( 
# Error checks of required information 
if ( boot==T & is. null(R) ) 
stop( For a bootstrapped sample R is required') 
if ( method=='imputed' & (what ! ='max' I what ! ='min' I what ! ='mean') ) 
stop( For imputed analysis specify what=max, min or mean') 
# Check a graphics device is active if plot is required 
if (plotit) 
par( cex=1 
# Define variables 
aqol <- rep( 0, length(id) ) 
OTR <- numeric( length( unique(id)) ) 
OAOOL <- numeric( length( unique(id)) ) 
OTWiST <- numeric( length( unique(id)) ) 
delta <- numeric( length( unique(id) ) 
tau <- numeric( length( unique(id) )) 
newgroup <- numeric( length( unique(id) ) 
# Calculate TNQOL for each patient 
patient <- 1 
for (i in unique(id) ){ 
m <- length( gol[id==i) ) 
if(m>1)( 
if ( gol[id==i][1 ]> cut. off ) 
aqol[id==i][1] <- gol. time[id==i][1 ]+(( gol. time[id==i][2] - gol. time[id==i][1 ]) /2 
if ( gol[id==i][m] > cut-Off ) 
agol[id==i][m] <- (( gol. time[id==i][m] - gol. time[id==i][m-1 ]2)+( 
survival[id==i][m] - gol. time[id==i][m] ) 
if (m> 2){ 
for (j in 2: (m-1) ) 
if ( gol[id==i][j] > cut. off ) 
agol[id==i][j] <- ( gol. time[id==i]0+1] - gol. time[id==i][j-1] )/2 
}#ENDm>2 
}# END m>1 
else{ 
if ( gol[id==i][1] > cut-off ) 
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agol[id==i][1] <- survival[id==i][1] 
}# END else 
if ( method =='censored' ){ 
OTR[patient] <- unique( survival[id==i] ) 
delta[patient] <- unique( status[id==i] ) 
OAQOL[patient] <- min( OTR[patient] , sum( agol[id==i]) ) 
OTWiST[patient] <- OTR[patient] - OAOOL[patient] 
}# END if censored 
if ( method =='truncated' I method =='Imputed')( 
OTR[patient] <- min( unique(survival[id==i]) , 
L) 
delta[patient] <- ifelse( OTR[patient] == LI unique( status[id==i] )==1,1 ,0) OAOOL[patient] <- min( OTR[patient] , sum( agol[id==i][dsr[id==i]<L]) , L) OTWiST(patient) <- OTR[patient] - OAOOL[patient] 
if ( method =='imputed' & delta(patient] == 0 ){ 
OTWiST[patient] <- switch( what, min= unique( survival[id==i]) - 
OAQOL[patient], 
max= L- unique( survival[id==i] ), 
mean= unique( survival[id==i]) - OAQOL[patient] + (0.5*( L- unique( 
survival[id==i] ))) ) 
}# END imputation 
}# END if truncated or imputed 
newgroup[patient] <- unique( group[id==i] ) 
patient <- patient +1 
}# END for 
if ( method =='Imputed')( 
test <- t. test( OTWiST[newgroup==Oj, OTWIST[newgroup==1] ) 
statistic <- matrix(c( mean(OTWIST[newgroup==O]) , mean( OTWIST[newgroup==1] 
var( OTWiST[newgroup==O] ), var( OTWiST[newgroup==1j)) , 2,2, T, list( c('Mean' , 'Variance') 
, c('Pump', 'Control')) ) 
print( test ) 
}# END Imputed 
else { 
test <- surv. diff( OTWIST, delta, newgroup ) 
print( test ) 
statistic <- c( QAS. f( OTWIST[newgroup==0] , deita[newgroup==0] , piotit=F , L=max(OTR) ), QAS. f( OTWIST(newgroup==1] , deita[newgroup==1], plotlt=F, L=max(OTR) )) 
# Bootstrapping variances If required 
if ( boot == T)( 
statistic <- rbind( statistic , rep(NA, 2) ) 
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dimnames(statistic) <- list( c('Mean', 'SEM') , c('Pump', 
'Control') ) 
for ( grp in 0: 1 ){ 
cat('\nBootstrapping variances using ', R, 'samples\n') 
samples <- NULL 
n <- length( OTWiST[newgroup==grp] ) 
for (r in 1: R ){ 
cat(r) 
sam <- sample(x = 1: n , size = n, replace =T) 
samples <- rbind( samples , 
OAS. f( OTWiST[newgroup==grp][sam] , 
delta[newgroup==grp][sam] , plotit=F , 
L=max(survival)) ) 
cat('\t') 
}# END resampling 
cat('\n') 
statistic[2, grp+1 ] <- sqrt( var( samples) ) 
# END group 
}# END bootstrap 
# Plot the results if required 
if ( plotit ){ 
surv. plot( OTW iST , 
delta, newgroup, Ity = unique(group)+1 
title(xlab = 'TNOOL (days)' , ylab = 
"Survival probability" ) 
}# END plotit 
}# END else 
if ( method =='imputed') 
method <- paste( method , what 
) 
invisible (list ( id=unique(id), method=method, OTR = OTR, OAQOL = OAQOL, 
OTNQOL = OTNOOL, delta = delta , group= newgroup , statistic=statistic )) 
# END function TWiST. f 
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A3.3.2 PQAS. f 
PQAS. f <- function( Id , survival , qol, qol. time , status , group=rep( 1, length(id)) , 
cutoff=19.5, weight=NULL, L=max(survival) , leg=NULL, boot=F, R=NULL, plotlt=F, ... ){ 
# Error consistency checks 
if ( boot==T & is. null(R) ) 
stop('For bootstrapping variances R is required') 
# Check the graphics device Is active 
if ( plotit ) 
par( cex=1 ) 
cat('\n Obtaining the cummulative survival times for each state ... \n') 
PQAS <- PQASTIMES. f( id, survival , qol , qol. time, status , group=group, cutoff=cutoff 
results <- list() 
cat('\n Calculating the area under the curve ... \n') 
for (g in 1: length(unique(group)) ){ 
grp <- unique(sort(group))[g] 
pqas <- PQAS[ PQAS[, 'group'] == grp, ] 
# Calculating the mean time spent in each state 
results[[g]] <- QAS. f( survival=pgas(, 'survival'] , status=pgas[, 'status'] , 
state=pgas[, 'state'] , plotit=plotit, 
L=L, leg=leg(g) , ... 
) 
# Bootstrapping variance if required 
if ( boot ){ 
cat('\nBootstrapping variances using', R, ' samples\n') 
samples <- NULL 
n <- length( unique(pqas[, 'id']) ) 
for (i in 1: R) ( 
cat(l) 
sam <- sample(x = 1: n, size = n, replace = T) 
sam <- c( sam, sam+n, sam+(2"n) ) 
samples <- rbind( samples, QAS. f( pgas[sam, 'survival'], pqas[sam, 'status'] , 
pgas[sam, 'state'] , plotit=F, L=L) ) 
cat('\t') 
}# END resampling 
# Estimating the weighted QUALITY ADJUSTED SURVIVAL for given weights 
if (lis. null(weight)){ 
temp <- matrix( results[[g]][, 1: length(weight)], length(weight), 1 ) 
temps <- samples[, 1: Iength(weight)] 
weight <- matrix( weight, 1, Iength(weight) ) 
results[[g]] <- cbind( results[[g]] , 'QAS'=weight%"%temp , 'var(QAS)'=weight %'% var(temps) %"% t(welght) ) 
)0 END applying weights 
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results[[g]] <- list ( means = results[[g]] , var=var(samples) ) } 
cat('\n\n') 
}# END for group g 
names(results) <- paste( 'group' , 1: length(unique(group)) , sep=") 
results 
}# END function PQAS. f 
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A3.3.3 giasziou. f 
glasziou. f <- function( Id , survival , status , qol , qol. time , group=rep(1, length(survival)) , days=seq( from=0 , to=max(survival) , by=20) , method='smooth', boot=F, R=NULL ) 
# Error consistency checks 
# Check the method of estimating qol to be used 
if ( method 1='smooth' & method 1='mean' & method 1='linear') 
stop( 'For Glasziou analysis method may be smooth, mean or linear') 
# For a bootstrapped variance, R is the number of samples 
if ( boot & is. null(R) ) 
stop( 'R is required for bootstrapping variances') 
# Setting estimation parameters 
# The number of people in total 
N <- length( unique( id) ) 
# Make sure the vector of days starts at zero. The total number of days is M 
if ( min(days)i=0 ) 
days <- c( O, days ) 
M <- length(days) 
# Make sure group is >0 
oldgroup <- group 
group <- group - min(group) +1 
cat('\n Performing an Integrated Quality-adjusted survival analysis ... \n') 
# For the survival analysis need unique values for each subjects 
ID <- unique(id) 
SURVIVAL <- numeric(N) 
STATUS <- numeric(N) 
GROUP <- numeric(N) 
patient <- 1 
for (I in unique(id))( 
GROUP[patient] <- unique( group[id==i] ) 
SURVIVAL[patient] <- unique( survival[id==i] ) 
STATUS(patient] <- unique( status[id==i] ) 
patient <- patient +1 
} 
# If the full follow-up Is not used, need to censor individuals who died after last day 
STATUS <- ifelse( STATUS==1 & SURVIVAL>max(days) 0, STATUS) 
# And also their survival 
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SURVIVAL <- if else( SURVIVAL>max(days), max(days), SURVIVAL) 
# qt gives the mean qol for subjects evaluated at each day 
if ( method=='mean')( 
qt <- matrix( NA ,M, N, T, list(as. character(days) , paste('pat', 
ID, sep=") )) 
cat('\nEstimating qt using subject specific means over time... \n') 
for (j in 1: M ){ 
patient <- 1 
for (i in ID ){ 
# Only if the patient is still alive can their qol be calculated 
if ( SURVIVAL[ID==i] > days[j] ){ 
lower <- gol. time[id==i][gol. time[id==i] max(qol. time[id==i][gol. time[id==i] 
<= days[j] ])][1] 
upper <- gol. time[id==i][gol. time[id==i] min(qol. time[id==i][qol. time[id==i] 
>= days[j] ])][1] 
qt[j , patient] <- mean( c(qol[id==iJ[gol. time[id==i]==Iower] , 
qol[id==i][gol. time[id==iJ==upper]) , na. rm=T ) 
}# END is the patient alive 
# Otherwise it is missing 
else 
qt[j , patient] <- NA 
patient <- patient +1 
)# END each patient 
}# END each follow-up time 
}# END if mean 
# OSt is the survival and qol product for the Glasziou analysis 
Ost <- list() 
# If a bootstrap is done a summary of the results are given by auc 
auc <- matrix(NA ,2, length(unique(group)) ,T, list(c('auc', 'SE'), paste('group', unique(group), sep=")) ) 
# Analysis done for each group in turn 
for (g in sort( unique(group) ){ 
cat('\nGroup', g, '.. ') 
# How many subjects in group g 
Ng <- sum( GROUP==g ) 
if (method=='mean') 
OSt[[g]] <- glas. f( 1: Ng, gt[, GROUP==g], days, SURVIVAL[GROUP==g], 
STATUS[GROUP==gl 
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, comment=T, summary=F, method=method ) 
else{ 
days <- dsr[group==g] 
QSt[[g]] <- glas. f( 1: Ng , cbind(gol. time, gol)[group==g, ] , days, SURVIVAL[GROUP==g], STATUS[GROUP==g] 
, comment=T, summary=F, id=id[group==g] , method=method ) 
} 
# Calculate the auc for the data set 
auc[1, g] <- AUC. f( QSt[[g]][, c('QSt', 'Time')] ) 
# Bootstrapping a variance if required 
if ( boot ){ 
cat('Bootstrapping a variance using', R, 'sampies ... \n') 
# Matrix of generated samples row by row 
samples <- matrix( NA ,R, Ng ) 
for(iin1: R) 
samples[i, ) <- sample( 1: Ng, Ng, replace=T) 
if ( method =='mean') 
bootstrapped. QSt <- apply( samples ,1, glas. f, qt[, GROUP==g], days, SURVIVAL[GROUP==g], STATUS[GROUP==g], 
method=method ) 
else 
bootstrapped. QSt <- apply( samples, 1, glas. f , 
cbind(gol. time, gol)[group==g, ] , days, 
SURVIVAL[GROUP==g], STATUS[GROUP==g], 
id=id[group==g], method=method ) 
bootstrapped. QSt <- 
array(bootstrapped. QSt, c(length(bootstrapped. QSt)/(R*2), 2, R), T) 
C8t('\n') 
# Calculating the area under the curve for each sample 
bootstrapped. auc <- apply( bootstrapped. QSt, 3, AUC. f ) 
auc[2, g] <- sqrt( var( bootstrapped. auc) ) 
)# END bootstrapping 
cat('\n') 
)# END group 
group <- oldgroup 
names(OSt) <- paste( 'group _', sort(unique(group)) ) 
if(lboot) 
return( QSt ) 
else 
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return( auc ) 
}# END function glas. f 
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A3.3.4 PQASTIMES. f 
PQASTIMES. f <- function( id, survival , qol , qol. time, status , group=rep( 1, length(id)) , 
L=max(survival) , cutoff=19.5 
){ 
# Set up the variables to be created 
n <- length(unique(id)) 
exitl. time <- numeric(n) 
exitl. status <- numeric(n) 
exit2. time <- numeric(n) 
exit2. status <- numeric(n) 
exit3. time <- numeric(n) 
exit3. status <- numeric(n) 
small. group <- numeric(n) 
# IS OOL ABNORMAL 
ab. qol <- qol > cutoff 
patient <- 1 
for (i in unique(id)){ 
# START IN POOR 
if ( ab. qol[id==i][1 ] == T ){ 
# STAY IN POOR 
if ( length( rle(ab. gol[id==i])[[11]) 1)( 
exit l . time[patient] <- min( L, unique( survival[id==i] 
)) 
exit l . status[patient] <- 
ifelse( exits . time[patlent]==L , 0, unique( status[id==i])) 
exit2. time[patient] <- min( L, unique( survival[id==i] )) 
exit2. status[patient] <- ifelse( exit2. time[patient]==L ,0, unique( status[id==i])) 
} 
#GOTOGOOD 
else ( 
exitl. time[patient] <- min( L, mean( c( gol. time[Id==i][ 1+ rle( ab. gol[Id==1] 
]) )) )[[111[111, gol. time[id==i][ rle( 11))) 
exitl. status[patient] <- ifelse( exitl. time[patient]==L ,0,1) 
# STAY IN GOOD 
if ( length( rle(ab. gol[id==i])[[1]]) 2 ){ 
exit2. time[patient] <- min( L, unique( survival[id==i]) ) 
exit2. status[patient] <- ifelse( ex1t2. time[patient]==L ,0 unique( 
status[id==i] )) 
} 
# GO BACK TO POOR 
else ( 
exit2. time[patient] <- min( L, mean( c( gol. time[id==i][1 + sum( rle( 
ab. gol[id==i])[[1]][1.2])] , gol. time[id==i][ sum( rle( ab. gol[id-°l))[[1 ]l[1: 2))1)) ) 
exit2. status[patient] <- ifelse( exlt2. time[patient]==L ,0,1) } 
}# END go to good 
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}# END start in poor 
# START IN GOOD 
else { 
exitl. time[patient] <- 0 
exit 1. status[patient] <- 1 
# STAY IN GOOD 
if ( length( rle( ab. gol[id==i])[[1]J) == 1 ){ 
exit2. time[patient] <- min( L, unique( survival[id==i]) ) 
exit2. status[patient] <- ifelse( exit2. time[patient]==L ,0, unique( status[id==i] ) 
}# END stay in good 
# GO TO POOR 
else { 
exit2. time[patient] <- min(L, mean( c( qol. time[id==i][1 + sum( rle( 
ab. qoI[id==i])[[1]][1])], qol. time[id==i][ sum( rle( ab. goI[id==i])[[1]J[1])] )) ) 
exit2. status[patient] <- ifelse(exit2. time[patient]==L ,0,1) 
}# END go to poor 
}# END start in good 
exit3. time[patient] <- min( L, unique( survival[id==i]) ) 
exit3. status[patient] <- ifelse( exit3. time[patient]==L ,0, unique( status[id==i]) ) 
small. group[patient] <- unique(group[id==i]) 
patient <- patient +1 
# END for each individual 
PQAS <- matrix( c( rep(unique(id), 3) , c( exitl. time , exit2. time , exit3. time) , c( 
exitl . status , exit2. status , exit3. status) , rep( 1: 3 , rep( length (unique(id)), 3)) , rep( 
small. group, 3)) , 3*length(unique(id)) ,5, byrow=F , dimnames=list( NULL , 
c('id', 'survival', ' status', 'state', 'group' )) ) 
# Returns the result which is the time spent in each qol state for each subject 
PQAS 
)# END PQASTIME. f 
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A3.3.5 G1AS. f 
QAS. f <- function( survival , status, state=rep( 1, length(survival) ), plotit=F , 
L=max(survival) , leg=NULL, ... 
){ 
# Check the graphics device is active 
if (plotit) 
par( cex=1 
# Set up the variables to be calculated 
nstate <- length( unique(state) ) 
survival <- ifelse( survival>L ,L, survival 
) 
if ( min(state)==0 ) 
state <- state+1 
mean. surv <- matrix( 0,1, nstate+1 ,F, 
list( NULL , c( paste('state' , 1: nstate , sep=" ) 
, 'survival' )) ) 
# Calculate the area under the survival curve for each state 
for( i in 1: nstate ){ 
fit <- surv. fit( survival[state == I] , status[state == 
i] ) 
area <- numeric( length(fit$time) ) 
area[1] <- fit$time[1] 
for (i in 2: length(fit$time) ) 
area[iJ <- ( fit$time[i] - fit$time[i-1] )' fit$surv[i-1] 
# Stops missing being generated when no time is spent in a state 
mean. surv[, i] <- ifelse( lis. na( sum(area)) , sum(area), 0) 
}# END estimation for each state 
# Plot the estimated survival curves If requested 
if ( plotit )( 
fit <- surv. fit( survival, status, state, ) 
plot( fit, Ity = rep(1, nstate) , xlim=c(O, L) , ... ) 
abline( v=L, Ity = 2) 
}# END plotting 
# If only one state, return the area under the survival curve otherwise calculate the areas 
within each state 
if ( nstate == 1) 
return(mean. surv[, 1 ]) 
else { 
mean. surv[, nstate+l] <- mean. surv[, nstate] 
for (i in nstate: 2 ) 
mean. surv[, i] <- mean. surv[, i] - mean. surv[, i-t] 
return(mean. surv) 
} 
}# END function OAS. f 
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A3.3.6 glas. f 
glas. f <- function( sam, qt, times , survival, status , comment=F, summary=T, 
id=NULL, 
method )( 
cat('. ') 
# Qt gives the mean survival of people alive at each of the specified time intervals given by 
the mean qt for each day 
if (comment ) 
cat('\n Estimating Qt ... 
\n') 
if ( method == 'mean' ) 
Qt <- apply( qt[, sam] ,1, mean , na. rm=T 
) 
else{ 
tempx <- split( qt[, 1 ], id ) 
tempy <- split( qt[, 21, id ) 
y <- numeric(O); x <- numeric(O) 
for (i in 1: Iength(sam) )( 
y<-c(y, tempy[[i]]) 
x<-c(xtempx[[i]]) 
} 
x <- x[! is. na(y)]; y <- y[! is. na(y)] 
y <- y[! is. na(x)]; x <- x[! is. na(x)] 
y <- y[order(x)]; x <- x[order(x)] 
if ( method =='smooth')( 
Qt<-Iowess(x, y) 
times <- Qt[[1 ]] 
Qt <- Qt[[2]] 
}# END if smooth 
else { 
beta <- sum( (x-mean(x)) ` (y-mean(y))) / sum( (x-mean(x))A2 ) 
alpha <- mean(y) - (beta*mean(x)) 
Qt <- alpha + (beta*x) 
times <- x 
}# END linear 
}# END method 1='mean' 
m <- length( times ) 
# St gives the probabilities for each group for each day 
if (comment) 
cat('\n Estimating St ... \n') 
St <- numeric( m) 
surv <- surv. fit( survival[sam] , status[sam] ) for (j in 1: m){ 
the. prob <- surv$surv[ surv$time== max(surv$time[ surv$time<times[j] ]) ] 
St[j] <- ifelse(length(the. prob)==1, the. prob, 1) 
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}# END of survival estimation 
# Return all the results 
if ( ! summary ) 
return( cbind('Time'=times , 'Qt'=Qt , 'St'=St , 'QSt'=Qt*St) ) 
# Or just a summary 
return( cbind('Time'=times , 'QSt'=Qt*St) 
) 
}# END function glas. f 
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A3.3.7 AUC. f 
AUC. f <- function(y, cummulative = F)( 
#y is a nx2 vector 
#M is the number of time points 
M <- nrow(y) 
x <- y[, 2]: y <- y[, 1 ] 
# area is a containing the area in each segment 
area <- numeric(M - 1) 
for( j in 1: (M - 1)) 
area[j] <- (x[j + 1] - x[j]) * mean(c(y[j + 1], y[j]), na. rm = T) 
# cummulative is an indicator whether the cummulative sum or sum is given 
if(cummulative == T) 
return(cumsum(c(O, area))) 
else 
return(sum(area, na. rm = T)) 
}# END function AUC. f 
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